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Abstract
In mammalian development, a single fertilized egg grows into a complex organism, comprised of
organs and tissues made up of hundreds of different specialized cell types. All of these cells
contain the same genome, but express distinct sets of genes and proteins, which give the cells
their specialized functions. Understanding how this process occurs is one of the fundamental
goals of biology.
Research using new technology for high-resolution genome-wide location analysis and gene
expression profiling has allowed characterization of the transcriptional regulatory circuitry of
cells in unprecedented detail. From this research emerges an improved understanding of how
these cells work, how they malfunction in disease, and several general principles. This thesis
describes several studies designed to understand the transcriptional regulatory circuitry of three
different medically important cell types; embryonic stem cells, regulatory T cells and MLL
leukemia cells.
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Chapter 1
Introduction: Transcriptional Regulatory Circuitry and Genomic Analysis
Abstract
Understanding how genes are selectively transcribed to generate cell type specific expression
programs is one of the fundamental goals of biology. New technology for high-resolution
genome-wide location analysis and gene expression profiling has begun to allow the
characterization of the transcriptional regulatory circuitry of several medically important cell
types in unprecedented detail. From this research is emerging an improved understanding of
how these cells work, how they malfunction in disease, and several general themes. In this
introduction, I briefly describe how transcription factors and chromatin regulators contribute to
the control of gene expression programs. I then describe the key types of high-throughput data
that are being used to investigate transcriptional control and focus the remainder of the chapter
on proper analysis of such genomic data.
Transcriptional Regulatory Circuitry
In mammalian development, a single fertilized egg grows into a complex organism, comprised of
organs and tissues made up of hundreds of different specialized cell types. All of these cells
contain the same genome, but express distinct sets of genes and proteins, which give the cells
their specialized functions. Understanding how this process occurs is one of the fundamental
goals of biology.
Cells use an array of biochemical mechanisms to control their gene expression programs
and, of these, the action of transcription factors and chromatin regulators is especially important.
These proteins physically interact with the genome and regulate transcription by modulating the
activity of various components of the transcriptional apparatus. By interacting differently with
different portions of the genome, they promote the expression of a subset set of genes at
appropriate levels and the repression of others. Furthermore, they provide a means for cells to
maintain gene expression programs over time and through cell division. We call the collection
of these elements, working together to control gene expression and cell state, the transcriptional
regulatory circuitry of the cell (Figure 1).
Developing new means to treat human disease is a constant beacon for biology research.
Understanding the transcriptional regulatory circuitry that controls cell type will play an
increasingly important role in developing new treatments for human disease. It is likely that
defects in normal regulatory circuitry are the cause of a subset of common human diseases, so
detailed knowledge of the circuitry of these diseased cells should help researchers to understand
the molecular underpinnings of disease.
Environmental Stimulus
Signal Transduction
Chromatin
Regulators
Transcription
Factors
miRNA
Global Gene Expression
Figure 1. Model of transcriptional regulatory circuitry
A schematic showing the hypothetical circuitry that connects signal transduction pathways,
transcription factors (blue circles), chromatin regulators (green circles), and their target genes
(orange rectangles) to form transcriptional regulatory circuitry (Jaenisch and Young 2008).
Figure 1
Transcription Factors
Early studies of the E. coli lac operon (Jacob and Monod 1961) are fundamental to our current
understanding how transcription is regulated by the action of transcription factors (TFs). In the
absence of lactose molecules, transcription of the lac operon is turned off by the Lac repressor
transcription factor. This protein binds to a specific DNA sequence that occurs close to the
transcription start site of the lac operon. When bound to this DNA element, the Lac repressor
interacts with RNA polymerase, preventing productive transcription. Lactose molecules, if
present, bind to the Lac repressor protein with high affinity, altering its conformation and
abolishing its ability to bind to DNA, thereby promoting transcription of the lac operon. Later
experiments in yeast showed how, in eukaryotes, a single TF species can regulate many genes
and control an entire gene expression program (Giniger et al. 1985; Harbison et al. 2004). Since
TFs can regulate the expression of many genes, in multicellular organisms they provide a
powerful mechanism for enabling cell type specific gene expression programs.
Work in Drosophila melanogaster examining the function of the bithorax gene cluster
demonstrated that cells contain genes that govern cell type during development (Lewis 1963;
Lewis 1978). Homeotic mutations such as the famous Antennapedia mutant, in which a fly's
normal antennae are replaced by a pair of legs, are caused by defects in these genes (Figure 2).
In the 1980s it was discovered that the genes within the bithorax gene cluster encode homeobox
TFs and that, remarkably, the homeobox genes clusters are conserved from flies to humans
(Figure 3) (McGinnis et al. 1984; Scott and Weiner 1984; McGinnis and Krumlauf 1992; Hughes
and Kaufman 2002). Thus, homeobox TFs govern cell type by enacting cell type specific gene
expression programs. For most well characterized cell types, a small set of TFs are key to those
cells' transcriptional regulatory circuitry and define their developmental state. We call these the
master regulator TFs of that cell type.
Figure 2
Figure 2. The phenotype of the Drosophila Antennapedia mutant
The head of a wild-type fly (left) is shown in comparison to the head of an Antennapedia mutant
fly (right), demonstrating a homeotic transformation of antennae into ectopic legs (Turner and
Mahowald 1979).
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Figure 3. Hox gene clusters are conserved through deuterostomes
The evolutionary relationships between deuterostome clades, the genomic organization of the
Hox cluster(s), and the anatomical expression patterns of the Hox genes are shown. There are
eight Hox gene clusters in teleost fishes, four Hox gene clusters in tetrapod vertebrates, and a
single cluster in invertebrates. In many species the Hox gene clusters are broken up onto two
chromosomes (Swalla 2006).
Figure 3
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Another early example of the power of a master regulator TF to control cell type was the
demonstration that mouse fibroblast cells could be converted into myoblast cells by the ectopic
expression of the gene encoding the transcription factor MyoD1 (Davis et al. 1987). It has since
been shown that the MyoD 1 TF can mediate trans-differentiation to generate myoblast cells from
many, but not all, starting cell types in several species including human (Weintraub et al. 1991).
The MyoD1 protein has been so highly conserved through evolution that the mouse protein can
effectively substitute for the human protein (Weintraub 1993). Deficiencies in the function of
MyoD1 and the partially redundant TF Myf5 result in failure to develop muscle cells (Rudnicki
et al. 1993), and MyoD1 is required for several cell types that occur sequentially during muscle
development (Buckingham et al. 2003).
The MyoD 1 transcription factor occupies many thousands of binding sites throughout the
genome in myoblast cells (Cao et al. 2010). These sites contain the specific DNA motif that is
bound by MyoD1, these motifs are significantly more conserved than neighboring sequences,
and are also significantly more conserved than instances of the same sequence that are not
occupied by MyoDI (Cao et al. 2010). MyoD1 tends to occupy gene promoter regions and is
biased towards genes that are expressed in muscle cells. It is even more strongly biased towards
genes that are specifically expressed in muscle cells, but not other cell types (Cao et al. 2010).
Lastly, ectopic expression of MyoD1 in ES cells results in MyoD1 occupying a large fraction of
the sites it occupied in muscle cells and promotes some parts of the muscle cell gene expression
program (Nishiyama et al. 2009).
The role of MyoD1 in the transcriptional regulatory circuitry of myoblast cells
demonstrates several general themes in the control of regulatory circuitry by master regulator
TFs. These properties are not necessarily true of all master regulator TFs, but do serve as useful
guides. Briefly, they are summarized as follows: 1) Master regulator TFs are usually necessary
for the proper development of the cells that they specify and can be sufficient to induce trans-
differentiation. 2) Master regulator TFs frequently specify several cell types that occur
sequentially during development. 3) Master regulator TFs are highly conserved through
evolution in terms of the cell types that they control, their protein structure, and the DNA motifs
to which they bind. 4) Master regulator TFs bind to thousands of sites in the genome,
particularly in gene promoter regions, and these sites are more likely to be conserved than
surrounding sequences. 5) The genes that are targeted by master regulator TFs are enriched in
genes that are actively expressed and highly enriched in genes which are expressed specifically
in that cell type.
The example of MyoD 1 was the first demonstration of TF mediated trans-differentiation,
but subsequently, numerous additional examples of this phenomenon have been reported. For
example, adipocyte cells can be created from several cell types including fibroblast cells using
the TF PPAR-gamma-2 (Tontonoz et al. 1994). Macrophage cells can be created from fibroblast
cells using the TFs PU. 1 and CEBP-alpha or CEBP-beta (Feng et al. 2008). Finally, the creation
of induced pluripotent stem cells (iPS) cells using several different sets of TFs, including Oct4,
Sox2, and Nanog demonstrate the power of TFs to control cell type and even force
reprogramming through transitions between cell types that are far from each other in
development (Takahashi and Yamanaka 2006; Takahashi et al. 2007; Wernig et al. 2007; Yu et
al. 2007).
DNA-binding transcription factors are the largest single class of proteins encoded in the
human genome, representing approximately 10% of all protein-coding genes (Lander et al. 2001;
Levine and Tjian 2003; Babu et al. 2004). The DNA binding specificities for a large portion of
these genes have been determined in vitro via protein binding microarray (Badis et al. 2009), and
the precise DNA elements that are bound in vivo have been determined for several transcription
factors with ChIP-Seq experiments (Barski et al. 2007; Robertson et al. 2007; Marson et al.
2008). Understanding the global role of transcription factors in controlling the transcriptional
regulatory circuitry of every cell cell types is an important goal for biology and medicine.
Chromatin Regulators
Another key molecular mechanism that cells use to control cell type specific gene expression
programs is the regulation of chromatin state. In mammalian cells, DNA exists together in
physical complexes with an array of proteins that together make up chromatin. The majority of
these proteins are histones, which form an octameric nucleosome core particle, wrapping 147
base pairs of DNA around their protein spool (Olins and Olins 1974; Finch and Klug 1976;
McGhee and Felsenfeld 1980; Luger et al. 1997; Davey et al. 2002). Nucleosomes physically
compact DNA and are also fundamentally important in the regulation of transcription (Li et al.
2007). Genomic regions that are densely populated by nucleosomes tend to be less
transcriptionally active than regions that have lower nucleosome density (Knezetic and Luse
1986; Gilbert et al. 2004). Nucleosomes are generally displaced from active transcription start
sites, and the presence of transcription factors and the transcriptional machinery can influence
local nucleosome positioning (Bernstein et al. 2004; Yuan et al. 2005; Segal et al. 2006; Mavrich
et al. 2008; Schones et al. 2008; Tirosh and Barkai 2008; Jiang and Pugh 2009).
Chromatin regulators can be subdivided into two general classes. The first, chromatin
remodeling complexes, can add, move, or remove nucleosomes from DNA, which can enhance
or reduce access to specific DNA sequences by transcription factors or affect mobility of the
transcription apparatus with consequent effects on gene activity (Tsukiyama et al. 1994; Causton
et al. 2001; Narlikar et al. 2002; de la Serna et al. 2006; Segal et al. 2006; Schones et al. 2008;
Ho and Crabtree 2010). Additionally, chromatin remodeling complexes can introduce variant
histones into chromatin as a means to regulate transcription (Ahmad and Henikoff 2002;
Mizuguchi et al. 2004).
The second class of chromatin state regulators are the histone modifying enzymes, which
catalyze the chemical modification (methylation, actelyation, phosphorylation, ubiquitinization,
sumolyation) of specific residues (lysine, serine, arginine) in the tails of histones (Phillips 1963;
Brownell et al. 1996; Ogryzko et al. 1996; Strahl and Allis 2000; Jenuwein and Allis 2001;
Pokholok et al. 2005). There are also histone modifying enzymes that catalyze the removal of
many of these modifications (Nagy et al. 1997; Jones et al. 1998; Nan et al. 1998; Agger et al.
2008). Modification of histones can create binding sites that recruit certain transcriptional
regulators and abolish binding sites for others. For example, the acetylation of lysine residues
forms binding sites for proteins that contain bromodomains (Haynes et al. 1992; Dhalluin et al.
1999; Mujtaba et al. 2007) and methylation of the same lysine residues forms binding sites for
proteins that contain chromodomains (Pearce et al. 1992; Ekwall et al. 1995; Fischle et al. 2003).
Additionally, chemical modification of histone tails can alter their charge or steric properties and
modify their interaction with DNA (Schiessel 2003; Korolev et al. 2006).
Many histone modifications are associated with local gene activation or repression and
with specific portions of gene bodies. For example, H3K4me3 modified nucleosomes occur at
the start site of genes that experience transcriptional initiation (Guenther et al. 2007).
H3K79me2 modified nucleosomes occur in the first exon and intron of genes that are being
actively transcribed (Marson et al. 2008) while H3K36me3 modified nucleosomes occur from
the second exon to the end of the transcribed region (Mikkelsen et al. 2007). H3K27me3 and
H2AK 119ub modified nucleosomes are associated with transcriptional repression and occur in
broad domains at the promoters of genes encoding key regulators of development (Ku et al.
2008). Most chromatin regulators do not have DNA sequence specific binding properties and
are recruited to specific sites in the genome by transcription factors, components of the
transcription apparatus, or non-coding RNA species. Consequently, understanding how key
chromatin regulators are recruited to their genomic targets is an area of active research.
Genomic Experiments and Analysis
Since the advent of DNA sequencing technologies in the 1980s, the adoption of the microarray in
the 1990s, and high throughput sequencing in this decade, new genomic technologies have
allowed biology researchers to generate unprecedented quantities of data about their systems of
interest. Unfortunately, in many cases, these data have not been fully exploited, in large part due
to a lack of expertise in dealing with genomic datasets. Genomic experiments produce large and
complex datasets and there are many different ways to analyze this data. The methods that are
used often have a critical impact on the ability to gain biological insight from the data.
Furthermore, technology in this area is rapidly changing, so developing and employing the best
possible data analysis methods is a constant challenge. Indeed, the development of new data
analysis techniques was crucial to the discoveries that are described in this thesis.
In the research conducted in the Young lab, there are two principle experimental
techniques that we rely upon to quantify the state of cells. The first, chromatin-
immunoprecipitation (ChIP) based location analysis experiments, allow the identification the
genomic sites occupied by a TF, chromatin regulator, or histone modification (Ren et al. 2000;
Farnham 2009). The second, RNA expression analysis experiments, allow the simultaneous
quantification of the transcription level of every gene in the genome.
In ChIP experiments, cells are crosslinked to chemically attach proteins to DNA, lysed,
and then sonicated to break the DNA into small fragments. Subsequently, a specific antibody is
used to immunoprecipitate the protein of interest, coupled with the DNA to which it was bound.
This DNA is then assayed to determine the regions of the genome that were occupied by the
protein. When the work described in this thesis was begun, our laboratory used microarrays
(ChIP-chip) to assay immunoprecipitated material from location analysis experiments (Lee et al.
2006). In 2007, the ChIP-Seq method was developed. ChIP-Seq uses high throughput
sequencing to assay ChIP material and offers genome-wide coverage as well as improved
sensitivity and specificity, as compared with ChIP-chip (Barski et al. 2007; Mardis 2007;
Robertson et al. 2007; Park 2009; Hawkins et al. 2010).
The other experimental technique that we rely upon heavily is RNA expression analysis.
As with location analysis, microarrays had been used as the principle means to assay RNA
abundance in RNA expression analysis. In these experiments RNA is isolated from a sample of
interest, converted into cDNA, labeled, and hybridized to a microarray which contains DNA
probes that are complementary to every gene. Probes that match highly transcribed genes will
have a bright signal when the microarray is scanned while probes that match genes which are not
transcribed will not light up. Just as in location analysis, high-throughput sequencing has
supplanted microarrays as a means to assay the genomic material for RNA expression analysis as
well (Mortazavi et al. 2008; Nagalakshmi et al. 2008). The RNA-Seq method allows accurate
quantification of RNA species and yields much more information about RNA splicing and novel
transcripts than microarray based gene expression experiments (Hawkins et al. 2010).
Both location analysis experiments and RNA expression experiments produce large and
complex datasets, and the choice of analysis methods has important implications in the
interpretation of the results of these experiments. In the remainder of this introductory chapter, I
will highlight some of the key features of the analysis of genomic data.
First, it is important to understand the structure of a genomic dataset. The results of a
single genomic experiment can usually be described as a vector. This vector contains the values
obtained for a large number of measurements made in parallel on a single sample. For RNA
expression experiments each row corresponds to the measured RNA expression level of a single
species of RNA. For location analysis experiments each row corresponds to the measured
occupancy level of a protein of interest at a single position in the genome. A typical gene
expression experiment measures the expression of between 10 and 100 thousand genes, while a
typical ChIP-Seq location analysis experiment measures the genomic occupancy at between 10
and 100 million positions in the genome. A genomic dataset, containing the results for multiple
samples can be described as a matrix. It is important to note that since both gene expression data
and location analysis data have a similar structure, many of the same analytic methods can be
used for each.
A second key feature of genomic data analysis is sample normalization. This is used to
make to signal values from different samples in a genomic dataset as comparable as possible.
Consider the following example in which three gene expression samples are being compared.
The first sample has a minimum signal of 3 units, a median signal of 213 units, and a maximum
signal of 25,123 units. The second sample has a minimum of 11, a median of 872, and a
maximum of 75,824. The third sample has a minimum of 52, a median of 541, and a maximum
of 60,996. In this example, if one wanted to compare data from these three samples, it would be
difficult, because each sample has a different range of values.
One of the best methods for sample normalization is quantile or rank normalization
which was described by Bolstad et al. (Bolstad et al. 2003). In quantile normalization, the row in
each dataset with the greatest signal is identified. The average of these values is calculated and
then the greatest signal in each dataset is replaced with that average. This is repeated for the
second greatest signal in each dataset, then third greatest signal in each dataset, and continues to
the lowest signal in each dataset. If two or more rows are tied then each is given the mean of the
set of ranks that the tied genes span. In the preceding example, after quantile normalization each
sample would have a minimum signal of 22 units, a median signal of 512 units, and a maximum
signal of 53,981 units. The result of quantile normalization is that each sample now the same
range of signal values and the samples are maximally comparable.
Two other common methods for sample normalization are linear scaling and locally
weighted scatterplot smoothing (LOESS) (Cleveland 1979; Smyth and Speed 2003). When
compared with linear scaling methods, quantile normalization does a much better job of
normalization over the full range of signal values, while remaining computationally simple.
When compared with LOESS methods, quantile normalization does a similar job of
normalization, and it is computationally much simpler (Bolstad et al. 2003). It the analysis of
genomic data, all things being equal, simpler is better. In my experience, it is generally a
mistake to use complicated analysis methods to derive a result, when simpler methods would be
adequate.
A third key feature of genomic data analysis is using an analysis of variance framework
(ANOVA) for identifying statically significant differences between the values of a measurement
for two or more groups of samples (Kerr et al. 2000; Wolfinger et al. 2001; Cui and Churchill
2003). ANOVA can be used to answer the question "Are two sets of measurements different
from each other?" Consider the following example (Example #1) of the values of a single gene
expression measurement made in two groups of samples:
Example #1:
Group 1: 2,036, 1,559, 2,124, 1,946, and 1,477
Group 2: 4,876, 3,538, 4,381, 4,315, and 3,879
In this example, it looks like the measurements here are pretty different, but how do we know?
Analysis of variance allows us to answer this question.
The basic principle behind ANOVA is a signal to noise calculation. For an ANOVA test
we calculate a t score which is the difference between the means of two set of measurements
divided by the standard error of those measurements, which is a function of the variability
occurring within each of the groups. This t score is then used to calculate a P value, which is the
probability of observing a given t score if there were truly no difference between the two groups.
In Example #1 the mean of the measurements in group 1 is about 1,800 with a standard
deviation of about 300 and in the measurements in group 2 average about 4,100 with a standard
deviation of about 500. If you plug those values into the ANOVA formula, you get a t score of a
little more than 10, which corresponds to a P value of 1 in a million. So, the probability of
observing this large a difference between the two groups of measurements if there were truly no
underlying difference between the two groups is about one in a million. So, for this example,
ANOVA tells us that there is a statistically significant difference between these two groups.
A fourth key feature of genomic data analysis is correcting for multiple hypothesis
testing. This is an important adjustment that must be made to significance levels in a genomic
experiment to account for the large number of statistical tests that are being performed. Consider
the following example (Example #2):
Example #2
Group 1: 1,215, 1,476, 1,187, 1,212, 1,368, and 1,092
Group 2: 1,814, 19,964, 1,735, 1,327, 1,840, and 1,537
When one performs the ANOVA calculations on this data it can be determined that the
measurements of from these two groups of samples are different from each other at a
significance level of .002, or 2 in 1,000. At first glance it seems like the statistics indicate that
this is a significant difference. You have to take into account however, that you are doing a large
number of statistical tests, so making a 2 in 1,000 observation is going to happen frequently. For
example, in a gene expression experiment, you might measure the expression level of 50,000
genes. Even if there is no difference between the two groups of samples, 2 out of 1,000 genes
will have a P value of .002 or less at random. Thus, we would expect that 100 genes in the
dataset would be false positives at a P value of .002.
Benjamini and Hochberg proposed a method to account for this issue and translate P
values into more meaningful False Discovery Rates (Benjamini and Hochberg 1995). The False
Discovery Rate associated with a given P value is the overall expected false positive rate at that
P value across the entire dataset. Thus if 200 genes in this experiment were significant at P less
than .002, then this would correspond to a false discovery rate of 50%. If 2,000 genes were
significant at a P value of less than .002, then this would correspond to a false discovery rate of
5%.
The fifth and final key feature of genomic data analysis that I want to highlight is
measurement error estimation. This serves to avoid false positives that are caused by spuriously
small variability in small numbers of measurements. Consider the following example
(Example#3):
Example #3
Group 1: 1,223, 1,212, 1,204, 1,198, 1,206, and 1,205
Group 2: 1,246, 1,250, 1,248, 1,237, 1,242, and 1,240
In this example the difference between the means of the two groups of samples is quite small, but
the standard deviation of the measurements within each group even smaller. Since the difference
between the means of the two groups is much larger than then the variability within the groups,
the t score is quite high and the P value is very low. In reality we know that our measurements
are not this precise and that if we made these measurements again, we would be extremely
unlikely to observe the same results. This is not a gene that we believe to have a meaningful
difference between the two groups of samples, but since the ANOVA calculations are based only
on this small set of measurements, this gene would be called significant.
The typical error of a gene expression measurement is determined in large part by the
overall signal intensity of the measurement. This is evident from a plot of the standard deviation
of a gene expression measurement as a function of signal intensity (Figure 4). We see here that a
measurement of approximately 1,000 units should have a standard deviation of at least 100 units.
Baldi and Long proposed a method that would incorporate our knowledge about
measurement error into ANOVA calculations (Baldi and Long 2001; Long et al. 2001). A
normal ANOVA uses the stand error from the actual measurements as the denominator in the t
score calculation. The method of Baldi and Long replaces this value with an estimate of
measurement error. The estimate is created by combining information from the actual error of
the measurements and a model of the error based on the signal intensity of the measurement.
This adjustment in ANOVA calculations results in data behaving like those from Example #3 no
longer being called statistically significant.
To do a statistical analysis on gene expression data using the framework that I just
described, there are several online tools such as the NIA array analysis tool
(http://lgsun.grc.nia.nih.gov/ANOVA/; Sharov et al. 2005), which I use, or cyber-T
(http://cybert.ics.uci.edu/). To conduct this analysis with ChIP-Seq data there are no tools
available. Consequently, I developed a set of code, written in the python language, to implement
these statistical methods for the analysis of ChIP-Seq data.
Since the form of ChIP-Seq data is similar to gene expression data, it is useful to
repurpose algorithms from gene expression analysis for ChIP-Seq. In ChIP-Seq data, each of the
principles that were outlined above are applicable. 1) ChIP-Seq data takes the form of a matrix.
2) Quantile normalization does a good job at sample normalization for ChIP-Seq data, and its
computational simplicity is nice since ChIP-Seq datasets are so much larger than gene expression
datasets. 3) An ANOVA framework is a logical choice for asking the question, "What regions
show statistically significant differences in ChIP-Seq density between two groups of samples?"
4) A multiple hypothesis testing correction is extremely important for the statistical analysis of
ChIP-Seq data, since millions of statistical test are performed. 5) Measurement error estimation
is extremely useful in the analysis of ChIP-Seq data because measurement error can be
accurately modeled as a function of signal intensity, because current experiments typically
contain only a small number of samples, and because analysis of ChIP-Seq data requires making
million of statistical tests, so there are many opportunities for spuriously small measurement
error.
Figure 4
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Figure 4. Measurement error in gene expression experiments is a function of signal
intensity.
The standard deviation of replicate gene expression measurements was plotted against the
average signal of those measurements. Data shown are from experiments performed using
Affymetrix GeneChip microarrays.
When our laboratory initially began doing ChIP-Seq experiments there was extremely
limited software available for analysis of the resulting data. Consequently, I developed a set of
code, written in the Python language (www.python.org), to analyze our ChIP-Seq data. I have
improved and expanded the code over time, as new functionalities were required, to best address
the analytic needs of the lab's experimental questions. This program now has many functions
including the ability to: 1) identify ChIP enriched genomic regions using background correction,
2) map enriched regions to genes, 3) output DNA sequences for motif discovery, 4) analyze
evolutionary conservation of enriched regions, 5) make genome browser track files, 6) make
heatmap and clustergram outputs, 7) filter input reads, 8) normalize multiple ChIP-Seq datasets
and 9) identify statistically significant differences between ChIP-Seq datasets using an ANOVA
framework with measurement error estimation and multiple hypothesis testing corrections. So
far, the program has been used by more than 40 researchers in 15 laboratories. Although there
have been many ChIP-Seq analysis software packages published (Fejes et al. 2008; Ji et al. 2008;
Zhang et al. 2008; Rozowsky et al. 2009), the vast majority of researchers at the Whitehead
Institute who are doing ChIP-Seq experiments are using the code I developed for analysis.
Research Summary
In graduate school, I have collaborated with wet lab researchers to best utilize the power of
genomics to try to answer some of the most important questions that are currently facing biology.
My principle research aim has been to develop and employ new algorithms, analytic methods,
and presentation techniques to best understand the results of genomic experiments. I have also
worked to create tools that will allow biologists to examine their own datasets and to teach them
how to use the suite of tools that I employ. My work has focused on understanding the
regulatory mechanisms that cells use to control cell type specific gene expression programs.
Chapter 2 describes research investigating whether induced pluripotent stem (iPS) cells
are an equivalent cell type to embryonic stem (ES) cells. Recent studies have suggested that ES
and iPS cells represent different pluripotent states with substantially different gene expression
programs. We compared global chromatin structure and gene expression data for a panel of
human ES and iPS cells. We found that while there may be small differences in chromatin state
and gene expression between various pluripotent cell lines, there is no consistent signature
separating iPS cells from ES cells. I originated this project, developed new methods for
normalizing and comparing ChIP-Seq datasets in an ANOVA framework and performed all data
analysis. In addition, I wrote the manuscript and was responsible for supplemental materials and
figure generation.
Chapter 3 describes research integrating miRNAs into expanded models of the regulatory
circuitry of ES cells. We developed a new map of the transcriptional regulatory circuitry of ES
cells that incorporates both protein-coding and miRNA genes, and which is based on high-
resolution ChIP-seq data, systematic identification of miRNA promoters, and quantitative
sequencing of short transcripts in multiple cell types. We found that the key ES cell
transcription factors are associated with promoters for most miRNAs that are preferentially
expressed in ES cells and with promoters for a set of silent miRNA genes. For this work, I
developed new methods and code for ChIP-Seq analysis and performed all data analysis. In
addition, I wrote the manuscript and supplemental materials and generated all figures.
Chapter 4 describes a study designed to elucidate the role of the transcription factor
Foxp3 in the transcriptional regulatory circuitry of regulatory T (Treg) cells. This sub-population
of helper T cells is essential for the prevention of autoimmunity because they can suppress the
proliferation and effector function of neighboring T cells. The forkhead transcription factor
Foxp3 is required for Treg development and function, and is sufficient to induce a Treg phenotype
in conventional helper T cells. Prior to our study the global set of genes regulated directly by
Foxp3 was not known. Consequently, how this transcription factor controls the Treg gene
expression program was not understood. We identified the genome-wide targets of Foxp3 and
report that many of these are key modulators of T cell activation and function. Remarkably, the
predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of
target genes on T cell stimulation. My contribution to this project included writing the
manuscript and supplemental materials, figure generation, and data analysis.
Chapter 5 describes research into how MLL fusion proteins corrupt the regulatory
circuitry of hematopoietic cells to generate leukemia. We show that the MLL-AF4 fusion
protein occupies developmental regulatory genes important for hematopoietic stem cell identity
and self-renewal in human leukemia cells, and these regions have grossly altered chromatin
structure. Our results define the direct targets of the MLL fusion protein, reveal the global role
of epigenetic misregulation in leukemia, and identify new targets for therapeutic intervention in
cancer. For this project I developed new methods for ChIP-Seq data analysis and performed all
data analysis. In addition, I wrote the manuscript and supplemental materials and was
responsible for all figure generation.
Chapter 6 describes an examination of the relationship between CpG islands and
Polycomb (H3K27me3) and Trithorax (H3K4me3) mediated chromatin modifications. The
action of these chromatin modifying complexes is vitally important for the control of cell type
during development, but how they are targeted to their sites of action is unknown. We report
that in pluripotent cells, but not other cell types, H3K4me3 modifications and CpG islands occur
at precisely the same genomic regions. Furthermore, we report that H3K27me3 modifications
occur at gene promoters with multiple CpG islands, but not at promoters with zero or one CpG
island. Lastly, we report that the occupancy of H3K27me3 modifications is consistent with a
model in which PcG proteins are recruited in part by ncRNA species that contain a characteristic
RNA stem loop structure. I originated this project, wrote the manuscript, developed new
computational methods, performed data analysis, and made figures and supplemental materials.
In addition to the work described in this thesis, I have been an integral part of many other
collaborations, which have resulted in several publications (Bilodeau et al. 2009; Bienvenu et al.
2010; Creyghton et al. 2010; Dejosez et al. 2010; Lengner et al. 2010; Novershtern et al. 2011)
and manuscripts in review (Whyte et al. 2010). My major contribution to these projects was the
development and application of genomic data analysis. However, my role also included writing
text, generating figures and tables, preparing supplemental materials, and preparing data for
submission to public repositories.
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Abstract
Knowledge of both the global chromatin structure and the gene expression programs of human
embryonic stem (ES) cells and induced pluripotent stem (iPS) cells should provide a robust
means to assess whether the genomes of these cells have similar pluripotent states. Recent
studies have suggested that ES and iPS cells represent different pluripotent states with
substantially different gene expression profiles. We describe here a comparison of global
chromatin structure and gene expression data for a panel of human ES and iPS cells. Genome-
wide maps of nucleosomes with histone H3K4me3 and H3K27me3 modifications indicate that
there is little difference between ES and iPS cells with respect to these marks. Gene expression
profiles confirm that the transcriptional programs of ES and iPS cells show very few consistent
differences. Although some variation in chromatin structure and gene expression was observed
in these cell lines, these variations did not serve to distinguish ES from iPS cells.
Introduction
Mammalian cells can be directly reprogrammed into induced pluripotent stem (iPS) cells by
introduction of defined sets of transcriptional regulators (Takahashi and Yamanaka, 2006;
Maherali et al., 2007; Nakagawa et al., 2007; Okita et al., 2007; Takahashi et al., 2007; Wernig
et al., 2007; Yu et al., 2007; Aoi et al., 2008). These iPS cells hold great potential for
regenerative medicine because they are similar to pluripotent embryonic stem (ES) cells and can
be derived in a patient-specific manner from adult somatic cells (Yamanaka, 2007; Saha and
Jaenisch, 2009). ES and iPS cells are highly similar in a broad range of phenotypic behaviors,
including cell morphology, expression of pluripotency markers, teratoma formation, ability to
differentiate into germ layers, and tetraploid complementation (Okita et al., 2007; Wernig et al.,
2007; Boland et al., 2009; Kang et al., 2009; Smith et al., 2009; Zhao et al., 2009). However,
recent studies comparing the gene expression profiles of ES cells and iPS cells have suggested
that iPS cells are a unique cellular subtype distinct from ES cells (Chin et al., 2009; Marchetto et
al., 2009) and that iPS cells retain some of the expression program of their cell of origin (Ghosh
et al., 2010). It is important to understand if there are genuine differences in the global
chromatin structure and the gene expression programs of human ES and iPS cells, as such
differences may impact the potential therapeutic use of iPS cells.
Trithorax group (TrxG) and Polycomb group (PcG) protein complexes are key regulators
of chromatin structure that are required for segmental identity in the developing embryo and
contribute to maintenance of the pluripotent ES cell state (Ringrose and Paro, 2004;
Schuettengruber et al., 2007; Pietersen and van Lohuizen, 2008). TrxG complexes catalyze
histone H3 lysine 4 trimethylation (H3K4me3) at promoters of protein-coding genes (Bernstein
et al., 2002; Santos-Rosa et al., 2002; Ng et al., 2003; Schneider et al., 2004; Guenther et al.,
2007; Mikkelsen et al., 2007), miRNA loci (Marson et al., 2008; Ozsolak et al., 2008), and non-
coding lincRNA loci (Guttman et al., 2009). The PcG protein complex PRC2 catalyzes histone
H3 lysine 27 trimethylation (H3K27me3), which contributes to repression of developmental
genes (Schuettengruber et al., 2007; Schwartz and Pirrotta, 2008; Simon and Kingston, 2009).
Histone H3K4me3 and H3K27me3 histone modifications are generally associated with
transcriptionally active and repressed domains of the genome, respectively, although both
modifications can occur at silent genes encoding developmental regulators that are poised for
future activation (Bernstein et al., 2006; Lee et al., 2006; Guenther et al., 2007). Genome-wide
maps of these histone modifications, which produce robust signals in ChIP-Seq experiments, can
be especially useful for comparing transcriptional and developmental states of cells, particularly
when coupled with gene expression profiling.
Microarray based gene expression profiling has proven to be a powerful approach to
characterize the transcriptional state of cells and to identify differences between cells of different
types or states (Ebert and Golub, 2004; Ivanova et al., 2006). Comparing the gene expression
profiles of ES and iPS cells could permit identification of any unique and consistent differences
between these two cell types. However, comparative analysis of expression data can be
challenging due to differences in the homogeneity of cell populations, cell handling, reagents,
and analytical techniques. In comparing the expression profiles of ES and iPS cells, it is
therefore important to use analytical methods that account for the noise in the data and require
reproducible results across multiple experiments (Bammler et al., 2005).
We have investigated whether a panel of human ES cells differ consistently from a panel
of human iPS cells using both genome-wide maps of histone H3K4me3 and H3K27me3
modifications and gene expression analysis. We have also re-analyzed a large collection of
previously published gene expression data using different analysis methods. Our results reveal
that small variations in the chromatin structure or gene expression occur among different ES and
iPS cell lines, but we do not observe a consistent signature that distinguishes iPS cell lines from
ES cell lines when examined after extended culture.
Results and Discussion
Genome-wide maps of chromatin modifications show human iPS cells share key features
with ES cells
We used ChIP-Seq to map H3K4me3 and H3K27me3 occupancy genome-wide in six
independent ES cell lines and six independent iPS cell lines grown under identical conditions
(Figure 1). The ES cells included two male lines (BG01 and WIBRI) and four female lines
(BG03, WIBR2, WIBR3 and WIBR7), each derived from a different donor (Lengner et al.,
2010). The iPS lines were generated from human fibroblasts using a doxycycline-inducible
reprogramming system with OCT4, SOX2 and KLF4 genes (Hockemeyer et al., 2008; Soldner et
al., 2009). Four of the iPS cells were derived from a female donor (iPS Al, iPS Cl, iPS4, and
iPS A6; described and characterized in Hockemeyer et al., 2008) and two from a male donor (iPS
PDB2 ox -17 and iPS PDB 21ox-21; described and characterized in Soldner et al., 2009). All iPS cell
lines contained integrated transgenes, but were doxycycline-independent for growth, indicating
that transgene expression was not required for propagation of these pluripotent cells.
The maps of histone H3K4me3 and H3K27me3 were highly similar at protein coding and
non-coding genes in all 12 ES and iPS cell lines when examined by enrichment profiles (Figure
1 A, 1 C), heat maps (Figure 1 B, 1 D) or inspection of gene tracks (Figure 1 E, 1 F). Nucleosomes
with H3K4me3 occurred at the vast majority of protein-coding genes in both ES and iPS cells
(~85%), with maximal enrichment occurring approximately 200 bp downstream of
transcriptional start sites (Figure 1A, B, E; Table Sl). H3K4me3 modified nucleosomes also
occupied the start sites of known and predicted noncoding RNAs in both cell types, which
include ES cell specific RNAs associated with pluripotency (Marson et al., 2008) (Table Sl).
H3K27me3 modified nucleosomes occurred primarily in the promoters of ~2,000 repressed
genes, many of which encode key regulators of development (Figure 1C, D, F; Table Sl).
H3K27me3 marked small domains (1-5kb) within certain gene promoter regions, and large
domains extending across >100kb of the HOX gene clusters. These results indicate that the
genomes of human iPS cells possess the general features of Trx and PcG -mediated histone
modifications previously described in ES cells (Bernstein et al., 2006; Boyer et al., 2006;
Bracken et al., 2006; Lee et al., 2006; Guenther et al., 2007; Pan et al., 2007; Zhao et al., 2007;
Mikkelsen et al., 2008).
Similarity in genes and regions occupied by modified histones in ES and iPS cells
Inspection of gene tracks revealed some variation in H3K4me3 and H3K27me3
nucleosome occupancy among these cells lines, prompting us to systematically compare the sets
of genes occupied by these histone modifications in each cell line with the set occupied in all
other lines (Figure 2; Supplemental Experimental Procedures). We first performed all pair-wise
comparisons among the ES cell lines and found that 1.4±0.8% of genes had different H3K4me3
occupancy and 5.5+2.0% of genes had different H3K27me3 occupancy. Similarly, 0.7±0.3%
genes varied for H3K4me3 and 6.0±2.6% varied for H3K27me3 among the iPS cell lines.
Pairwise comparison of ES and iPS cell lines revealed that the variation for H3K4me3
(1.3+0.7%) and H3K27me3 (6.0±2.4%) occupied genes was not significantly different than the
variation observed within ES cell lines or within iPS cell lines. In contrast, comparisons of the
genes enriched for H3K4me3 or H3K27me3 between pluripotent cells (ES and iPS cells) and
adult fibroblast cells revealed significantly larger differences (12.3±0.4% for H3K4me3;
67.8+2.8% for H3K27me3) (Figure 2; Table S2). Thus, we observed no more variation between
ES and iPS cells than was evident within the ES cell lines or within the iPS cell lines. We also
examined the magnitude of the ChIP-Seq peaks associated with each gene and again found that
differences between ES and iPS cells were no greater than the differences observed within ES
cell lines and within iPS cell lines (Table S2). These results suggest that there were few, if any,
consistent differences in the set of genes occupied by H3K4me3 or H3K27me3 between these
human ES and iPS cells.
We developed a statistical method (Supplemental Experimental Procedures) to scan the
entire genome and identify regions with significant differential H3K4me3 and H3K27me3
occupancy between ES and iPS cells. To confirm the sensitivity and specificity of this method,
we compared all male ES and iPS lines to all female ES and iPS lines, and found a number of
regions with significant differences in histone modifications, which were located almost
exclusively on the sex chromosomes, as expected (Supplemental Table S3). We then compared
female ES cells to female iPS cells and found that iPS cells showed increased H3K27me3
occupancy relative to ES cells at several X-linked genes including Xist. We believe these
differences in occupancy are likely a consequence of exposing female iPS cells to high oxygen
conditions during derivation, since high oxygen growth conditions induce X-inactivation in
human pluripotent cells (Lengner et al., 2010). To further validate our ability to detect chromatin
differences, we compared all pluripotent cells (ES and iPS cells) to donor fibroblasts, and
observed a large number of regions with differences in histone modifications (Table S3) that
were strongly associated with differences in gene expression (Figure 2B,C).
We then applied this method to identify statistically significant differences in chromatin
structure between ES and iPS cells and found 50 genomic regions (29 genes) with differential
H3K4me3 occupancy and 4 regions (2 genes) with differential H3K27me3 occupancy
(Supplemental Table S3). These regions of differential occupancy represent a tiny fraction of the
genome (0.003%), and although there was no obvious theme associated with them, we
considered several possible causes for the differential modification. First, we investigated if
these differences were due to the presence of exogenous reprogramming factors in iPS cells, but
there were no significant differences in these chromatin modifications between trans-gene
containing and trans-gene excised iPS cells (Table S2; Soldner et al., 2009). Second, we
investigated if the chromatin differences between ES and iPS cells were due to residual
epigenetic signatures left from the parental fibroblast cell line, but found no evidence that iPS
cells contain H3K4me3 or H3K27me3 signatures that reflect their cell of origin (Table S4).
Lastly, we asked if any gene expression changes were associated with differences in histone
modification between ES and iPS cells, but found that this was not the case (Figure Sl). We
conclude that there are a small number of regions in these human ES and iPS cells that show
differences in H3K4me3 and H3K27me3 modified nucleosomes, which involves a small fraction
of the genome and has little or no influence on gene expression. However, we cannot exclude the
possibility that these small chromatin differences observed in undifferentiated cells may exert
subtle effects on cells upon differentiation.
Limited variation in gene expression between human ES and iPS cells
Although the H3K4me3 and H3K27me3 profiles of the human ES and iPS cells were nearly
identical, we investigated the possibility that there were differences in the gene expression
profiles between these ES and iPS cells. All 12 ES and iPS cell lines, in addition to donor
fibroblast cells, were subjected to expression profiling and the data were analyzed using a single-
factor analysis of variance for testing statistical significance with a Bayesian model of
measurement error and a false discovery rate correction for multiple hypothesis testing (Sharov
et al., 2005; Supplemental Experimental Procedures). We found zero genes with statistically
significant differential expression between ES and iPS cells using this method. To gain greater
statistical power to identify small differences in transcript levels between ES and iPS cells, we
included expression datasets from several additional ES and iPS cells lines that were not used in
the chromatin studies and repeated the analysis. In this panel of 39 samples, we found only 4
genes with statistically significant differential expression between ES and iPS cells (Figure 3A,
B; Table S5). These results are consistent with a study that shows the overall mRNA and
microRNA expression patterns of isogenic mouse ES and iPS cells are nearly indistinguishable
within the exception of a few transcripts on chromosome 12qF1 (Stadtfeld et al., 2010).
Previous reports have observed that ES and iPS cells exhibit considerable differences in
gene expression (Chin et al., 2009; Marchetto et al., 2009). To determine if these gene
expression differences were consistently observed in multiple laboratories, we re-examined a
large collection of previously published expression data comparing ES and iPS cells (Table S5)
(Maherali et al., 2008; Chin et al., 2009; Yu et al., 2009). If there were truly consistent gene
expression differences between ES and iPS cells that were not a product of laboratory specific
biases in cell culture conditions, passage number, RNA preparation methods, or data processing
methods, it would be expected that similar sets of genes would be identified as differentially
expressed in more than one of these studies. However, we found that overlap between the genes
identified in each of these studies was extremely low (Figure 3B, D) and conclude that there are
very few, if any, consistent differences in the gene expression programs of ES and iPS cell lines.
In contrast, the differential expression observed between pluripotent (ES and iPS) cell lines and
fibroblast lines was highly reproducible across laboratories (Figure 3C,E; Table S5).
Several studies have described a few hundred to several thousand genes that show
statistically significant differential expression between ES and iPS cells (Chin et al., 2009;
Marchetto et al., 2009; Ghosh et al., 2010). There are several possible reasons why this result
may have been obtained even if there is not, in reality, a unique and consistent expression
signature that distinguishes iPS from ES cells. Cell culture conditions, derivation method,
passaging technique, reagents, amount of time in culture, microarray methods, and operator-
specific microarray assay biases can affect gene expression profiles. It is likely that uncontrolled
variables such as these contributed to the observation of differential gene expression between the
ES and iPS samples, because we observe that ES and iPS cell expression data cluster by
laboratory and not by ES/iPS identity (Figure 4). Our own data indicates that differences in gene
expression do exist between various ES and iPS cell lines, but these differences do not
consistently distinguish iPS cells from ES cells.
Discussion
ES and iPS cells have been shown to share key features of pluripotency, including expression of
pluripotency markers, teratoma formation, cell morphology, ability to differentiate into germ
layers, and tetraploid complementation (Okita et al., 2007; Wernig et al., 2007; Boland et al.,
2009; Kang et al., 2009; Smith et al., 2009; Zhao et al., 2009; Stadtfeld et al., 2010). Human iPS
cells offer great promise for regenerative medicine and the establishment of patient or subgroup-
specific disease models, but some reports suggest that ES and iPS cells may not be equivalent
(Chin et al., 2009; Marchetto et al., 2009; Ghosh et al., 2010). We have mapped two histone
modifications that are critical for cell state and development in human ES and iPS cells and find
a very small number of consistent differences between ES and iPS cells for these marks. These
differences in chromatin structure are not associated with differential gene expression.
Furthermore, the consistent differences between ES and iPS cells are considerably smaller than
the overall variability among these cell lines. In our analysis of gene expression data across
several studies we find that variations in gene expression occur among different ES and iPS cell
lines, but we do not observe a consistent signature that distinguishes iPS cell lines from ES cell
lines.
Previous studies comparing the gene expression profiles of human ES and iPS cells
argued that a recurrent gene expression signature appears in iPS cells regardless of their origin or
the method by which they were generated, and suggested that iPS cells should be considered a
unique subtype of pluripotent cell (Chin et al., 2009). This interpretation is inconsistent with our
own. This discrepancy is likely due to four features of the analytic methods used by Chin et al.
(2009) that, in our view, are key to accurate data interpretation. First, a correction for multiple
hypothesis testing was not used, so the number of statistically significant differentially expressed
genes was greatly over-estimated. Second, there was not a requirement that gene expression
change in the same direction. Third, the same ES cell expression data was compared to both
"early" and "late" passage iPS cells, negating the assumption that these sets of differentially
expressed genes would be independent. Fourth, biases were introduced into the identification of
differentially expressed genes that violate the assumption of independent assortment, which is
relied upon to calculate the statistical significance of gene list overlaps. The use of a fold change
threshold creates a bias towards identifying genes with larger measurement error, and collapsing
measurements for several probesets into a single measurement for each gene could cause some
genes to be more likely identified as differentially expressed across several datasets. In studies
that came to the conclusion that ES and iPS cells have different gene expression signatures (Chin
et al., 2009; Marchetto et al., 2009; Ghosh et al., 2010), we believe uncontrolled laboratory-
specific variables likely contributed to the observation of differential gene expression. When we
repeat the analysis of published data using standard methods, we do not observe significant
overlap between the genes that are differentially expressed between ES and iPS cells across
several laboratories (Figure 3B,C). Instead, we find that ES and iPS cell expression data clusters
more by laboratory than by ES/iPS identity (Figure 4). Similarly, in mouse, most expression
differences between ES and iPS cells are not consistently observed across laboratories and are
likely caused by variations in genetic background or method of iPS cell production (Chin et al.,
2009; Stadtfeld et al., 2010).
In summary, our experiments and analysis do not demonstrate a significant difference
between the H3K4me3 or H3K27me3 modifications or a consistent difference in the gene
expression programs of ES and iPS cells. It is possible that there are small differences between
ES and iPS cells that we lacked the statistical power to observe, or that differences may occur in
non-coding or regulatory RNAs. Additionally, it is possible that there exist important epigenetic
differences between ES and iPS cells that are not reflected in the chromatin marks that we
examined, such as DNA methylation events (Meissner et al., 2008; Doi et al., 2009). These
possible changes in histone modification, DNA methylation or other epigenetic marks may result
in subtle functional differences that could affect differentiation or other cell processes (Feng et
al.; Hu et al., 2010). Nevertheless, our results and the phenotypic similarities shared by ES and
iPS cells (Smith et al., 2009; Zhao et al., 2009), support the view that ES and iPS cells are nearly
identical cell types.
Experimental Procedures
Human ES and iPS cell culture
All primary fibroblast cell lines described in this paper were purchased from the Coriell Cell
Repository (Camden, NJ). Fibroblasts were cultured in fibroblast medium (Dulbecco's modified
Eagle's medium [DMEM] supplemented with 15% fetal bovine serum [FBS; Hyclone], 1 mM
glutamine [Invitrogen], 1% nonessential amino acids [Invitrogen], and penicillin/streptomycin
[Invitrogen]).
hiPS cells iPS Al, iPS Cl, iPS4, iPS A6 (Hockemeyer et al. 2009); hiPS cells iPS PDB 2-17
and iPS PDB 0x-21 (Soldner et al. 2009); hESC lines BG01 and BG03 (National Institutes of
Health code: BG01 and BG03; BresaGen, Inc., Athens, GA); and hESC cell lines WIBRi,
WIBR2, WIBR3, and WIBR7 (Whitehead Institute Center for Human Stem Cell Research)
(Lengner et al., 2010) were maintained on mitomycin C (MMC)-inactivated mouse embryonic
fibroblast feeder layers in hESC medium (DMEM/F12 [Invitrogen] supplemented with 15% FBS
[Hyclone], 5% KnockOut Serum Replacement [Invitrogen], 1 mM glutamine [Invitrogen], 1%
nonessential amino acids [Invitrogen], 0.1 mM p-mercaptoethanol [Sigma], and 4 ng/ml FGF2
[R&D Systems]). Cultures were passaged every 5 to 7 days either manually or enzymatically
with collagenase type IV (Invitrogen; 1.5 mg/ml).
ChIP-Seq
Detailed descriptions of antibodies, antibody specificity, ChIP, and ChIP-Seq analysis methods
used in this study have been published previously and are provided in the Supplemental
Experimental Procedures. The antibodies for ChIP were specific for H3K4me3 (ab8580; Abcam)
and H3K27me3 (ab6002; Abcam). Purified immunoprecipitated DNA was prepared for
sequencing according to a modified version of the Solexa Genomic DNA protocol, applied to a
flow-cell using the Solexa Cluster Station fluidics device, and sequenced according to Illumina's
standard protocols. Images acquired from the Solexa sequencer were processed through the
bundled Solexa image extraction pipeline and aligned to the March 2006 build (NCBI36. 1/hg 18)
of the human genome using Bowtie software (Langmead et al., 2009). Complete ChIP-Seq data
has been submitted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)
database under accession number pending.
Expression analysis
For RNA analysis, hES and hiPS colonies were mechanically isolated and pooled for RNA
extraction. Total RNA was isolated from ES, iPS, and fibroblast cells using RNeasy MiniKit
(Qiagen). 5 microgram of total RNA was labeled according to standard Affymetrix protocols
and hybridized to Affymetrix HG-U133 2.0 plus arrays. The data were analyzed by using
Affymetrix Gene Chip Operating Software using default settings. Complete gene expression
data has been submitted to the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)
database under accession number pending. Expression data was quantile normalized and
analyzed for differential expression using the NIA Array Analysis Tool
(http://lgsun.grc.nia.nih.gov/ANOVA/). A more detailed description of the gene expression
analysis methods is provided in the Supplemental Experimental Procedures.
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Figure 1. Genome-wide maps of chromatin modifications show human iPS cells share key
features with ES cells
A. Composite H3K4me3 enrichment profile for all RefSeq genes in ES cells (solid blue) and iPS
cells (dashed blue). The transcription start site (TSS) and direction of transcription of the average
gene is noted by an arrow.
B. ChIP-Seq density heat map of histone H3K4me3 (blue) for all Refseq genes. Gene order was
determined by highest average ChIP-Seq density in ES cells and arranged from highest to lowest
density. The TSS and direction of transcription of genes is indicated by an arrow and the
genomic region from -4.5kb to +4.5kb relative to the TSS shown.
C. Composite H3K27me3 enrichment profile for all RefSeq genes enriched for H3K27me3 in ES
cells (solid green) and iPS cells (dashed green). The TSS and direction of transcription of the
average gene is noted by an arrow.
D. ChIP-Seq density heat map of histone H3K27me3 (green) for all RefSeq genes. Gene order
was determined by highest average ChIP-Seq density in ES cells and arranged from highest to
lowest density. The TSS and direction of transcription of genes is indicated by an arrow and the
genomic region from -4.5kb to +4.5kb relative to the TSS shown.
E. ChIP-Seq density for H3K4me3 (blue) at the OCT4 locus in human ES, iPS, and fibroblast
cell lines. The position of the loci within chromosome 6 and the scale is shown above the gene
tracks.
F. ChIP-Seq density for H3K27me3 (green) in the HOXA cluster in human ES, iPS, and
fibroblast cell lines. The position of the cluster within chromosome 7 and the scale is shown
above the gene tracks. See also Tables Sl-S4.
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Figure 2. Similarity in genes and regions occupied by modified histones in ES and iPS cells
A. Pairwise comparisons of genes occupied by H3K4me3 in ES, iPS, and fibroblast cells. Each
blue bar represents an individual pairwise comparison of the set of genes identified as enriched
in one cell line with the set enriched in a second cell line. Comparisons between two ES lines
(ES vs ES), between two iPS lines (iPS vs iPS), between an ES line and an iPS line (ES vs iPS),
and between an ES or iPS line and fibroblast cells (ES/iPS vs fibroblast) are shown in separate
columns. Gene occupancy was determined as described in Supplemental Experimental
Procedures.
B. Pairwise comparisons of genes occupied by H3K27me3 in ES, iPS, and fibroblast cells. Each
green bar represents an individual pairwise comparison of the set of genes identified as enriched
in one cell line with the set enriched in a second cell line as in (A).
C. Expression data for genes differentially occupied by H3K4me3 in pluripotent cells (ES and
iPS) and fibroblast cells. Genes are ordered by the magnitude of differential H3K4me3
occupancy and relative gene expression is shown. Samples with higher than average expression
are shown in red and samples with lower than average expression are shown in green (scale in
standard deviations).
D. Expression data for genes differentially occupied by H3K27me3 in pluripotent cells (ES and
iPS) and fibroblast cells. Genes are ordered by the magnitude of differential H3K27me3
occupancy and relative gene expression is shown. Samples with higher than average expression
are shown in red and samples with lower than average expression are shown in green (scale in
standard deviations). See also Figure Sl and Tables SI-S4.
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Figure 3. Limited variation in gene expression between human ES and iPS cells
A. Unsupervised hierarchical clustering of whole genome expression data from ES cells (closed
circle), iPS cells (open circle), and fibroblasts (hashed circle). Expression data were ordered by
the magnitude of differential expression between pluripotent cells (ES or iPS) cells and fibroblast
cells. Normalization and analysis for all expression data is described in Supplemental
Experimental Procedures.
B. Differential gene expression between ES and iPS cells across multiple expression datasets.
For each dataset (top to bottom) the transcripts with statistically significant differential
expression between ES and iPS cells are shown. Within the set of differentially expressed
transcripts from each dataset, expression data was ordered by the statistical significance of
differential expression between ES and iPS cells and then aligned to all other datasets for
comparison. Samples with higher than average expression are shown in red and samples with
lower than average expression are shown in green (scale in standard deviations).
C. Differential gene expression between fibroblasts and pluripotent (ES and iPS) cells.
Expression data were ordered by the statistical significance of differential expression between
fibroblasts and ES/iPS cells in each dataset and then aligned to all other datasets for comparison.
Samples with higher than average expression are shown in red and samples with lower than
average expression are shown in green (scale in standard deviations).
D. Overlap of differentially expressed genes between ES and iPS cells in various expression
datasets. The numbers of genes differentially expressed between ES and iPS cells are indicated
in black. The total overlap of all gene sets is zero.
E. Overlap of differentially expressed genes between fibroblast and pluripotent (ES and iPS)
cells in various expression datasets. The numbers of genes differentially expressed between
fibroblast and pluripotent cells are indicated in black. The total overlap of all gene sets is shown
in white. See also Figure S2 and Table S5.
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Figure 4. Human ES and iPS cell expression data clusters more by laboratory than by
ES/iPS identity
Gene expression datasets for human ES, iPS, and fibroblasts cells from four laboratories
(Guenther et al., present study; Maherali et al., 2008; Chin et al., 2009; Yu et al., 2009) were
quantile normalized as one group. Genes were Z-score normalized and data were subjected to
hierarchical clustering (centered correlation distance, centroid linkage) of samples. Genes were
ordered from greatest to least magnitude of differential expression between pluripotent and
fibroblast cells. Solid circles indicate ES cell samples, empty circles indicate iPS cell samples,
and hashed circles represent fibroblast cell samples. Data from individual labs are coded by color
as Guenther et al (blue), Maherali et al. (red), Chin et al. (purple), Yu et al. (green). See also
Table S5.
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Abstract
MicroRNAs (miRNAs) are crucial for normal embryonic stem (ES) cell self-renewal and cellular
differentiation, but how miRNA gene expression is controlled by the key transcriptional
regulators of ES cells has not been established. We describe here a new map of the
transcriptional regulatory circuitry of ES cells that incorporates both protein-coding and miRNA
genes, and which is based on high-resolution ChIP-Seq data, systematic identification of miRNA
promoters, and quantitative sequencing of short transcripts in multiple cell types. We find that
the key ES cell transcription factors are associated with promoters for most miRNAs that are
preferentially expressed in ES cells and with promoters for a set of silent miRNA genes. This
silent set of miRNA genes is co-occupied by Polycomb Group proteins in ES cells and expressed
in a tissue-specific fashion in differentiated cells. These data reveal how key ES cell
transcription factors promote the miRNA expression program that contributes to self-renewal
and cellular differentiation, and integrate miRNAs and their targets into an expanded model of
the regulatory circuitry controlling ES cell identity.
Introduction
Embryonic stem (ES) cells hold significant potential for clinical therapies because of their
distinctive capacity to both self-renew and differentiate into a wide range of specialized cell
types. Understanding the transcriptional regulatory circuitry of ES cells and early cellular
differentiation is fundamental to understanding human development and realizing the therapeutic
potential of these cells. Transcription factors that control ES cell pluripotency and self-renewal
have been identified (Chambers and Smith, 2004; Niwa, 2007; Silva and Smith, 2008) and a
draft of the core regulatory circuitry by which these factors exert their regulatory effects on
protein-coding genes has been described (Boyer et al., 2005; Loh et al., 2006; Lee et al., 2006;
Boyer et al. 2006; Jiang et al., 2008; Cole et al., 2008; Kim et al., 2008). MicroRNAs (miRNAs)
are also likely to play key roles in ES cell gene regulation (Kanellopoulou et al., 2005;
Murchison et al., 2005; Wang et al., 2007), but little is known about how miRNAs participate in
the core regulatory circuitry controlling self-renewal and pluripotency in ES cells.
Several lines of evidence indicate that miRNAs contribute to the control of early
development. miRNAs appear to regulate the expression of a significant percentage of all genes
in a wide array of mammalian cell types (Lewis et al., 2005; Lim et al., 2005; Krek et al., 2005;
Farh et al., 2005). A subset of miRNAs is preferentially expressed in ES cells or embryonic
tissue (Houbaviy et al., 2003; Suh et al., 2004; Houbaviy et al., 2005; Mineno et al., 2006).
Dicer-deficient mice fail to develop (Bernstein et al., 2003) and ES cells deficient in miRNA
processing enzymes show defects in differentiation, self-renewal and perhaps viability
(Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007; Calabrese et al., 2008).
Specific miRNAs have been shown to participate in mammalian cellular differentiation and
embryonic development (Stefani and Slack, 2008). However, how transcription factors and
miRNAs function together in the regulatory circuitry that controls early development has not yet
been examined.
The major limitation in connecting miRNA genes to the core transcriptional circuitry of
ES cells has been sparse annotation of miRNA gene transcriptional start sites and promoter
regions. Mature miRNAs, which specify post-transcriptional gene repression, arise from larger
transcripts that are then processed (Bartel, 2004). Over 400 mature miRNAs have been
confidently identified in the human genome (Landgraf et al., 2007), but only a minority of the
primary transcripts have been identified and annotated. Prior attempts to connect ES cell
transcriptional regulators to miRNA genes have searched for transcription factor binding sites
only close to the annotated mature miRNA sequences (Boyer et al., 2005; Loh et al., 2006; Lee
et al., 2006). Additionally, studies of the core transcriptional circuitry of ES cells have compared
transcription factor occupancy to mRNA expression data, but have not systemically examined
miRNA expression in ES cells and differentiated cell types, limiting our knowledge of
transcriptional regulation of miRNA genes in these cells (Boyer et al., 2005; Loh et al., 2006;
Lee et al., 2006; Cole et al. 2008).
To incorporate miRNA gene regulation into the model of transcriptional regulatory
circuitry of ES cells, we began by generating new, high-resolution, genome-wide maps of
binding sites for key ES cell transcription factors using massive parallel sequencing of chromatin
immunoprecipitation (ChIP-Seq). These data reveal highly overlapping occupancy of Oct4,
Sox2, Nanog and Tcf3 at the transcriptional start sites of miRNA transcripts, which we
systematically mapped based on a method that uses chromatin landmarks and transcript data.
We then carried out quantitative sequencing of short transcripts in ES cells, neural precursor
cells (NPCs) and mouse embryonic fibroblasts (MEFs), which revealed that Oct4, Sox2, Nanog
and Tcf3 occupy the promoters of most miRNAs that are preferentially or uniquely expressed in
ES cells. Our data also revealed that a subset of the Oct4/Sox2/Nanog/Tcf3 occupied miRNA
genes are silenced in ES cells by Polycomb Group proteins, but are expressed later in
development in specific lineages. High-resolution transcription factor location analysis,
systematic mapping of the primary miRNA transcriptional start sites in mouse and human, and
quantitative sequencing of miRNAs in three different cell types provide a valuable data resource
for studies of the gene expression program in ES and other cells and the regulatory mechanisms
that control cell fate. The data also produce an expanded model of ES cell core transcriptional
regulatory circuitry that now incorporates transcriptional regulation of miRNAs, and post-
transcriptional regulation mediated by miRNAs, into the molecular understanding of
pluripotency and early cellular differentiation.
Results
High-resolution genome-wide location analysis in ES cells with ChIP-Seq
To connect miRNA genes to the core transcriptional circuitry of ES cells, we first generated
high-resolution genome-wide maps of Oct4, Sox2, Nanog, and Tcf3 occupancy (Figure 1). ChIP-
Seq allowed us to map transcription factor binding sites and histone modifications across the
entire genome at high resolution (Barski et al., 2007; Johnson et al., 2007; Mikkelsen et al.,
2007; Robertson et al., 2007), and we optimized the protocol to allow for robust analysis of
transcription factor binding in murine ES cells (Supplemental Material). Oct4, Sox2, Nanog and
Tcf3 were found to co-occupy 14,230 sites in the genome (Figure 1A, Supplemental Figures Sl
and S2, Supplemental Tables SI-S3). Approximately one quarter of these occurred within 8kb
of the transcription start site of 3,289 annotated genes, another one quarter occurred within genes
but more than 8kb from the start site, and almost half occurred in intergenic regions distal from
start sites (Supplemental Text). Binding of the four factors at sites surrounding the Sox2 gene
(Figure 1B) exemplifies two key features of the data: all four transcription factors co-occupied
the identified binding sites and the resolution was sufficient to determine the DNA sequence
associated with these binding events to a resolution of <25bp. Composite analysis of all bound
regions provided higher resolution and suggested how these factors occupy their common DNA-
sequence motif (Supplemental Figure S3, Supplemental Table S4). Knowledge of these binding
sites provided data necessary to map these key transcription factors to the promoters of miRNA
genes.
Identification of miRNA promoters
Imperfect knowledge of the start sites of primary miRNA transcripts has limited our ability to
identify the transcription factor binding events that control miRNA gene expression in
vertebrates. Previous strategies to identify the 5' ends of primary miRNAs have been hampered
because they relied on isolation of transient primary miRNA transcript, required knowledge of
the specific cell type in which each given miRNA is transcribed, or focused only on potential
start sites proximal to mature miRNAs (Fukao et al., 2007; Mikkelsen et al., 2007; Zhou et al.,
2007; Barrera et al., 2008). To systematically identify transcriptional start sites for miRNA
genes in the mouse and human genomes, we took advantage of the recent observation that
histone H3 is tri-methylated at its lysine 4 residue (H3K4me3) at the transcriptional start sites of
most genes in the genome, even when genes are not productively transcribed, and knowledge
that this covalent modification is restricted to sites of transcription initiation (Barski et al., 2007;
Guenther et al., 2007). We used the genomic coordinates of the H3K4me3 enriched loci derived
from multiple cell types (Supplemental Table S5, Barski et al., 2007; Guenther et al., 2007;
Mikkelsen et al., 2007) to create a library of candidate transcription start sites in both human and
mouse (Figure 2 and Supplemental Figure S4).
High-confidence promoters were identified for over 80% of miRNAs in both mouse and
human (Figure 2, Supplemental Figure S4 and Supplemental Tables S6 and S7). These
promoters were associated with 185 murine primary microRNA transcripts (pri-miRNAs)
(specifying 336 mature miRNAs), and 294 human pri-miRNAs (specifying 441 mature miRNAs)
(Supplemental Table S6 and S7). To identify promoters for miRNA genes, the association of
candidate transcriptional start sites with regions encoding mature miRNAs was scored based on
proximity to annotated mature miRNA sequences (Landgraf et al., 2007), available EST data,
and conservation between species (Figure 2A and Supplemental Figure S5 and Supplemental
Text). Four lines of evidence indicate that this approach identified genuine transcriptional start
sites for miRNA genes. Existing EST data provided evidence that the predicted transcripts do in
fact originate at the identified start sites and continue through the annotated loci of mature
miRNAs (Figure 2B and Supplemental Figures S5). In addition to the chromatin signature of
promoters, a high fraction of these regions contained CpG islands, a DNA sequence element
often associated with promoters (Figure 2B and Supplemental Table S6 and S7). Third, in some
instances where evidence of primary miRNA transcripts, which may be present only transiently
before processing, were not available in published databases at the identified transcriptional start
sites, chromatin marks associated with transcriptional elongation including nucleosomes
methylated at H3 lysine 36 (H3K36me3) and H3 lysine 79 (H3K79me2), provided evidence that
such transcripts are actively produced (Figure 2C and Mikkelsen et al., 2007). Finally, most
miRNA promoters showed evidence of H3K4me3 enrichment in multiple tissues, as observed at
the promoters of most protein-coding genes (Barski et al., 2007; Guenther et al., 2007;
Heintzman et al., 2007) (Figure 2D).
Occupancy of miRNA promoters by core ES cell transcription factors
The binding sites of the ES cell transcription factors Oct4, Sox2, Nanog and Tcf3 were next
mapped to these high-confidence miRNA promoters (Figure 3). In murine ES cells, Oct4, Sox2,
Nanog, and Tcf3 co-occupied the promoters for 55 distinct miRNA transcription units, which
included three clusters of miRNAs that are expressed as large polycistrons, thus suggesting that
these regulators have the potential to directly control the transcription of 81 distinct mature
miRNAs (Figure 3A and Supplemental Tables S6). This set of miRNAs occupied by
Oct4/Sox2/Nanog/Tcf3 represents roughly 20 percent of annotated mammalian miRNAs, similar
to the -20 percent of protein-coding genes that are bound at their promoters by these key
transcription factors (Supplemental Table S2).
To determine if transcription factor occupancy of miRNA promoters is conserved across
species, we performed genome-wide location analysis for Oct4 in human ES cells using
microarray-based analysis. We found extensive conservation of the set of miRNA genes that
were occupied at their promoters by Oct4, as exemplified by the mir-302 cluster (Figure 3A and
3B and Supplemental Tables S7 and S8). Transcription factor occupancy does not necessarily
mean that the adjacent gene is regulated by that factor; conserved transcription factor occupancy
of a promoter, however, suggests gene regulation by that factor. Thus, our data identify a set of
miRNA genes that are bound at their promoters by key ES cell transcription factors in mouse and
human cells (Figure 3C), suggesting that core ES cell transcription factor regulation of these
particular miRNA transcripts has functional significance.
Regulation of Oct4 bound miRNA transcripts during differentiation
Oct4 and Nanog are rapidly silenced as ES cells begin to differentiate (Chambers and Smith,
2004; Niwa, 2007). If the Oct4/Sox2/Nanog/Tcf3 complex is required for activation or
repression of its target miRNAs, the targets should be differentially expressed when ES cells are
compared to a differentiated cell-type. To test this hypothesis, Solexa sequencing of 18-30
nucleotide transcripts in ES cells, mouse embryonic fibroblasts (MEFs), and neural precursors
(NPCs), was performed to obtain quantitative information on the abundance of miRNAs in
pluripotent cells relative to two differentiated cell types (Figure 4).
In each cell type examined, a small subset of mature miRNA transcripts predominated
(Figure 4A). Members of the mir-290-295 cluster, which encodes multiple miRNAs with the
same seed sequence, constituted approximately two thirds of all mature miRNA transcripts in
murine ES cells. Let-7 family members constituted roughly one quarter and one half of miRNAs
in MEFs and NPCs, respectively. The mir-290-295 cluster, which dominated the expression
profile of ES cells, but was scarce in both MEFs and NPCs, is occupied at its promoters by Oct4,
Sox2, Nanog and Tcf3 (Figure 3A), consistent with the hypothesis that these factors are
important for maintaining the expression of the mir-290-295 miRNA cluster in ES cells.
To determine if the behavior of the mir-290-295 cluster is typical of the
Oct4/Sox2/Nanog/Tcf3-occupied miRNAs, we further examined the expression of this set of
miRNAs in the three cell types. Figure 4B shows how the abundance of this group of miRNAs
changed in MEFs and NPCs relative to ES cells. Approximately half of the miRNAs dropped
more than an order of magnitude in abundance in MEFs and NPCs relative to ES cells. A small
subset of the Oct4/Sox2/Nanog/Tcf3-occupied miRNAs, which will be further discussed below,
were expressed only at low levels in ES cells and showed increased abundance in MEFs and
NPCs.
Oct4/Sox2/Nanog/Tcf3-occupied miRNAs are, in general, preferentially expressed in
embryonic stem cells, as demonstrated by the analysis shown in Figure 4C. Whereas most
miRNAs are unchanged in expression in ES cells relative to MEFs or NPCs, a significant portion
of Oct4/Sox2/Nanog/Tcf3 occupied miRNAs are 100 fold more abundant in ES cells than in
MEFs (p<5 x 10-"5), and 1,000 fold more abundant in ES cells than in NPCs (p<5 x 10-9). This
group of Oct4/Sox2/Nanog/Tcf3 bound miRNAs that is significantly more abundant in ES cells
than in NPCs and MEFs, was also found to be actively expressed in induced pluripotent stem
(iPS) cells (generated as described in Wernig et al., 2007), at levels comparable to that in ES
cells, consistent with the hypothesis that core ES cell transcription factors maintain the
expression of these miRNAs in pluripotent cells (Supplemental Figure S6).
Polycomb Group Proteins co-occupy tissue-specific miRNAs that are silenced in ES cells
We noted that the Oct4/Sox2/Nanog/Tcf3-bound miRNAs include the majority of miRNAs that
were preferentially expressed in ES cells, but the data also revealed a second, smaller group of
Oct4/Sox2/Nanog/Tcf3-bound miRNA genes that appeared to be transcriptionally inactive in ES
cells (Figure 4B). This is reminiscent of previous observations with protein-coding genes in ES
cells: Oct4 occupied a set of transcriptionally active genes, but also occupied, with Polycomb
Group proteins, a set of transcriptionally repressed genes that are poised for expression upon
cellular differentiation (Lee et al., 2006; Bernstein et al., 2006; Boyer et al., 2006). We reasoned
that Polycomb complexes might also co-occupy Oct4 bound promoters for miRNA genes that
showed little or no evidence for expression, and thus contribute to their silencing. Indeed, new
ChIP-Seq data for the Polycomb Goup protein Suzl2 in murine ES cells supported this
hypothesis (Figure 5A and Supplemental Tables S6, S7, S 10). As expected, these promoters
were also enriched for nucleosomes with histone H3K27me3, a chromatin modification
catalyzed by Polycomb Group proteins (Figure 5A and Supplemental Table S6 and Mikkelsen et
al., 2007). In keeping with the repressive function of the Polycomb Group proteins reported at
protein coding genes, miRNAs occupied at their promoters by Suzl2 in ES cells were
significantly less abundant in ES cells compared to all other miRNAs (Figure 5B).
Approximately one quarter of the Oct4/Sox2/Nanog/Tcf3-occupied miRNAs belonged to the
repressed set of miRNA genes bound by Suzl2 in murine ES cells (Supplemental Tables S6 and
S7).
To further examine the behavior of this set of miRNAs during embryonic cell-fate
commitment, we returned to our quantitative sequencing data of short transcripts in ES cells,
MEFs and NPCs (Figure 5C). Notably, miRNAs that were bound by Polycomb Group proteins
in ES cells are among the transcripts that are specifically induced in each of these cell types. For
example, transcript levels of miR-9, a miRNA previously identified in neural cells and which
promotes neural differentiation (Lagos-Quintana et al., 2002; Krichevsky et al., 2006), are
significantly elevated in NPCs relative to ES cells, but this miRNA remains repressed in MEFs.
Similarly, miR-218 and miR-34b/34c expression is induced in MEFs, but remains at low levels
in NPCs (Figure 5C). Consistent with Polycomb-mediated repression of these lineage-specific
miRNAs, the repressive chromatin mark deposited by Polycomb Group proteins, H3K27me3, is
selectively lost at the promoters of the miRNAs in the cells in which they are induced (Figure 5C
and Mikkelsen et al., 2007).
The tissue-specific expression pattern of miRNAs repressed by Polycomb in ES cells is
consistent with these miRNAs serving as determinants of cell-fate decisions in a manner
analogous to the developmental regulators whose genes are repressed by Polycomb in ES cells
(Lee et al., 2006; Bernstein et al., 2006; Boyer et al., 2006). Such a function in cell-fate
determination would require that these miRNAs remain silenced in pluripotent ES cells. Indeed,
the miRNAs that are repressed in ES cells by Polycomb Group proteins appear to be induced,
later in development, in a highly restricted subset of differentiated tissues specific to each
miRNA (Supplemental Figure S7), unlike the majority of miRNAs identified in mouse (Landgraf
et al., 2007). The miRNAs with promoters bound by Polycomb Group proteins in ES cells are
significantly enriched (p<0.005) among the set of the most tissue-specific mammalian miRNAs
(Supplemental Fig. S7 and Landgraf et al., 2007). This suggests a model whereby Polycomb
Group proteins repress a set of tissue-specific miRNA genes in ES cells, a subset of which are
co-occupied by Oct4, Sox2, Nanog and Tcf3 (Figure 5D).
Discussion
Here we provide new high-resolution, genome-wide maps of core ES cell transcription factors,
identify promoter regions for most miRNA genes, and deduce the association of the ES cell
transcription factors with these miRNA genes. We also provide quantitative sequence data of
short RNAs in ES cells, NPCs and MEFs to examine changes in miRNA transcription. The key
transcriptional regulators in ES cells collectively occupied the promoters of many of the
miRNAs that were most abundant in ES cells, including those that were down-regulated as ES
cells differentiate. In addition, these factors also occupied the promoters of a second, smaller set
of miRNAs that were repressed in ES cells and were selectively expressed in specific
differentiated cell types. This second group of miRNAs constitutes a subset of the miRNAs that
were silenced by the Polycomb group proteins in ES cells, which is also known to silence key
lineage-specific, protein-coding developmental regulators. Together these data reveal two key
groups of miRNAs that are direct targets of Oct4/Sox2/Nanog/Tcf3, one group of miRNAs that
is preferentially expressed in pluripotent cells and a second group that is silenced in ES cells by
the Polycomb group proteins, and is poised to contribute to cell fate-decisions during mammalian
development.
miRNA contribution to ES cell identity
Several miRNA ploycistrons, which encode the most abundant miRNAs in ES cells and which
are silenced during early cellular differentiation (Houbaviy et al., 2003; Suh et al., 2004;
Houbaviy et al., 2005), were occupied at their promoters by Oct4, Sox2, Nanog and Tcf3. These
include the mir-290-295 cluster, which contains multiple mature miRNAs that share seed
sequences with members of the murine mir-302 cluster, as well as the human mir-371-373 and
mir-302 clusters. miRNAs in the 17-92 cluster also share a highly similar seed sequence.
miRNAs in this family have been implicated in cell proliferation (O'Donnell et al., 2005; He et
al., 2005; Voorhoeve et al., 2006), consistent with the impaired self-renewal phenotype observed
in miRNA-deficient ES cells (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al.,
2007). The zebrafish homologue of this miRNA family, mir-430, contributes to the rapid
degradation of maternal transcripts in early zygotic development (Giraldez et al., 2006), and
mRNA expression data suggests that this miRNA family also promotes the clearance of
transcripts in early mammalian development (Farh et al., 2005).
In addition to promoting the rapid clearance of transcripts as cells transition from one
state to another during development, miRNAs also likely contribute to the control of cell identity
by fine-tuning the expression of genes. mir-430, the zebrafish homologue of the mammalian
mir-302 family, serves to precisely tune the levels of Nodal antagonists Leftyl and Lefty 2
relative to Nodal, a subtle modulation of protein levels that has pronounced effects on embryonic
development (Choi et al., 2007). Recently, a list of -250 murine ES cell mRNAs that appear to
be under the control of miRNAs in the mir-290-295 cluster was reported (Sinkkonen et al.,
2008). This study reports that Lefty] and Lefty2 are evolutionarily conserved targets of the mir-
290-295 miRNA family. These miRNAs also maintain the expression of de novo DNA
methyltransferases 3a and 3b (Dnmt3a and Dnmt3b), perhaps by dampening the expression of
the transcriptional repressor Rbl2, helping to poise ES cells for efficient methylation of Oct4 and
other pluripotency genes during differentiation.
Knowledge of how the core transcriptional circuitry of ES cells connects to both miRNAs
and protein-coding genes, reveals recognizable network motifs downstream of
Oct4/Sox2/Nanog/Tcf3, involving both transcriptional and post-transcriptional regulation, that
further reveal how this circuitry controls ES cell identity (Figure 6). Lefty] and Lefty2, both
actively expressed in ES cells, are directly occupied at their promoters by
Oct4/Sox2/Nanog/Tcf3. Therefore, the core ES cell transcription factors appear to promote the
active expression of Lefty] and Lefty2, but also fine-tune the expression of these important
signaling proteins by activating a family miRNAs that target the Lefty] and Lefty2 3'UTRs. This
network motif whereby a regulator exerts both positive and negative effects on its target, termed
"incoherent feed-forward" regulation (Alon, 2007), provides a mechanism to fine-tune the
steady-state level or kinetics of a target's activation (Figure 6A). Over a quarter of the proposed
targets of the mir-290-295 miRNAs also are likely under the direct transcriptional control of
Oct4/Sox2/Nanog/Tcf3 based on our binding maps, suggesting that these miRNAs could
participate broadly in tuning the effects of ES cell transcription factors (Figure 6A).
The miRNA expression program directly downstream of Oct4/Sox2/Nanog/Tcf3 could
help poise ES cells for rapid and efficient differentiation, consistent with the phenotype of
miRNA-deficient cells (Kanellopoulou et al., 2005; Murchison et al., 2005; Wang et al., 2007;
Calabrese et al., 2008). Oct4/Sox2/Nanog/Tcf3 also likely contributes to this poising by their
occupancy of the Let-7g promoter. Mature Let-7 transcripts are scarce in ES cells, but were
among the most abundant miRNAs in both MEFs and NPCs (Figure 3). Primary Let-7g
transcript is abundant in ES cells, but its maturation is blocked by Lin28 (Viswanathan et al.,
2008 and data not shown). We now report that the promoters of both Let-7g and Lin28 are
occupied by Oct4/Sox2/Nanog/Tcf3, suggesting that the core ES cell transcription factors
promote the transcription of both primary Let-7g and Lin28, which blocks the maturation of Let-
7g. In this way Let-7 and Lin-28 appear to participate in an incoherent feed-forward circuit
downstream of Oct4/Sox2/Nanog/Tcf3 to contribute to rapid cellular differentiation (Figure 6B).
Notably, ectopic expression of Lin28 in human fibroblasts promotes the induction of
pluripotency (Yu et al., 2007), suggesting blocked maturation of pri-Let-7 transcripts plays an
important role in the pluripotent state. Additionally, Dnmt3a and Dnmt3b, which are indirectly
up-regulated by the mir-290-25 miRNAs (Sinkkonen et al., 2008), are also occupied at their
promoters by Oct4/Sox2/Nanog/Tcf3, providing examples of "coherent" regulation of important
target genes by ES cell transcription factors and the ES cell miRNAs maintained by those
transcription factors (Figure 6C).
Multi-layer regulatory circuitry of ES cell identity
The regulatory circuitry we present for miRNAs in ES cells can now be integrated into the model
of core regulatory circuitry of pluripotency we have proposed previously (Boyer et al., 2005; Lee
et al., 2006; Cole et al., 2008), as illustrated in Figure 7. Our data reveal that Oct4, Sox2, Nanog
and Tcf3 occupy the promoters of two key sets of miRNAs, similar to the two sets of protein-
coding genes regulated by these factors: one set that is actively expressed in pluripotent ES cells
and another that is silenced in these cells by Polycomb Group proteins and whose later
expression might serve to facilitate establishment or maintenance of differentiated cell states.
The expanded circuit diagram presented here integrates transcription factor occupancy of
miRNA genes and existing data on miRNA targets into our model of the molecular control of the
pluripotent state. These data suggest that miRNAs that are activated in ES cells by
Oct4/Sox2/Nanog/Tcf3, serve to modulate the direct effects of these transcription factors,
participating in incoherent feed-forward regulation to tune levels of key genes, and modifying
the gene expression program to help poise ES cells for efficient differentiation. Core ES cell
transcription factors and the miRNAs under their control coordinately contribute transcriptional
and post-transcriptional gene regulation to the network that maintains ES cell identity.
Concluding Remarks
The regulatory circuitry controlled by ES cell transcription factors, Oct4, Sox2, Nanog and Tcf3,
and the Polycomb Group proteins, which is required for the normal ES cell state, has offered
insights into the molecular control of ES cell pluripotency and self-renewal and cellular
reprogramming (Jaenisch and Young, 2008). We now provide high-resolution genome-wide
location analysis of these factors provided by ChIP-Seq data, and quantitative sequencing of
short transcripts in multiple cell types, to connect miRNA genes to the core circuitry of ES cells.
This information should prove useful as investigators continue to probe the role of miRNAs in
pluripotency, cell-fate decisions, and perhaps regenerative medicine.
Experimental Procedures
A detailed description of all materials and methods used can be found in Supplemental
Information.
Cell culture
V6.5 (C57BL/6-129) murine ES cells were grown under typical ES conditions (see Supplemental
Information) on irradiated mouse embryonic fibroblasts (MEFs). For location analysis, cells
were grown for one passage off of MEFs, on gelatinized tissue-culture plates. To generate
neural precursor cells, ES cells were differentiated along the neural lineage using standard
protocols (see Supplemental Information). V6.5 ES cells were differentiated into neural
progenitor cells (NPCs) through embryoid body formation for 4 days and selection in ITSFn
media for 5-7 days, and maintained in FGF2 and EGF2 (R&D Systems) (See Supplemental
Information). Mouse embryonic fibroblasts were prepared and cultured from DR-4 strain mice as
previously described (See Supplemental Information).
Antibodies and ChIP assays
Detailed descriptions of antibodies, antibody specificity and ChIP methods used in this study are
provided in Supplemental Information. Crosslinked cells (~1 x 107 per IP) were lysed and
sonicated using a Misonix 3000 sonicator to solubilize and shear crosslinked DNA to a 200bp-
1000bp fragment size. Batch sonicated whole cell extract was incubated 12-18 hours at 4*C with
100 pl of Dynal Protein G magnetic beads (Dynal) that has been pre-bound to 10 pg of the
appropriate antibody. Immunoprecipitates were washed with RIPA buffer and the DNA eluted in
1% SDS at 65*C for 1 hour. Chemical cross-links were reversed for 10 hours to allow isolation
of immunoenriched DNA fragments. Immunoprecipitated DNA and control whole cell extract
DNA were purified by treatment with RNAse A, proteinase K and two consecutive
phenol:chloroform:isoamyl alcohol extractions.
ChIP-Seq
Crosslinked cells (1 x 107 per IP) were lysed and sonicated using a Misonix 3000 sonicator to
solubilize and shear crosslinked DNA to a 200bp-1000bp fragment size. Batch sonicated whole
cell extract was incubated 12-18 hours at 4*C with 100 pl of Dynal Protein G magnetic beads
(Dynal) that has been pre-bound to 10 pg of the appropriate antibody. Immunoprecipitates were
washed with RIPA buffer and the DNA eluted in 1% SDS at 65*C for 1 hour. Chemical cross-links
were reversed for 10 hours to allow isolation of immunoenriched DNA fragments.
Immunoprecipitated DNA and control whole cell extract DNA were purified by treatment with
RNAse A, proteinase K and two consecutive phenol:chloroform:isoamyl alcohol extractions.
Purified immunoprecipitated DNA were prepared for sequencing according to a modified
version of the Solexa Genomic DNA protocol. Fragmented DNA was end repaired and subjected
to 18 cycles of LM-PCR using oligos provided by Illumina. Amplified fragments between 150 and
300bp (representing shear fragments between 50 and 200nt in length and ~100bp of primer
sequence) were isolated by agarose gel electrophoresis and purified. High quality samples were
confirmed by the appearance of a smooth smear of fragments from 100-1000bp with a peak
distribution between 150 and 300bp. 3ng of Linker-ligated DNA was applied to the flow-cell using
the Solexa Cluster Station fluidics device. Following bridge amplification the cluster density and
morphology were confirmed by microscopic analysis of flow-cells stained with a 1:5000 dilution
of SYBR Green I (Invitrogen). Samples were then subjected to 26 bases of sequencing according
to Illumina's standard protocols.
Images acquired from the Solexa sequencer were processed through the bundled Solexa
image extraction pipeline and aligned to both mouse NCBI build 36 and 37 using ELAND. Only
sequences uniquely matching the reference genome without mismatches were used. Mapped reads
were extended to 200bp and allocated into 25bp bins. Groups of bins containing statistically
significant enrichment for the epigenetic modification were identified by comparison to a
Poissonian background model as well as comparison to an empirical distribution of reads obtained
from whole cell extract DNA.
Quanititative short RNA sequencing
A method of cloning the 18-30nt transcripts previously described (Lau et al., 2001) was modified
to allow for Solexa (Illumina) sequencing (manuscript submitted). Single-stranded cDNA
libraries of short transcripts were generated using size selected RNA from mouse embryonic
stem cells, mouse neural precursors, and mouse embryonic fibroblasts. RNA extraction was
performed using Trizol, followed by RNeasy purification (Qiagen).
5pg of RNA was size selected and gel purified. 3' Adaptor
(pTCGTATGCCGTCTTCTGTTG [idT]) was ligated to RNA with T4 RNA ligase and also,
separately with RNA Ligase (Rnl2(1-249)k->Q). Ligation products were gel purified and mixed.
5' adaptor (GUUCAGAGUU CUACAGUCCGACGAUC) was ligated with 4 RNA Ligase.
RT-PCR (Superscript II, Invitrogen) was performed with 5' primer (CAAGCAGAAGA
CGGCATA). Splicing of overlapping ends PCR (SOEPCR) was performed (Phusion, NEB) with
5' primer and 3' PCR primer (AATGATACGGCGACCACCGACAGGTTCAGAGTTCTAC
AGTCCGA), generating cDNA with extended 3' adaptor sequence. PCR product (40 pl) was
denatured (85 C, 10 min, formamide loading dye), and the differently sized strands were purified
on a 90% formamide, 8% acrylamide gel, yielding single-stranded DNA suitable Solexa
sequencing.
The single-stranded DNA samples were resuspended in 10mM Tris (EB buffer)/0.1%
Tween and then used as indicated in the standard Solexa sequencing protocol (Illumina). Each
library was run on one lane of the Solexa sequencer.
Promoter array design and data extraction
The design of the oligonucleotide-based whole genome array set and data extraction methods are
described in Lee et al., 2006. The microarrays used for location analysis in this study were
manufactured by Agilent Technologies (http://www.agilent.com).
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Figure 1. High-resolution genome-wide mapping of core ES cell transcription factors with
ChIP-Seq
A. Summary of binding data for Oct4, Sox2, Nanog and Tcf3. 14,230 sites are co-bound genome
wide and mapped to either promoter proximal (TSS +/- 8kb, dark green) (27% of binding sites),
genic (>8kb from TSS, middle green) (30% of binding sites), or intergenic (light green) (43% of
binding sites). The promoter proximal binding sites are associated with 3,289 genes.
B. (upper) Binding of Oct4 (blue), Sox2 (purple), Nanog (orange) and Tcf3 (red) across 37.5kb
of mouse chromosome 3 surrounding the Sox2 gene (black below the graph, arrow indicates
transcription start site). Short sequences uniquely and perfectly mapping to the genome were
extended to 200bp (maximum fragment length) and scored in 25bp bins. The score of the bins
were then normalized to the total number of reads mapped. Highly enriched regions are
highlighted by a dotted box. Oct4/Sox2 DNA binding motifs (Loh et al., 2006) were mapped
across the genome and are shown as grey boxes below the graph. Height of the box reflects the
quality of the motif. (lower) Detailed analysis of three enriched regions (Chromosome 3:
4,837,600-34,838,300, 34,845,300-34,846,000, and 34,859,900-34,860,500) at the Sox2 gene
indicated with boxes above. The 5' most base from ChIP-Seq were separated by strand and
binned into 25bp regions. Sense (darker tone) and anti-sense (light tone) of each of the four
factors tested are directed towards the binding site, which in each case occurs at a high-
confidence Oct/Sox2 DNA binding motif indicated below.
Figure 2
CANDIDATES -
Use H3K4me3 enrichment
from multiple cell types to
identify start sites up to 250kb
upstream of each miRNA
60,580,000
mES
NPC
MEF
SCORE
(+) Proximal (<5kb) from miRNA
(+) Overlapping Gene I EST(+/-)Conservation
(-) Intervening promoters
(-) Non-overlapping Gene / EST
MOUSE
Chromosomal Position
60,610,000
1 m111 a
CpG
V 4 1
E
I
hES
B-cell
Liver
T-cell
B1696529
mmu-mir-15a, 16-1
49,560,000
Cap
CpG
W_ IDENTIFICATION
Select promoters for each miRNA
from positive scoring candidates.
In the absence of a positive
score, the nearest candidate is
selected unless negative.
HUMAN
Chromosomal Position
49,515,000
a en
-BBC055417
hsa-mir-15a, 16-1
Chromosomal Position
148,920,000
IEuema e I Ie I mI I I
G mI"
CpG mmU-mir-34a
9,185,000
hES K111
B-cell amu
Liver i
T-cell all a
CpG
Chromosomal Position
9,140,000
I
- DB286351
hsa-mir-34a
84,548,000 Chromosomal Position
................
CpG Mou-mir-130
84,538,000
c 16'
0 12'
8'
V 00 30,130,000 Chromosomal Position 30,105,000
[*---------.
. .. ... .. r-
CpG mmu-mir-183,96, 182
H3K4me3 at
miRNA Promoters
3+ tissues
2 tissues
I tissue
Human Mouse
(246) (192)
148,885,000
mES
NPC
MEF
. ......... 
. ...... .. .
Figure 2. Identification of miRNA promoters
A. Description of algorithm for miRNA promoter identification. A library of candidate
transcriptional start sites was generated with histone H3 lysine 4 tri-methyl (H3K4me3) location
analysis data from multiple tissues (Barski et al., 2007; Guenther et al., 2007; Mikkelsen et al.,
2007). Candidates were scored to assess likelihood that they represent true miRNA promoters.
Based on scores, a list of mouse and human miRNA promoters was assembled. Additional
details can be found in Supplemental Text.
B. Examples of identified miRNA promoter regions are shown. A map of H3K4me3 enrichment
is displayed in regions neighbouring selected human and mouse miRNAs for multiple cell types:
human ES cells (hES), REH human pro-B cell line (B cell), primary human hepatocytes (Liver),
primary human T cells (T cell), mouse ES cells (mES), neural precursor cells (NPCs) and mouse
embryonic fibroblasts (MEFs). miRNA promoter coordinates were confirmed by distance to
mature miRNA genomic sequence, conservation and EST data (shown as solid line where
available). Predicted transcriptional start site and direction of transcription are noted by an arrow,
with mature miRNA sequences indicated (red). CpG islands, commonly found at promoters, are
indicated (green). Dotted lines denote presumed transcripts.
C. Confirmation of predicted transcription start sites for active miRNAs using chromatin
modifications. Normalized ChIP-Seq counts for H3K4me3 (red), H3K79me2 (blue) and
H3K36me3 (green) are shown for two miRNA genes where EST data was unavailable. Predicted
start site (arrow), CpG islands (green bar), presumed transcript (dotted lines) and miRNA
positions (red bar) are shown.
D. Most human and mouse miRNA promoters show evidence of H3K4me3 enrichment in
multiple tissues.
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Figure 3. Oct4, Sox2, Nanog and Tcf3 occupancy of miRNA promoters
A. Oct4 (blue), Sox2 (purple), Nanog (orange) and TCF3 (red) binding is shown at four murine
miRNA genes as in Figure IA. H3K4me3 enrichment in ES cells is indicated by shading across
genomic region. Presumed transcripts are shown as dotted lines. Coordinates for the mmu-mir-
290-295 cluster are derived from NCBI build 37.
B. Oct4 ChIP enrichment ratios (ChIP-enriched versus total genomic DNA) are shown across
human miRNA promoter region for the hsa-mir-302 cluster. H3K4me3 enrichment in ES cells is
indicated by shading across genomic region.
C. Schematic of miRNAs with conserved binding by the core transcription factors in ES cells.
Transcription factors are represented by dark blue circles and miRNAs are represented by purple
hexagons. miRNAs from the miR-302 cluster and miR290-295 (mouse)/371-372(human) cluster
are selectively expressed in ES cells (Houbaviy et al., 2003).
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Figure 4 Regulation of Oct4/Sox2/Nanog/TCF3-bound miRNAs during differentiation
A. Pie charts showing relative contributions of miRNAs to the complete population of miRNAs
in mES cells (red) , MEFs (blue) and neural precursors (NPCs, green) based on quantification of
miRNAs from by small RNA sequencing. A full list of the miRNAs identified can be found in
Supplemental Table S6.
B. Normalized frequency of detection of individual mature miRNAs whose primary transcripts
are occupied by Oct4, Sox2, Nanog and Tcf3 in mouse. Red line in center and right panel show
the level of detection in ES cells.
C. Histogram of changes in frequency of detection. Changes for miRNAs whose primary
transcripts are occupied by Oct4, Sox2, Nanog and Tcf3 in mouse are shown as bars (red for ES
enriched, blue for MEF enriched and green for NPC enriched). The background frequency for
non-occupied miRNAs is shown as a grey line.
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Figure 5. Polycomb represses lineage-specific miRNAs in ES cells
A. Suzl2 (light green) and H3K27me3 (dark green, Mikkelsen et al., 2007) binding are shown
for two miRNA genes in murine ES cells. Predicted start sites (arrow), CpG islands (green bar),
presumed miRNA primary transcript (dotted line) and mature miRNA (red bar) are shown.
B. Expression analysis of miRNAs from mES cells based on quantitative small RNA sequencing.
Cumulative distributions for PcG bound miRNAs (green line) and all miRNAs (grey line) are
shown.
C. Expression analysis of miRNAs bound by Suz12 in mES cells. Relative counts are shown for
mES (red), NPCs (orange) and MEFs (yellow). miR-9 transcript levels were selectively induced
in NPCs, while miR-218 and miR-34c were induced in MEFs. H3K27me3 (green line) was lost
from the miR-9-1 and the miR-9-2 promoters in NPCs, while the promoters retained H3K4me3
(blue line) (Mikkelsen et al., 2007). H3K27me3 was lost at the miR-218 and miR-34c promoters
in MEFs.
D. Schematic of a subset of miRNAs bound by Suzl2 in both mES and hES cells. Cells known
to selectively express these miRNAs based on computation predictions (Farh et al., 2005) or
experimental confirmation (Yi et al., 2006; Yi et al., 2008; Landgraf et al.,2007) are indicated.
Transcription factors are represented by dark blue circles, and Suz12 by a green circle. miRNA
gene promoters are represented by purple hexagons.
incoherent Feed-Forward Regulation
::-0.0
-_
-_
Signaling
Transcriptional
Regulation
Incoherent Feed-Forward Regulation
Coherent Feed-Forward Regulation
00
rIi
" 
--
I
Figure 6
.: ........... .......... . .. . .... . .. . ... _._  . : :: ........... - - --------1-_- _- - -- - . :::::.:.. v:mz;: -
Figure 6. miRNA modulation of the gene regulatory network in ES cells
A. An incoherent feed-forward motif (Alon 2007) involving a miRNA repression of a
transcription factor target gene is illustrated (left). Transcription factors are represented by dark
blue circles, miRNAs in purple hexagons, protein-coding gene in pink rectangles and proteins in
orange ovals. Particular instances of this netowrks motif identified in ES cells, where signaling
molecules or transcriptional regulators directly downstream of Oct4/Sox2/Nanog/Tcf3 are tuned
or silenced by miRNAs maintained in ES cells by Oct4/Sox2/Nanog/Tcf3, are illustrated (right).
B. Another incoherent feed-forward motif (Alon 2007) where a protein, encoded by a gene under
the control of Oct4/Sox2/Nanog/Tcf3, inhibits the maturation of a primary miRNA transcript
maintained in ES cells by Oct4/Sox2/Nanog/Tcf3, is illustrated (left). In ES cells, Lin28 blocks
the maturation of primary Let-7g (Visiwanthan et al., 2008). Lin28 and the Let-7g gene are
occupied by Oct4/Sox2/Nanog/Tcf3. Also, noted by the purple dashed line is the Targetscan
prediction (Grimson et al., 2007), that mature Let-7g would target Lin28 (right).
C. A coherent feed-forward motif (Alon 2007) where a miRNA represses the expression of
transcriptional repressor, which indirectly activates the expression of a gene maintained in ES
cells by Oct4/Sox2/Nanog/Tcf3, is illustrated (left). This motif is found in ES cells, where mir-
290-295 miRNAs repress Rbl2 indirectly maintaining the expression of Dnmt3a and Dnmt3a,
which are also occupied at their promoters by Oct4/Sox2/Nanog/Tcf3 (right).
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Figure 7. Multi-level regulatory network controlling ES cell identity
Updated map of ES cell regulatory circuitry is shown. Interconnected auto-regulatory loop is
shown to the left. Active transcripts are shown at the top right, and PcG silenced transcripts are
shown at the bottom. Transcription factors are represented by dark blue circles, and Suzl2 by a
green circle. Gene promoters are represented by red rectangles, gene products by orange circles,
and miRNA promoters are represented by purple hexagons.
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Abstract
Foxp3*CD4*CD25* regulatory T (Treg) cells are essential for the prevention of autoimmunity
(Sakaguchi et al., 1995; Baecher-Allan et al., 2006). Treg cells have an attenuated cytokine
response to T cell receptor stimulation, and can suppress the proliferation and effector function
of neighbouring T cells (Shevach, 2002; von Boehmer, 2005). The forkhead transcription factor
Foxp3 (forkhead box P3) is selectively expressed in Treg cells, is required for Treg development
and function, and is sufficient to induce a Treg phenotype in conventional CD4*CD25~ T cells
(Hori et al., 2003; Fontenot et al., 2003; Khattri et al., 2003; Fontenot et al., 2005). Mutations in
Foxp3 cause severe, multi-organ autoimmunity in both human and mouse (Brunkow et al., 2001;
Bennett et al., 2001; Wildin et al., 2001). FOXP3 can cooperate in a DNA-binding complex with
NFAT (nuclear factor of activated T cells) to regulate the transcription of several known target
genes (Wu et al., 2006b). However, the global set of genes regulated directly by Foxp3 is not
known and consequently, how this transcription factor controls the gene expression program for
Treg function is not understood. Here we identify Foxp3 target genes and report that many of
these are key modulators of T cell activation and function. Remarkably, the predominant,
although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on
T cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function
of Treg cells, because overactive variants of some target genes are known to be associated with
autoimmune disease.
Foxp3 occupancy and regulation of key target genes during T cell stimulation
We developed a strategy to identify genes whose promoters are bound by Foxp3 and whose
expression is dependent on that transcription factor (Figure 1). To generate two cell lines that are
genetically matched except for Foxp3, we transduced a Foxp3CD4* murine T cell hybridoma
with FLAG-tagged Foxp3. This approach was favoured over comparison of ex vivo cells, which
are heterogeneous with regard to activation status. The lines provided sufficient numbers of
homogeneous cells with appropriate controls to facilitate both location analysis and expression
analysis. FACS (fluorescence-activated cell sorting) analysis confirmed that Foxp3 is expressed
in the hybridoma at levels comparable to those in ex vivo CD4*CD25* Treg cells (Supplemental
Figure Sl). Previous work has shown that conventional CD4* T cells ectopically expressing
Foxp3 do not upregulate interleukin 2 (112) secretion following T cell receptor (TCR) dependent
stimulation (Schubert et al., 2001). To confirm that the Foxp3* hybridomas contain functional
Foxp3, we assayed Foxp3 and Foxp3* cells for 112 secretion. Indeed, FACS analysis revealed
that 112 secretion is strongly inhibited in phorbol myristate acetate (PMA)/ionomycin stimulated
Foxp3* hybridomas compared to stimulated Foxp3 hybridomas (Supplemental Figure S2).
To identify direct targets of Foxp3, DNA sequences occupied by the transcription factor
were identified in a replicate set of experiments using chromatin-immunoprecipitation (ChIP)
combined with DNA microarrays. For this purpose, DNA microarrays were used that contain 60-
mer oligonucleotide probes covering the region from -8 kilobases (kb) to +2 kb relative to the
transcript start sites for approximately 16,000 annotated mouse genes (Boyer et al., 2006). The
sites occupied by Foxp3 were identified as peaks of ChIP-enriched DNA that span closely
neighbouring probes (Figure 2). Foxp3 was found to occupy the promoters of 1,119 genes in
PMA/ionomycin stimulated hybridomas (Supplemental Tables S1 and S2). The well-
characterized Foxp3 target gene (Wu et al., 2006b; Chen et al., 2006), 112, was among the genes
occupied by Foxp3 (Figure 2A). Most of the promoters occupied by Foxp3 in stimulated T cells
were also occupied in unstimulated cells (Supplemental Tables S1 and S2, and Supplemental
Figure S3). However, at some promoters Foxp3 binding increased considerably in cells
stimulated with PMA/ionomycin (Figure 2A and Supplemental Figure S3). Control
immunoprecipitation experiments in Foxp3 cells, which produced few positive signals,
confirmed the specificity of these results (Supplemental Figure S4). Our confidence in the
binding data was further strengthened by the discovery of a DNA sequence motif, which matches
100
the consensus forkhead motif, at the genomic loci that were bound by Foxp3 (Figure 2B and
Supplemental Table S5). This motif distinguishes Foxp3 bound regions from unbound regions
tiled on the promoter arrays with a high level of confidence (p < 1041). Instances of this motif are
significantly more likely to be conserved in Foxp3 bound regions than in promoter regions that
are not bound by Foxp3 (p < 1023), suggesting that these sites serve a functional role
(Supplemental Table S5).
To gain insights into the cellular functions that are directly regulated by Foxp3
transcriptional control, we compared the list of genes occupied by Foxp3 in stimulated
hybridomas to the biological pathways annotated by the Kyoto Encyclopedia of Genes and
Genomes (KEGG) (Kanehisa et al., 2000). Among these pathways, Foxp3 target genes are most
strongly associated with the TCR signalling pathway (p = 1.4 x 10-5) (Figure 2C). Foxp3 target
genes encode proteins that participate at multiple levels of this pathway, including cell surface
molecules, signalling components and transcriptional regulators. Many genes with known roles
in T cells are missed with existing automated surveys, so we also manually inspected the list of
Foxp3 target genes. This revealed that many additional Foxp3 targets are probably important for
T cell function, including microRNAs that are differentially expressed between Treg cells and
conventional T cells (Figure 2A and Supplemental Table S3 and Cobb et al., 2006). Surprisingly,
Ctla4 was not among the Foxp3 targets, but analysis by RT-PCR (polymerase chain reaction
with reverse transcription) revealed no Ctla4 expression in Foxp3 and Foxp3* hybridomas (data
not shown). However, the Foxp3 targets included genes previously reported to be upregulated in
Treg cells, such as Il2ra (CD25) (Sakaguchi et al., 1995), Tnfrsf18 (GITR) (McHugh et al, 2002),
Nrp] (Bruder et al., 2004) and Ccr4 (Lellem et al., 2001), consistent with predictions that these
are directly regulated by Foxp3.
Previous reports have shown that only a portion of transcription factor binding events is
associated with transcriptional regulation (Harbison et al., 2004). To identify the set of genes
whose expression is dependent on Foxp3, we performed gene expression profiling on Foxp3
and Foxp3* T cell hybridoma cells before and after PMA/ionomycin stimulation. Comparison of
data from unstimulated Foxp3 and Foxp3* cells revealed few differentially expressed genes,
suggesting that the transcription factor had little influence on global gene expression in
unstimulated hybridomas (Supplemental Table S8). In contrast, PMA/ionomycin-stimulated
Foxp3 and Foxp3* cells showed significant differences in expression of almost 1% of mouse
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genes. Many of these genes were directly occupied by Foxp3, and Foxp3 binding was
predominantly, but not exclusively, associated with genes whose expression is downregulated in
stimulated Foxp3+ hybridomas. Foxp3 occupied the promoters of approximately half of the
genes in this cluster (Figure 3A). This set of downregulated target genes is enriched for genes
that are implicated in TCR signalling (p = 6.1 x 10-3). Underscoring the significance of this
finding, E2f4, an unrelated control transcription factor that occupies ~800 genes in these
hybridomas, was found to occupy only one of these promoters (Supplemental Table S4).
Only a subset of all Foxp3 occupied genes was found to be differentially expressed. One
reason for this could be that Foxp3 requires cofactors to modulate transcription. Recently,
FOXP3 was shown to cooperate with NFAT in a DNA-binding complex to activate or repress
target gene expression (Wu et al., 2006b). Consistent with this report, Foxp3 exerts a more
pronounced transcriptional effect in stimulated hybridoma cells than in non-stimulated cells.
Importantly, in our experiments, the set of Foxp3 bound genes are enriched (P < 10 19) for the
presence of an Nfat DNA sequence motif neighbouring the sites of Foxp3 occupancy
(Supplemental Table S5).
We next examined whether the genes regulated by Foxp3 in the T cell hybridomas show
similar regulatory behaviour in ex vivo T cells. Hybridoma cells were used initially because they
afforded cells that differ only by Foxp3 status, they provided a homogenous population of non-
stimulated T cells, and we could have confidence in genome-wide location data using FLAG-
tagged Foxp3. Nonetheless, microarray expression profiling was performed on ex vivo T cells
from different mice that express a transgenic TCR alone or together with the TCR agonist ligand
(Klein et al., 2003), from which relatively pure populations of naive CD4*CD25 T helper and
Foxp3*CD4*CD25* Treg cells, respectively, could be isolated. This analysis revealed that many,
although not all, of the regulated targets that were identified in the hybridomas show consistent
expression patterns in stimulated ex vivo cells (Figure 3B and Supplemental Fig. S5). Some
differences in gene expression, especially genes that are activated by Foxp3 only in Treg cells,
may be due to the fact that ex vivo Treg cells are generated through antigenic stimulation (Jordan
et al., 2001; Kretschmer et al., 2005) and hence could contain transcriptional cofactors that differ
from those in hybridoma cells.
Our findings were further validated for a panel of nine Foxp3 targets. Site-specific
primers were used to confirm the binding of Foxp3 to the promoters of these genes (Figure 3C)
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and quantitative RT-PCR was used to assay messenger RNA levels in non-stimulated and
stimulated hybridomas and ex vivo cells, in the presence and absence of 2 pM cyclosporin A
(Figure 3D). These experiments confirmed the direct effects of Foxp3 at targets that were
identified in the genome scale experiments. Notably, in these experiments (Figure 3D) all genes
that were activated following stimulation in Foxp3 cells and repressed in Foxp3* cells were
activated in a calcineurin dependent manner, consistent with the notion that Nfat is involved in
their activation. In addition, just as Foxp3 regulates the protein levels of secreted 112
(Supplemental Fig. S2), cell surface staining and FACS analysis show that Foxp3 regulates the
level of Ly6a protein, demonstrating that Foxp3 transcriptional regulation of its targets
modulates protein levels (Supplemental Fig. S6).
Taken together, the results from ex vivo T cells and the hybridoma system identify a core
set of Foxp3 regulatory targets (Figure 4A), most of which showed suppressed activation in
stimulated Foxp3* cells. A smaller number of Foxp3 target genes was upregulated in stimulated
Foxp3* cells, including some encoding cell surface molecules with known roles in
immunoregulation, such as Ly6a (Stanford et al., 1997) and Tnfrsf9 (4-1BB) (Myers et al.,
2005). The results from the hybridoma system indicate that Foxp3 occupies regions of most of its
target promoters in both unstimulated and stimulated conditions, but increased binding at some
promoters and regulation of most targets is observed after stimulation. Furthermore, in
hybridomas the major function of Foxp3 at these genes is to suppress the level of gene activation
that would occur if this transcription factor were not expressed (Figure 4B). Conceivably, the
Foxp3 dependent downregulation of T cell activation and cytokine genes, and upregulation of
immunosuppressive cell surface molecules, contribute to both the hyporesponsive and
suppressive Treg phenotype.
Mutations in some Foxp3 target genes are already known to be associated with
autoimmune disease. The protein tyrosine phosphatase Ptpn22 is a notable example. In our
experiments, Ptpn22 is one of the highest confidence direct targets of Foxp3; it is upregulated on
stimulation in Foxp3 cells, and this upregulation is inhibited in Foxp3+ hybridomas (Figure 3A)
and ex vivo Treg cells (Figures 3B and 3D). Ptpn22 modulates the signal cascade downstream of
the TCR, and mutations in the human PTPN22 have been associated with type 1 diabetes,
rheumatoid arthritis, systemic lupus erythematosus and Graves' disease, as well as other
autoimmune diseases (Bottini et al., 2004; Wu et al., 2006a; Bottini et al., 2006). A recent report
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suggests that one PTPN22 single-nucleotide polymorphism associated with autoimmunity is a
gain-of-function mutation (Vang et al., 2005). Our findings are compatible with the hypothesis
that the gain-of-function mutation might be pathogenic if mutant PTPN22 is overactive in Treg
cells (Vang et al., 2005).
In summary, our data indicate that Foxp3 binds to the promoters of well-characterized
regulators of T cell activation and function. In the T cell hybridomas studied here, the major role
of this transcription factor is to dampen the induction of key genes when Treg cells are stimulated.
In ex vivo Treg cells, Foxp3 could also activate the expression of a greater number of genes,
perhaps owing to the greater abundance of certain transcriptional cofactors in these cells. Some
of the identified Foxp3 target genes have been previously implicated in autoimmune diseases,
implying that a therapeutic strategy to recapitulate the function of this transcription factor may
have clinical utility for these diseases.
Experimental Procedures
A detailed description of all materials and methods used can be found in Supplemental
Information.
Growth of murine CD4* T cell hybridomas and ex vivo T cells
CD4* 5B6-2 hybridoma cells expressing a PLP 139.151-specific TCR, which was kindly provided
by V. Kuchroo, were cultured in Dulbecco's modified Eagle medium (Invitrogen). Primary
murine CD4* T cells were cultured in RPMI-1640 medium (Invitrogen). For gene expression
profiling, real-time RT-PCR, and location analysis, cells were cultured in the absence or
presence of 50 ng ml-1 phorbol 12-myristate 13-acetate (PMA) and 200 ng ml-1 ionomycin at
37 'C and harvested after 6 h. Where indicated, cells were preincubated for 1 h with 2pM
cyclosporin A. Details of cell generation and isolation are provided in Supplemental Information.
Antibodies and ChIP assays
Detailed descriptions of antibodies, antibody specificity and ChIP methods used in this study are
provided in Supplemental Information. All microarray data from this study are available from
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ArrayExpress at the EBI (http://www.ebi.ac.uk/arrayexpress) under accession code E-TABM-
154.
Promoter array design and data extraction
The design of the oligonucleotide-based promoter array set and data extraction methods are
described in Supplemental Information. The microarrays used for location analysis in this study
were manufactured by Agilent Technologies (http://www.agilent.com).
Motif analysis
Discovery of the Foxp3 sequence motif from the ChIP-chip binding data was performed using
the THEME algorithm. The Foxp3 motif learned by THEME and the Nfat motif from the
TRANSFAC database (version 8.3) were used to scan all arrayed sequences to identify matches
to the motifs.
Functional classification of bound genes
Comparison of Foxp3 target genes to annotated KEGG biological pathways was performed using
the online DAVID tool (http://niaid.abcc.ncifcrf.gov/).
Gene expression profiling
For each hybridoma culture condition, total RNA was prepared from 1 x 107 cells using Trizol
(Gibco) followed by additional purification using the RNeasy Mini Kit (Qiagen). Biotinylated
antisense cRNA was then prepared according to the Affymetrix standard labelling protocol (one
amplification round). For each primary T cell culture condition, total RNA was isolated from
5 x 105 cells with RNeasy. Biotinylated antisense cRNA was prepared by two rounds of in vitro
amplification using the BioArray RNA Amplification and Labelling System (Enzo Life
Sciences) according to the protocol for 10-1,000 ng of input RNA provided by the manufacturer.
Biotinylated cRNAs of hybridomas and primary T cells were fragmented and hybridized to
Affymetrix GeneChip Mouse Expression Set 430 2.0 arrays at the Microarray Core Facility
(Dana-Farber Cancer Institute).
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Quantitative RT-PCR
To determine transcript levels in T cell hybridomas and ex vivo T cells, RNA was isolated,
reverse-transcribed and subjected to real-time PCR performed on an ABI PRISM thermal cycler
using SYBR Green PCR core reagents (Applied Biosystems). Detailed information is provided
in Supplemental Information.
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Figure 1
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Figure 1. Strategy to identify direct Foxp3 transcriptional effects
Genetically matched Foxp3* and Foxp3- cell populations were generated by transduction of
FLAG-tagged Foxp3 into a Foxp3- murine T cell hybridoma. Foxp3 binding sites at promoters
across the genome were identified by ChIP experiments with an anti-FLAG antibody. Foxp3
dependent transcriptional regulation was identified by gene expression profiling performed on
each of these cell types.
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Figure 2. Direct Foxp3 targets include key modulators of T cell function
A. Foxp3 ChIP enrichment ratios (ChIP-enriched versus total genomic DNA) across indicated
promoters are shown for stimulated (pink) and unstimulated (blue) cells. Exons (blocks) and
introns (lines) of genes and the mir- 155 precursor (grey) are drawn to scale below the plots, with
direction of transcription noted by an arrow.
B. Foxp3 bound genomic regions are enriched for the presence of a forkhead DNA motif,
represented here in WebLogo (http://weblogo.berkeley.edu).
C. The KEGG (Kanehisa et al, 2000) TCR signalling pathway, enriched (p = 1.4 x 10-5) for
proteins encoded by direct targets of Foxp3 (blue outline), is displayed.
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Figure 3. Foxp3 directly suppresses the activation of target genes
A. Replicate expression data for the 125 genes with Foxp3 dependent differential expression in
stimulated hybridomas (False Disovery Rate [FDR] <0.05) - were hierarchically clustered and
displayed. - The Z-score normalized induction (red) or repression (green) is shown for each gene.
Direct targets of Foxp3 in stimulated hybridomas are indicated (dark blue for FDR <0.05, light
blue for FDR < 0.10).
B. For repressed (green) and induced (red) Foxp3-bound targets in (A) log2(fold difference) in
expression between stimulated ex vivo effector (Teff) T cells and Treg cells is displayed. Slc 7a6
and Adam10 are not expressed in the ex vivo samples.
C. Site-specific PCR on 10 ng of ChIP DNA confirmed selected targets. Immunoprecipitated
(IP) DNA was compared to serial dilutions (90, 30 and 10 ng of DNA) of unenriched whole cell
extract (WCE) DNA. Enrichment ratios, shown at top right of each sub-panel, are normalized
relative to the unenriched beta-actin control. DNA fragment size (bp) is indicated on the left of
each row.
D. The transcript levels of the panel of Foxp3 targets presented in c and of Foxp3 were analysed
by real-time RT-PCR in stimulated and unstimulated cells, with (grey) and without (black)
cyclosporin A. Mean values ± s.d. of relative expression, determined in triplicate, are shown for
indicated genes.
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Figure 4. Core direct regulatory effects of Foxp3
A. Shown here are a subset of direct Foxp3 targets that exhibit consistent transcriptional
behaviour in hybridomas and in ex vivo T cells (Supplemental Fig. S5).
B. Foxp3 binds to a large set of promoters both in unstimulated and stimulated T cells, but Foxp3
transcriptional regulation is more extensive in stimulated T cells. The genomic regions where
Foxp3 binds are enriched for an Nfat binding site DNA motif. In the hybridomas, Foxp3
predominantly acts to directly suppress the activation of its target genes.
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Aberrant Chromatin at Genes Encoding Stem Cell Regulators
in Human Mixed-Lineage Leukemia
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Richard A. Young (2008). Aberrant chromatin at genes encoding stem cell regulators in human
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Abstract
Mixed-lineage leukemia (MLL) fusion proteins are potent inducers of leukemia, but how these
proteins generate aberrant gene expression programs is poorly understood. Here we show that the
MLL-AF4 fusion protein occupies developmental regulatory genes important for hematopoietic
stem cell identity and self-renewal in human leukemia cells. These MLL-AF4-bound regions
have grossly altered chromatin structure, with histone modifications catalyzed by trithorax group
proteins and DOTI extending across large domains. Our results define direct targets of the MLL
fusion protein, reveal the global role of epigenetic misregulation in leukemia, and identify new
targets for therapeutic intervention in cancer.
117
Introduction
Chromosomal translocations involving the mixed-lineage leukemia gene (MLL) are a frequent
occurrence in human acute leukemias of both children and adults (Eguchi et al. 2005). In over
half of all infant acute leukemias, the MLL protein fuses to one of >50 identified partner genes,
resulting in a MLL fusion protein that acts as a potent oncogene (Krivtsov and Armstrong 2007).
While extensive gene expression signatures have been determined for primary human leukemia
samples (Armstrong et al. 2002; Yeoh et al. 2002; Ferrando et al. 2003; Ross et al.
2003; Rozovskaia et al. 2003; Haferlach et al. 2005), the direct genomic targets of MLL fusion
proteins remain unknown. This information is essential to determine how MLL fusion proteins
impose oncogenic transcriptional programs and to identify targets for therapeutic intervention in
human disease.
Distinct chromatin-modifying complexes and histone modifications are associated with
distinct phases of transcription (Li et al. 2007). The trithorax group proteins, including MLL,
catalyze histone H3-Lys-4 trimethyl (H3K4me3) modifications at the start sites of
transcriptionally engaged genes (Ruthenburg et al. 2007). These H3K4me3-modified regions are
largely constrained to the transcription start site regions of genes that are transcriptionally
initiated, but not necessarily fully transcribed (Bernstein et al. 2006; Barski et al. 2007; Guenther
et al. 2007). As a gene becomes fully transcribed, elongating RNA Polymerase 1I (Pol II)
molecules proceed through gene coding regions along with associated elongation factors
including DOT1, which catalyzes dimethylation of histone H3-Lys-79 (H3K79me2) (Li et al.
2007). Physical interactions between the most common MLL partner proteins and transcriptional
elongation components suggest that defects in H3K4 and H3K79 methylation might be a key
factor in MLL leukemogenesis (Erfurth et al. 2004; Milne et al. 2005b; Okada et al. 2005; Zeisig
et al. 2005; Bitoun et al. 2007; Mueller et al. 2007), but the mechanism and extent of H3K79
methylation targeting throughout the genome is poorly understood in human cancer cells.
In order to define the portion of gene regulatory circuitry that is controlled directly by
MLL fusion proteins in human leukemia, we determined the binding patterns of an MLL fusion
protein and chromatin modifications across the entire human genome. We performed this
mapping in leukemic cells harboring the MLL-AF4 fusion gene, because this rearrangement is
the most common among MLL fusions and is associated with an extremely poor prognosis in
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infants and adults (Eguchi et al. 2005). Our results reveal that the MLL-AF4 oncogene produces
gross defects in chromatin structure at a newly defined set of hematopoietic stem cell genes.
Results and Discussion
Identification of MLL-AF4-occupied regions of the genome in human leukemia cells
We used chromatin immunoprecipitation (ChIP) coupled to massively parallel sequencing
(ChIP-Seq) to determine how the MLL-AF4 fusion protein was distributed across the entire
genome in human leukemia cells. This was performed using two acute lymphoblastic leukemia
(ALL) cell lines (Figure 1). The SEM cell line, which was derived from precursor B-cell ALL
patient blast cells (Greil et al. 1994) harbors a t(4; 11) chromosomal translocation and expresses
MLL-AF4 fusion protein, endogenous MLL and endogenous AF4. The REH precursor B-cell
ALL patient-derived cell line (Rosenfeld et al. 1977), which expresses only wild-type MLL and
wild-type AF4, served as a control to identify regions bound by normal MLL and AF4, but not
by the MLL-AF4 fusion protein. Because REH cells were derived from patients with B-cell
ALL, these cells also served to control for general effects of B-cell-type leukemia.
We mapped protein-DNA interactions for the MLL-AF4 protein in SEM cells using
antibodies to the C terminus of AF4 (anti-AF4c) and the N terminus of MLL (anti-MLLN)
(Figure 1A). Since REH cells do not express MLL-AF4 fusion protein, the sites of MLL and
AF4 occupancy that were highly similar in SEM and REH cells are most likely due to binding of
normal MLL or AF4 proteins. We expected large numbers of regions in both SEM and REH to
be occupied by either AF4 or MLL, since these proteins are widely involved in activated
transcription by Pol II (Guenther et al. 2005;Milne et al. 2005a; Bitoun et al. 2007). Indeed, we
found that MLL or AF4 localized near the transcription start sites of several thousand genes in
both SEM and REH cells (Supplemental Table Sl). These bound regions tended to be relatively
small, extended 1-3 kb into the 5' end of the transcribed portion of the gene (Supplemental
Figure Sl), and were associated with transcriptionally active genes (>80% of transcripts called
present by array-based methods in each cell type) (Supplemental Table S2). These data identified
the set of genes occupied by MLL and/or AF4 in precursor B ALL cells and confirmed that these
genes tend to be transcriptionally active.
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We next examined the genome for evidence of binding events specific to MLL fusion
protein. To identify MLL-AF4 fusion protein targets, we applied an algorithm that identifies
coincident ChIP-Seq signals for MLLN and AF4c (Supplemental Material). We identified 226
regions of MLL-AF4 co-occupancy across the genome in SEM cells. This co-occupancy pattern
did not occur in REH cells. Many of the MLL-AF4 target regions showed a striking behavior;
the signal spanned regions of 5-100 kb (Figure 1B). This binding pattern of MLL-AF4 occurred
at genes encoding a variety of important developmental regulators (Figure 2). For example, it
occurred at the PROM] (prominin-1/CD133) gene (Figure 1B), which encodes a defining
antigen of hematopoietic stem cells and is purported to play a role in asymmetric cell divisions in
adult stem cells (Wagner et al. 2004; Toren et al. 2005), and HOXA7, HOXA9, HOXA10 (Figure
2A), whose overexpression are hallmarks of ALLs carrying the t(4; 11) chromosome
translocation (Rozovskaia et al. 2001, 2003; Armstrong et al. 2002;Yeoh et al. 2002; Ferrando et
al. 2003). Overall, MLL-AF4 occupied large domains of 169 known RefSeq genes that were
previously unknown as direct targets (Figure 2B,C; complete gene list in Supplemental Table
S2).
MLL-AF4 target genes encode hematopoietic stem cell developmental regulators
MLL-AF4 target genes were analyzed by Gene Set Enrichment Analysis (GSEA,
htttp://www.broad.mit.edu/gsea) (Subramanian et al. 2005) to determine whether any known
phenotypes were associated with the gene set. The most highly enriched subsets were genes
overexpressed in leukemia cells and genes that encode transcription factors involved in
hematopoiesis (Figure 2D). Genes from the transcription factor group included HOXA9, RUNX]
and ETV6, all of which displayed large areas of MLL-AF4 binding that extended well into the
coding regions of these important proleukemia genes. We also discovered other developmental
regulators not previously associated with ALL, including the TWIST] gene. The TWIST]
transcription factor is an essential mediator of metastatic growth in human breast cancer cells and
also plays a role in nephroblastomas, neuroblastomas, and gastric cancer progression (Pajer et al.
2003; Yang et al. 2004). The TWISTI protein has also been shown to inhibit apoptosis (Puisieux
et al. 2006). Other targets, including the RUNX2 transcription factor and JMJD]C histone
demethylase, were previously shown to be up-regulated in MLL-AF9-induced leukemic stem
cells (Krivtsov et al. 2006), but were not known to be direct targets of MLL fusion proteins.
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Interestingly, UTX is a chromatin modifier responsible for activating HOX loci (Cloos et al.
2008), suggesting a possible reinforcement of HOXA locus overexpression in leukemia. Another
category of genes observed in the GSEA analysis was a set of genes differentially expressed in
hematopoietic stem cells (Figure 2D; Ramalho-Santos et al. 2002). These included
PROM1/CD133, which encodes a surface antigen that is a defining marker of hematopoietic
stem and progenitor cells and is highly expressed in tumor-initiating cells of the colon and brain
(Toren et al. 2005; O'Brien et al. 2007), and the FLT3 signaling mediator. The enrichment for
developmental regulatory factors indicates that the MLL-AF4 oncogene activates specialized
transcriptional programs in cancer cells.
MLL-AF4 targets predict leukemia subclass in human patients
We next tested whether MLL-AF4 target genes identified in SEM cells had altered gene
expression patterns in human patients with MLL-associated leukemia. If MLL-AF4 target genes
specify the MLL-associated leukemia subclass in human cancer, we would expect up-regulation
of these genes in patients exhibiting MLL-associated acute leukemia, but not in patients
exhibiting non-MLL-linked leukemia. RNA transcript levels from leukemic blasts of 132
pediatric ALL patients of B and T lineages (Ross et al. 2003) were compared for expression of
the MLL-AF4 target genes discovered in SEM cells (Figure 3; Supplemental Figure S4).
Significantly, about two-thirds of MLL-AF4 targets in SEM cells were at least 50%
overexpressed in patients with MLL-associated leukemia, but not in non-MLL-associated
leukemia. This overexpression of MLL-AF4 targets was evident not only in MLL-AF4-derived
patients' samples, but also in MLL-AF9 and other MLL-derived leukemias (Ross et al. 2003),
suggesting a central role of this core gene set in the most common MLL-associated leukemias.
The concordance of our MLL-AF4 targets discovered in SEM cells and gene expression
signatures in human leukemia patients indicates that the MLL-AF4 target genes discovered in
vitro are important for disease progression in vivo.
Aberrant chromatin domains occur at regions of MLL-AF4 occupancy
Aberrant modification of chromatin is linked to disease progression in leukemia and other
cancers (Jones and Baylin 2007). Among these modifications is the methylation of histone H3 at
Lys-79 (H3K79me2), which occurs at the 5' coding regions of genes that are experiencing
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productive transcriptional elongation (Steger et al. 2008), and is a critical checkpoint in
transcriptional control (Peterlin and Price 2006; Saunders et al. 2006). Many common MLL
partner proteins have been shown to interact with transcriptional elongation components,
suggesting that H3K79 methylation might be a key factor in MLL leukemogenesis (Erfurth et al.
2004; Milne et al. 2005b; Okada et al. 2005; Zeisig et al. 2005; Bitoun et al. 2007; Mueller et al.
2007), but the mechanism and extent of H3K79me2 targeting throughout the genome is poorly
understood in human cancer cells.
We used ChIP-Seq to determine how the H3K79me2 chromatin modification was
distributed across the genome in SEM cells and to ascertain whether this modification was
associated with all of the MLL-AF4 target regions (Figure 4). We found -8,000 regions of
H3K79me2 enrichment in MLL-AF4 leukemia cells or control cells, with the vast majority
(95%) mapping to known transcripts (Supplemental Tables S14, S19). As expected, most genes
(-95%) marked by H3K79me2 in MLL-AF4 leukemia and in control cells produced transcripts
that were detectable by microarray-based methods (Supplemental Table S2), with peak
enrichment occurring downstream from the transcription start sites (Figure 4D; Supplemental
Figure S5). We next extracted the set of H3K79me2-enriched regions in SEM cells and
compared them with genomic regions enriched for MLL-AF4 fusion protein. This analysis
revealed that -98% of MLL-AF4 targets were enriched for the H3K79me2 elongation mark.
Strikingly, most of these H3K79me2 enrichments formed abnormal domains spanning 5-100 kb
extending upstream of and/or downstream from target gene transcriptional start sites in a highly
similar pattern to the MLL-AF4 fusion protein (Figure 4A,B). In fact, there was a 92% overlap
between the MLL-AF4 target regions and H3K79me2-enriched regions at the DNA base-pair
level. Based on the induction of these chromatin modifications at MLL-AF4 target regions, we
speculate that the MLL-AF4 fusion protein is directly involved in establishing these aberrant
chromatin domains in MLL-linked cancer cells.
Since the elongation-linked H3K79me2 modification forms across large domains with
MLL-AF4 (Figure 4A-C), we asked whether regulators of the elongation checkpoint behaved
similarly. Indeed, elongation proteins were present across aberrant H3K79me2 domains as
determined by ChIP-chip and co-immunoprecipitation experiments. The ENL elongation factor
(eleven-nineteen leukemia) bound across aberrant H3K79me2 domains at the HOXA and MEIS]
loci (Supplemental Figure S6; data not shown) and MLL-AF4 associated with ENL and the
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pTEFb elongation factor in SEM cells (Supplemental Figure S7; data not shown). Together,
these results indicate that the MLL-AF4 protein, the elongation-associated H3K79me2
modification, and additional elongation factors are mistargeted to regions of the genome
encoding key developmental regulators.
We next carried out ChIP-Seq experiments in MLL-AF4 leukemia cells using an
antibody directed against the histone H3K4me3 modification. This modification is a mark of
transcriptional initiation that can be deposited by the MLL complex near the start sites of genes
in normal cells (Ruthenburg et al. 2007). Since MLL suffers a monoallelic deletion of its SET-
containing the H3K4 methyltransferase domain in MLL-AF4 leukemia, we asked whether MLL-
AF4 leukemia cells were able to deposit this histone modification normally across the genome.
We found that H3K4me3 modification occurred normally at the start sites of most active genes
(-90%) in MLL-AF4 leukemia cells (Supplemental Table S2). Strikingly, at many areas of
H3K79me2 mistargeting, H3K4me3 was not only present, but also extended across broad
domains of similar size (Figure 4A-C). These chromatin modifications overlapped highly with
the MLL-AF4 fusion and occurred at key leukemia and stem cell-associated genes including
HOXA 7, HOXA9, PROM], and HMGA2 (Figure 4; Supplemental Table S2). This mislocalization
of both H3K79me2 and H3K4me3 modifications in MLL-AF4-induced leukemia suggests that
the MLL-AF4 fusion protein, a strong transcriptional activator, may be acting at target loci by
directly coupling transcriptional initiation and elongation machinery.
A model for MLL-AF4-mediated activation of stem cell-like transcriptional program in
leukemia
We describe here the first genome-wide assessment of chromatin modifications and oncogene
binding in the most common form of human MLL-associated acute leukemia. The results
indicate that MLL-AF4 fusion proteins selectively occupy regions of the genome that contain
developmental regulators important for stem cell identity and self-renewal. Our results also show
that abnormal patterns of chromatin modifications, including histone H3K79 and histone H3K4
hypermethylation, occur within large domains of MLL-AF4 occupancy. The observation that
MLL-AF4 occupies regions of H3K79 hypermethylation and evidence that MLL-AF4 is
physically associated with elongation factors including DOTI strongly suggests that the fusion
protein is responsible for generating large domains of H3K79 hypermethylation. The presence of
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these aberrant chromatin domains demonstrates that chromatin mistargeting to key regions
across the genome is a feature of leukemogenesis.
The presence of aberrant chromatin domains in MLL-linked cancer cells suggests that an
abnormal "epigenetic" state exists in these cells. Unlike "genetic lesions" that involve changes in
genome sequence in disease cells, "epigenetic lesions" include changes to histone modification
states, DNA methylation states, or distribution of chromatin-modifying enzymes (Esteller
2007; Feinberg 2007). By this definition, the aberrant chromatin domains associated with MLL-
AF4 binding may thus be considered epigenetic lesions. While it has not been established that
these epigenetic lesions cause disease, the H3K79 methylation within these domains likely
contributes to oncogenesis since H3K79 methyltransferase activity is required for transformation
in MLL-AF10-induced leukemia (Okada et al. 2005). The mechanism of how MLL-AF4 and
epigenetic lesions are targeted in the genome remains a central question in leukemia biology.
The binding of the MLL-AF4 fusion protein to a distinct set of developmental genes is of
particular interest. Rather than associating with most cellular genes that are engaged in the act of
transcription, the fusion protein imposes a more specialized gene expression program.
Components of this program include genes not associated previously with MLL-AF4/H3K79me2
mistargeting in leukemia patient-derived cells. These include developmental transcription
factors, chromatin regulators, and signaling proteins that are central to leukemia stem cell
identity, hematopoietic stem cell identity, and self-renewal (Figure 5). Our findings suggest that
MLL-AF4 directly activates a partial hematopoietic stem cell-like transcriptional program found
in leukemia stem cells (Krivtsov et al. 2006; Barabe et al. 2007) in concert with an underlying
gross defect in chromatin structure.
Materials and Methods
A detailed description of all experimental procedures and data analysis methods can be found in
the Supplemental Material.
Cells and cell culture
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Human SEM cells with the t(4; 11) translocation and REH control cells were purchased from the
American Type Culture Collection (ATCC). All cell lines were maintained in RPMI medium
1640 supplemented with 10% FBS. Cells were cross-linked with 1% formaldehyde as described
in the Supplemental Material.
ChIP-Seq
ChIP was combined with direct sequencing as described in detail (Supplemental Material).
Briefly, DNA from 1 x 108 cells was immunoprecipitated with epitope-specific antibody.
Amplified DNA was gel purified and prepared for sequencing using Illumina's Genomic DNA
sample kit. Clustering and 26-cycle sequencing were performed using an Illumina Cluster station
and IG analyzer as per the manufacturer's instructions. ChIP-Seq reads were aligned to the
human genome and analyzed as described in the Supplemental Material.
Gene expression analysis
Total RNA was isolated from 5 x 106 REH or SEM cells by TRIzol extraction. One microgram
of total RNA was labeled according to Affymetrix protocols and hybridized to Affymetrix HG-
U133 2.0 plus arrays. The data were analyzed by using Affymetrix Gene Chip Operating
Software using default settings. Additional gene expression data from human leukemia patient
samples was collated from Ross et al. (2003). Gene expression data and analysis results are
provided in the Supplemental Material.
ChIP-Seq, ChIP-chip, and microarray gene expression data and analysis
Complete ChIP-Seq, ChIP-chip, and microarray gene expression data, analysis methods, and
results are provided in the Supplemental Material section and in the Gene Expression Omnibus
(http://www.ncbi.nlm. nih.gov/geo) database under accession number GSE13313.
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Figure 1. Mapping MLL-AF4 fusion protein-binding sites in human leukemia cells
A. Schematic diagram of strategy for mapping MLL-AF4 fusion protein-binding sites. SEM
precursor B acute leukemia cells express the MLL-AF4 fusion protein. REH precursor B acute
leukemia cells express only endogenous AF4 and MLL 1. The N terminus of MLL (blue) is
recognized by ChIP antibody anti-MLL-N (blue) and immunoprecipitates both wild-type MLL
and MLL-AF4 fusion protein in SEM cells. The C terminus of AF4 (red) is recognized by ChIP
antibody anti-AF4-C and immunoprecipitates both wild-type AF4 and MLL-AF4 fusion protein
in SEM cells. Wild-type AF4 and MLL-N are immunoprecipitated by anti-AF4-C and anti-MLL-
N, respectively.
B. Binding of AF4 (red) and MLL-N (black) in SEM cells (top panels) and REH cells
(bottom panels) as determined by ChIP-Seq. Binding profiles are shown across an 800-kb portion
of the genome surrounding the PROM 1 gene (gene models shown in black below graph; a black
arrow indicates transcription start sites). MLL-AF4 fusion protein binding is indicated by a red
bar.
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D. Selected results of GSEA (http://www.broad.mit.edu/gsea) of MLL-AF4 target genes.
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Figure 3. MLL-AF4 target genes define MLL-linked leukemia in vivo
Hierarchical clustering of relative expression levels of 42 genes occupied by MLL-AF4 fusion
protein target regions >10 kb. Comparisons were made across the SEM and REH cell lines and
132 peripheral blood samples of patients diagnosed with leukemia. Each row corresponds to a
gene that is bound by MLL-AF4 for which expression data were available. Each column
corresponds to a single gene expression microarray. For each gene, expression is shown relative
to the average expression level of that gene across all samples, with shades of red indicating
higher than average expression and green lower than average expression. Columns and rows
were ordered by unsupervised hierarchical clustering. A detailed description of data analysis
methods is provided in the Supplemental Material.
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Figure 4. Mistargeting of chromatin modifications occur as epigenetic lesions at MLL-AF4
target regions
A. Binding of H3K79me2 (green) and H3K4me3 (blue) in SEM cells as determined by ChIP-
Seq. Binding profiles are shown across an 800-kb portion of the genome surrounding
the PROM]gene. Gene models shown in black below the graph; a black arrow indicates
transcription start sites. MLL-AF4 fusion protein-binding regions are indicated by red bars.
B. Binding of H3K79me2 ChIPs (green) and H3K4me3 ChIPs (blue) in SEM cells as determined
by ChIP-Seq. Binding profiles are shown across 15- to 150-kb portions of the genome
surrounding the HOXA9, TWIST], HMGA2, and RUNX2 genes. Gene models are shown in black
(below graph). A black arrow indicates transcription start sites. MLL-AF4 fusion protein binding
is indicated by a red bar.
C. H3K79me2 (green) and H3K4me3 (blue) binding profiles for all MLL-AF4 target genes in
SEM cells. Genes are ordered as in Figure 2C.
D. Composite H3K79me2 ChIP enrichments (green) and H3K4me3 ChIP enrichments (blue) for
all genes (left) and all MLL-AF4 target genes (right). The start site and direction of transcription
of the average gene are indicated by an arrow.
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Figure 5. Model of MLL-AF4-mediated gene activation in leukemia
Schematic diagram of transcriptional misregulation in MLL-AF4-induced leukemia. MLL-AF4
associates with elongation proteins (pTEFb, ENL, and DOTI) at sites of epigenetic lesions.
Phosphorylated and elongating RNA Pol II shown in yellow. Blue (H3K4me3) and green
(H3K79me2) circles represent histone modifications at aberrant chromatin domains. Genes
annotated as bound by MLL-AF4 and playing a role in hematopoietic stem cell function are
shown to the right and subdivided into functional categories.
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Chapter 6
CpG Island Structure Defines Polycomb/Trithorax Chromatin Domains
in Human ES and iPS Cells
Garrett M. Frampton, David A. Orlando, Matthew G. Guenther, and Richard A. Young.
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Abstract
Trithorax Group (TrxG) and Polycomb Group (PcG) protein complexes play key roles in the
epigenetic regulation of development. It is not clear however, what directs these chromatin
regulators to specific sites throughout the genome to generate H3K4me3 and H3K27me3
modified nucleosomes. We demonstrate here that CpG island structure predicts TrxG/PcG
chromatin structure and does this uniquely in human pluripotent stem cells.
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CpG island structure defines Polycomb/Trithorax chromatin domains in human ES and
iPS cells
Trithorax group (TrxG) and Polycomb group (PcG) genes were discovered in Drosophila
melanogaster as activators and repressors of Hox transcription factor genes, which specify cell
identity along the anteroposterior axis of segmented animals. TrxG proteins catalyze
trimethylation of histone H3 lysine 4 (H3K4me3) at the promoters of active genes and facilitate
maintenance of active gene states during development, in part by antagonizing the functions of
PcG proteins. PcG proteins catalyze trimethylation of histone H3 lysine 27 (H3K27me3) and
function to silence genes encoding key regulators of development. TrxG and PcG proteins have
been implicated in control of cell identity, proliferation, X inactivation, genomic imprinting and
cancer (Schwartz and Pirotta, 2007; Simon and Kingston, 2009; Surface et al., 2010). Further
knowledge of how these regulators function is thus fundamentally important for understanding
many biological phenomena.
How TrxG and PcG protein complexes are recruited to their sites of action in vertebrate
cells is not fully understood. Nucleosomes with H3K4me3 are found immediately downstream
of transcription initiation sites (Guenther et al., 2007) consistent with proposals that TrxG
complexes are recruited to active promoter regions by transcription factors and/or the
transcription initiation apparatus (Li et al., 2007; Thomson et al., 2010). In embryonic stem (ES)
cells and induced pluripotent stem (iPS) cells, regions that are occupied by PcG proteins contain
a "bivalent" chromatin structure, containing nucleosomes with both H3K4me3 and H3K27me3,
and occur at the promoters of genes encoding key developmental regulators (Bernstein et al.,
2006; Guenther et al., 2010). There is evidence that PcG protein complexes are recruited to
some of these sites by ncRNAs (Rinn et al., 2007; Pandey et al., 2008; Zhao et al., 2008; Khalil
et al., 2009; Gupta et al., 2010; Kanhere et al., 2010; Tsai et al., 2010; Yap et al., 2010) and
DNA-binding cofactors (Shen et al., 2009; Peng et al., 2009; Li et al., 2010; Pasini et al., 2010).
Several models have been proposed to explain the recruitment of PcG proteins genome-wide
(Mendenhall and Bernstein, 2008; Margueron and Reinberg, 2010; Guenther and Young, 2010).
CpG islands are small genomic elements, ~1kb in length, which lack the suppression of
CG dinucleotides that is found throughout the rest of the genome (Illingworth and Bird, 2009).
Two features of CpG islands led us to investigate the potential relationship between them and the
chromatin structure catalyzed by TrxG and PcG proteins. First, the majority of CpG islands are
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located at the transcription start sites (TSS) of genes, and this is coincident with the genomic
locations of nucleosomes with H3K4me3 and H3K27me3. Second, some of the ncRNA species
that recruit PcG complexes have characteristic GC-rich stem loop structures that are required for
their function (Wutz et al., 2002; Zhao et al., 2008; Kanhere et al, 2010; Yap et al., 2010; Tsai et
al., 2010), suggesting that transcription of CpG islands might generally be involved in PcG
complex recruitment.
We compared the genome-wide localization of CpG islands to the occupancy of
H3K4me3 and H3K27me3 modified nucleosomes for a collection of human ES and iPS cells as
well as several differentiated cell types (human primary fibroblasts, primary CD4+ T cells, and
IMR90 fetal lung fibroblasts) from published and unpublished ChIP-Seq experiments
(Supplemental Information). We observed a striking relationship between H3K4me3 and CpG
islands in ES and iPS cells. In human pluripotent stem cells, CpG islands and H3K4me3
nucleosomes occurred in precisely the same regions across the genome (Figure 1A) with almost
no H3K4me3 modified nucleosomes occurring outside of a CpG island. This relationship was
specific to pluripotent stem cells as compared to several differentiated cell types. Genes
occupied by H3K4me3 in pluripotent cells, but not in differentiated cells were nearly always
associated (93-94%) with CpG islands. On the other hand, genes occupied by H3K4me3 in
differentiated cells but not pluripotent cells were infrequently associated with CpG islands (12-
14%; Table S2A).
Comparing H3K27me3 to CpG islands revealed a more complicated relationship.
Although most CpG islands (86-88%) in ES cells did not contain H3K27me3 modified
nucleosomes, nearly all (86-91%) H3K27me3 occupied regions were associated with CpG
islands. Like H3K4me3, the association between H3K27me3 and CpG islands was specific for
pluripotent cells. Genes occupied by H3K27me3 in differentiated cells but not in pluripotent
cells were frequently not associated with CpG islands (41-52%; Table S2B). Unlike H3K4me3
however, H3K27me3 was not entirely coincident with CpG islands in pluripotent cells and
frequently occurred in the regions between closely spaced CpG islands.
To understand how these results relate to genes, we classified the complete set of human
genes by the number of CpG islands in their promoter regions (Figure IB). We found that -30%
of genes do not have a CpG island at their TSS, ~60% of genes have a single CpG island at their
TSS, and ~10% of genes have two or more CpG islands at their TSS (Table S2D). As expected,
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in ES and iPS cells, the genes with zero CpG islands were occupied by neither H3K4me3 nor
H3K27me3 modified nucleosomes. The genes with a single CpG island were occupied by
H3K4me3, but very few of these genes were also occupied by H3K27me3. The genes with
clusters of multiple CpG islands were nearly all occupied by H3K4me3. Remarkably, the
majority of these genes were also occupied by H3K27me3 (p < 10400; Figure 1C) and they were
highly enriched for genes encoding key regulators of development (p < 10400). In fact, clusters
of CpG islands are found spanning the promoters of nearly every homeobox transcription factor
(Table S3A). These results demonstrate that the number of CpG islands that occur at a gene's
promoter is highly predictive of the TrxG/PcG chromatin structure at those genes in pluripotent
stem cells.
We examined the genes with bivalent chromatin and multiple CpG islands in more detail
and observed that the H3K4me3/H3K27me3 modified nucleosomes and CpG island clusters
spanned the same genomic regions and that the peaks of H3K4me3 occupancy in these regions
were aligned with the individual CpG islands. This phenomenon is most prominent in the four
Hox gene clusters, which each contain -40 CpG islands (Figure S1), but was clearly evident at
approximately 1,000 genes encoding developmental regulators and cellular signaling
components (Table S3B). These results indicate that the TrxG/PcG chromatin structure at
bivalent genes is highly aligned with the local CpG island structure.
Previous studies have identified aspects of the phenomena we describe here, but have not
revealed the striking "rules" that apparently govern the genome-wide occupancy of histone
H3K4me3 and H3K27me3 in human pluripotent stem cells. Previous work (Mikkelsen et al.,
2007) has shown that, in ES cells, H3K4me3 occupancy is correlated with CpG islands. We
demonstrate that H3K4me3 nucleosomes and CpG islands are entirely co-incident across the
genome in pluripotent cells and that this relationship does not extend to differentiated cell types.
Other studies have noted that PcG occupancy can be predicted from the locations, sizes, and
motif contents of CpG islands (Ku et al., 2008), by conservation properties (Tanay et al., 2007)
or by DNA sequence motifs (Liu et al., 2010), but did not reveal that specifically in pluripotent
stem cells, H3K27me3 nucleosomes occur at those promoters that have multiple CpG islands.
These rules for histone H3K4me3 and H3K27me3 occupancy in pluripotent cells help to
constrain models for the function of PcG and TrxG complexes in pluripotent cells and during
differentiation.
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Why do nucleosomes with histone H3K4me3 occur at all CpG islands in human
pluripotent stem cells? One possibility is that transcription initiation occurs at all these sites
(Guenther et al., 2007) and that TrxG proteins are recruited via the transcription apparatus
(Essenberg and Shilatifard, 2009). Another possibility is that proteins that bind to CG
dinucleotides, such as Cfp1, recruit TrxG proteins to all these sites (Thomson et al., 2010).
Why do nucleosomes with histone H3K27me3 occur at genes with multiple CpG islands
in ES and iPS cells? Recent evidence that RNA species containing GC-rich stem loop structures
can contribute to PcG complex recruitment and that transcripts from promoter regions frequently
contain these structures suggests a general model for establishing PcG domains that involves
transcripts from these domains (Guenther and Young, 2010; Wutz et al., 2002; Zhao et al., 2008;
Kanhere et al., 2010; Yap et al, 2010; Tsai et al., 2010).
We investigated the possibility that DNA elements with the potential to encode such GC-
rich RNA structures were enriched in the promoters of genes with multiple CpG islands.
Beginning with the known examples of small ncRNAs that bind to PcG proteins (Figure 2A;
Wutz et al., 2002; Zhao et al., 2008), we examined the promoter sequence of every gene looking
for sequence elements that would be likely to form the characteristic GC-rich stem loop structure
(Figure 2A; Table S2D; Supplemental Information). We found that the promoter regions with
more than one CpG island have a much higher probability of forming the GC-rich RNA
structures that bind PcG protein complexes than those that contain zero or one CpG island (p <
10400, Figure 2B). Furthermore, we found that among genes with one CpG island and among
genes with more than one CpG island, those that were occupied by H3K27me3 had a much
higher probability of forming the characteristic stem loops than those that were not occupied by
H3K27me3 (p < 10100; Figure 2C).
In summary, we have identified several striking relationships between the histone
modifications catalyzed by TrxG and PcG proteins and CpG island structure in human gene
promoters. These relationships are specific to pluripotent stem cells, and are not retained in
differentiated cells. First, H3K4me3 modified nucleosomes and CpG islands and coincident
genome-wide. Second, essentially all H3K27me3 modified nucleosomes occur in close
association with CpG islands. Third, genes that do not have a CpG island at their start site are
occupied by neither H3K4me3 nor H3K27me3. Fourth, genes that have a single CpG island are
occupied by H3K4me3, but not H3K27me3. Fifth, genes with three or more CpG islands are
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occupied by H3K4me3 and H3K27me3, and these chromatin domains precisely span the CpG
island clusters. We also note that genomic regions containing multiple CpG islands have a
higher probability of producing RNA species that could recruit PcG proteins, providing a likely
explanation for why genes with multiple CpG islands are occupied by H3K27me3. We conclude
that CpG island structure plays a fundamental role in defining TrxG/PcG chromatin structure in
human pluripotent stem cells.
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Figure 1. CpG island structure defines the genomic occupancy of H3K4me3 and
H3K27me3 modified nucleosomes in pluripotent stem cells
A. H3K4me3 occupancy is coincident with CpG islands in pluripotent cells. Across the genome,
in the human ES cell line WIBR2, local CG dinucleotide density and H3K4me3 ChIP-Seq
density were tabulated and are presented in a heatmap.
B. Genes were categorized by the number of CpG islands associated with their transcription start
site. The genes encoding the homeobox transcription factor sine oculis homeobox homolog 2
(SIX2), RNA polymerase I polypeptide B (RPOL 1 B), and sodium channel, voltage-gated, type I
alpha (SCN1A), all located on chromosome 2 are shown as examples. H3K27me3 and
H3K4me3 ChIP-Seq density in the hES line WIBR2, local CG dinucleotide density, and CpG
islands are shown.
C. The portion of genes with zero, one, two, and three or more CpG islands that are occupied by
H3K4me3 and H3K27me3 modified nucleosomes in pluripotent stem cells is shown. Error bars
indicate the standard deviation of the values for all ES and iPS cell lines. The * symbol indicates
that the difference between the values for this class of genes and the genome-wide average is
statistically significant (p < 1010) as calculated with a Chi-square test.
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Figure 2. DNA elements encoding RNA species with characteristic GC rich hairpins are
enriched at gene promoters with multiple CpG islands
A. The dual stem-loop RNA hairpin that is known to bind PRC2 is shown.
B. The number of RNA hairpin hits around the TSS (+/-5kb) for genes within zero, one, two, and
three or more CpG islands shows a bias for more hits in genes with multiple CpG islands (see
Supplemental Information for the definition of an RNA hairpin hit). The relative fold
enrichment versus all genes is shown for each CpG class. The * symbol indicates that the
difference between the values for this class of genes and the genome-wide average is statistically
significant (p < 10400) as calculated with a Chi-square test.
C. The number of RNA hairpin hits for genes with one CpG island with or without H3K27me3
occupancy and for genes with more than one CpG island with or without H3K27me3 occupancy
is shown. Data are represented as in (b). The * symbol indicates that the difference between the
values for genes occupied by H3K27me3 and genes not occupied by H3K27me3 is statistically
significant (p < 1040) as calculated with a Mann-Whitney U test.
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Chapter 7
Concluding Remarks
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Concluding Remarks
Tremendous progress has been made in understanding the molecular mechanisms that cells use
to control cell type during development. Despite this strong foundation, there are still immediate
and important questions facing biologists. In these concluding remarks, I describe a few of the
most important, timely, and interesting areas for future research that I have encountered.
Identification of master regulators of cell type based on mining the GEO database
The epigenetic landscape described by Waddington (Waddington 1957) provides a useful model
to describe the development of pluripotent cells from their undifferentiated state to progressively
more specialized cell types (Figure 1). Normal development is unidirectional, proceeding from a
single pluripotent cell, through multi-potent intermediates, to fully differentiated adult cells.
Reprogramming experiments, which allow creation of induced pluripotent stem cells from a
large array of somatic cell types, provide a striking example of the power of master regulator
transcription factors (TF) to control cell type and even promote cell state transitions that do not
occur during normal development (Takahashi and Yamanaka 2006).
Regenerative medicine promises to treat human disease by creating and delivering
healthy cells and tissues to substitute for those that are malfunctioning. The ability to manipulate
cell type has great potential for regenerative medicine because, perhaps, it will enable the
creation of immune-compatible replacements for diseased or damaged cells. Consequently, a
system-wide understanding of the sets of TFs that act as master regulators for each cell type will
be key to advancing the science of regenerative medicine.
The aim of systems biology is to create predictive models of biological systems in order
to understand how they work. Consequently, a detailed account of the complete set of genes
encoding master regulator TFs in the human genome, the cell types that they specify, and the
regulatory networks that they control is necessary for a systems biology description of human
development. Computational methods are likely to be crucial in guiding wet lab research in
achieving such an account. Genes encoding master regulator TFs can be identified based on
characteristic protein domains, cell type specificity can be determined by mining gene expression
data, and regulatory networks architecture and cis-regulatory elements can be predicted using
network prediction algorithms (Segal et al. 2003).
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Figure 1
Figure 1. Waddington's epigenetic landscape
A pluripotent stem cell is positioned at the top of the landscape, poised to begin traveling
towards a differentiated cell type. As the cell differentiates, it loses those properties of
pluripotency and gains the features of a differentiated cell type. (Waddington 1957)
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The TFs Oct4 and Nanog were originally identified as master regulators of ES cells
because, they are homeobox TFs and because they are expressed at a high level specifically in
ES cells and not in other cell types (Scholer et al. 1989a; Scholer et al. 1989b; Nichols et al.
1998). We reasoned that it would be possible to apply a systems biology approach to predict the
master regulator TFs for any cell type. We developed a method that will identify candidate
master regulator TFs for any cell type based on two properties of master regulator TFs. First,
master regulator TFs contain protein domains, such as homeobox and helix-loop-helix domains,
which are characteristic of TFs that regulate cell type during development. Second, master
regulator TFs are expressed at high levels in the cell types that they specify, and are expressed at
low levels or not at all in other cell types. This approach successfully identifies known master
regulator TFs and can identify candidate master regulator TFs for any cell type. The algorithm is
described in detail below.
First, a list of the protein domains that are characteristic of master regulator TFs was
compiled. This was done by identifying all of the genes that are annotated in the Gene Ontology
(GO) database (http://www.geneontology.org/) as transcription factors (GO:0003702: RNA
polymerase II transcription factor activity) and as participating in development (GO:0032502:
developmental process). The PFAM protein domains (http://pfam.sanger.ac.uk/) occurring in
these genes were tabulated and then compared to background frequencies of protein domains
among all genes in the genome. The protein domains occurring significantly more frequently
among the developmental TFs were identified. Subsequently, all genes were examined for the
presence of any of these protein domains. This approach identifies a set of 1,088 human and
1,023 mouse genes that contain protein domains characteristic of master regulator TFs.
The second part of the algorithm for identifying candidate master regulator TFs relies on
finding genes that are expressed in a highly cell type specific manner. These genes are expressed
at high levels in the cells of interest, relative to the full range of expression values observed
across all cell types. To determine the range of expression values for each gene we utilized the
wealth of publically available gene expression data from the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo/) (Edgar et al. 2002). The GEO database contains
more than 46,000 human gene expression samples from the Affymetrix U133 Plus 2.0 platform
(GPL570) and more than 19,000 mouse gene expression samples from the Affymetrix 430 2.0
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platform (GPL1261). These samples provide a rich background that allows accurate
determination of the range of possible expression values for each gene across al.1 cell types.
In order to accurately compare expression signal values from the large variety of samples
in the GEO database it is critical to normalize the samples, so that, for a given gene, an
expression signal has the same meaning for each sample. This was accomplished using a
quantile/rank normalization approach. For the GPL570 and GPL1261 microarray platforms, the
complete set of expression data was downloaded from the GEO database. Samples that were
missing data were discarded and control probesets were discarded. Within each sample, the gene
with the greatest expression signal was identified. The mean of these values was calculated, and
the gene with the greatest signal in each sample was assigned this mean value. This was
repeated for all genes from the greatest signal to the least, assigning each the average expression
signal for all genes of that rank across all samples. Following normalization of the full GEO
datasets, the range of expression values was examined and the 20th and 8 0 th percentile
expression signals for each gene were recorded.
In reality, cell type specificity is a continuum, not a binary property of genes. We created
a heuristic formula to score the degree of cell type specificity of a given gene in an expression
dataset. This score is calculated as follows:
Cell Type Specificity Score = ( Expression Signal - p20 ) / (p80 - p20)
p80 = 80th percentile expression signal
p20 = 20th percentile expression signal
For each gene in an expression dataset, the Cell Type Specificity (CTS) Score is calculated and
all genes in the dataset are ranked from greatest to least CTS Score. The genes are then filtered
to retain those containing protein domains that are characteristic of TFs that control cell type
during development.
In order to test the ability of the CTS algorithm to predict master regulator TFs we
required a set of positive controls. To do this we needed to determine precise criteria that would
define a set of known master regulator TFs and the cell types that they specify. Though many
criteria could be used, the ability to promote trans-differentiation from one cell type to another is
a relatively stringent definition of a master regulator TF. In addition to the example of
reprogramming to iPS cells using several different set of TFs including Oct4, Sox2, Klf4, c-Myc,
Nanog and Esrrb (Takahashi and Yamanaka 2006; Takahashi et al. 2007; Wemig et al. 2007; Yu
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et al. 2007; Feng et al. 2009), several other examples of TF mediated trans-differentiation have
been described. The TF Myodl promotes trans-differentiation of many cell types into myoblast
cells (Davis et al. 1987; Weintraub 1993; Berkes and Tapscott 2005). The TF PPAR-gamma-2
causes trans-differentiation of fibroblasts into adipocyte cells (Tontonoz et al. 1994; Hu et al.
1995). The TFs PU.1 and CEBP-alpha or CEBP-beta cause trans-differentiation of fibroblast
cells into macrophage cells (Feng et al. 2008). Finally, the TF Foxp3 causes conventional helper
T cells to assume a suppressive phenotype characteristic of regulatory T cells. The CTS method
does an excellent job of predicting most of the known TF that mediate trans-differentiation. For
ES cells, Oct4, Sox2, Nanog, and Esrrb are all in the top 10 predicted TFs. Klf4 and c-Myc are
not predicted as master regulators of ES cells, though n-Myc is. For myoblast cells, MyoD1 is
the 2rd predicted TF. For adipocyte cells, PPAR-gamma-2 is the 3 'd predicted TF. For
macrophage cells, PU.1 is the 4th predicted TF, but neither CEBP-alpha nor CEBP-beta is
predicted. Lastly, Foxp3 in the 3rd predicted TF in regulatory T cells.
One of the weaknesses of microarray gene expression data is that the expression values
for different genes are not directly comparable. RNA species have different efficiencies in
microarray sample preparation and each probe on a microarray has a different hybridization
efficiency and background signal. Furthermore, mRNAs have different translational efficiencies.
Consequently, there is a poor correlation between the expression signal of a gene in a microarray
experiment and the amount of that protein that is present in a cell. An expression signal of 1,000
units for one gene does not have the same meaning as an expression signal of 1,000 for a
different gene. As a result, in expression data analysis, the expression level of a gene can be
meaningfully compared across samples, but it is generally not meaningful to compare the
expression levels of different genes within one sample. One of the reasons why the CTS
approach is so successful is that it transforms all of the expression values for different genes in
one expression sample onto the same scale. Within this scale, different genes can be directly
compared to each other. Normalization based on the range of observed expression values for
each gene across the GEO dataset provides context to interpret absolute expression values.
In the future there are several elements that I plan to add to this project prior to
publication. First, I will create a web-tool, hosted on the Whitehead Institute website, which will
allow biology researches around the world to apply the Cell Type Specificity algorithm to their
datasets of interest. Users would input GEO database accession numbers and the web-tool
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would download those datasets from GEO and subject them to CTS analysis with no additional
user input necessary. I also plan to allow users to upload and analyze personal datasets that are
not in the GEO database.
The Cell Type Specificity web-tool will have significant utility beyond the ability to
predict master regulator TFs. The CTS algorithm can also be used to identify other classes of
genes, such as signaling components, chromatin regulators, or any other subset of genes, that
define a cell type of interest. I am working to define precisely which genes belong to these
additional classes beyond transcription factors. Additionally, the web-tool will output CTS
scores for all genes in an expression dataset without filtering. Cell type specific genes provide
significant of information about a cell type of interest. I plan to find a few strong examples of
how identifying cells with highly cell type specific gene expression patterns can give important
information to biology researchers outside the field of transcriptional regulation. Finally, the
website will be a powerful tool for gene expression data mining, retrieval and normalization,
even if users are not interested in conducting CTS analysis.
It has recently been reported that cell type specific genes tend to be targeted by the
Mediator and Cohesion protein complexes (Kagey et al. 2010) and by H3K4me2 modified
nucleosomes (Pekowska et al. 2010). I plan to test whether the CTS scoring metric is a good
predictor of targeting by Mediator, Cohesin, and H3K4me2. In Chapter 1, I hypothesize that
targeting cell type specific genes is a general property of master regulator TFs. I plan to test this
hypothesis by examining existing location analysis datasets profiling the occupancy of Oct4,
Sox, and Nanog in ES cells (Marson et al. 2008), the occupancy of MyoDI in myoblast cells
(Cao et al. 2010), the occupancy of PU. 1 in hematopoietic cells (Novershtern et al. 2010), the
occupancy of PPAR-gamma in adipocyte cells (Mikkelsen et al. 2010), and the occupancy of
Foxp3 in regulatory T cells (A. Marson, personal communication).
Future Directions
It is not well understood why transcription factors occupy some sites in the genome, while other
sites with the same DNA sequence are not occupied. For example, in ES cells, the DNA element
that is bound by the master regulators Oct4, Sox2, and Nanog (OSN) is well characterized. This
16 basepair DNA motif (Figure 2) occurs at all high confidence ChIP-Seq binding sites for OSN
and is significantly more conserved than surrounding sequences (Marson et al. 2008). We do not
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currently understand why, however, only a small fraction of the instances of this DNA element
genome-wide are occupied by OSN. It is believed that there are additional DNA elements
surrounding the core OSN motifs that are occupied by additional TFs, which physically interact
with OSN. These additional TF binding sites could theoretically add information specifying
which instances of the OSN motif should be occupied, but no other DNA elements that specify
the occupancy of the OSN TFs have been described. Whether this phenomenon is truly
important for specifying the genome-wide occupancy of OSN has not been investigated. A
genome-wide examination of whether there exist additional DNA elements, beyond the core
OSN motif, that specify the occupancy of OSN could help to clarify why only some sites in the
genome are occupied by master regulator TFs. Alternatively, it is possible that occupancy of
OSN in ES cells is specified by an epigenetic mark whose genomic occupancy is not ultimately
dependent on the underlying DNA sequence. How this process could occur however, has not
been described.
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Figure 2. The DNA motif that is bound by OCT4, SOX2, and NANOG in ES cells
One hundred basepairs of genomic sequence, centered at the five hundred largest OCT4 ChIP-
Seq peaks (Marson et al. 2008), were submitted to the motif discovery tool MEME (Bailey and
Elkan 1995; Bailey et al. 2006) to search for over-represented DNA motifs. A single sixteen
basepair motif was discovered by the MEME algorithm. This motif was significantly (p < 10400)
over-represented, occurring in 92% of the Oct4 bound sequences. The figure image was
generated using the online tool WebLogo (http://weblogo.berkeley.edu/).
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Much of the current knowledge of the role of transcriptional regulatory circuitry in
control of cell type has been obtained in the context of a static cell state. It is important to
remember, however, that during development, the differentiation of cells from one cell type to
another is fundamentally important. Consequently, we would like to better understand how
transcriptional regulatory circuitry works as a cell transitions from one type to another. In what
ways are cells primed to shut down existing circuitry and how are new circuitry elements turned
on? Is normal development always unidirectional? What are the logic circuits describing cell
fate decisions for all of human development? Though most of these questions are unanswered,
great progress in this area is likely to occur over the next few years, and a few general principles
have emerged from existing research. Master regulator TFs sometimes occupy sites in
progenitor cells that will be important for later cell types (Novershtern et al. 2010). Additionally,
master regulator TFs sometimes co-occupy the genome with co-factors that are required for
terminating the action of the master regulators upon differentiation (Whyte et al. 2010).
It has become increasingly evident that non-coding RNAs (ncRNA) play an important
role in a diverse array of cellular processes including genomic imprinting, heterochromatin
formation (Buhler and Moazed 2007), recruitment of histone modifying enzymes (Rinn et al.
2007), translational inhibition, and degradation of mRNAs (Bartel 2009). There are a number of
reasons why the importance of ncRNAs may have been underappreciated until recently. First,
RNA molecules are generally less chemically stable than DNA or polypeptides, so species of
interest are harder to detect. Additionally, the complexity of RNA species that exist within a cell
is much greater than the complexity of DNA or protein species due to the huge set of possible
transcription start and end sites in combination with the RNA splicing and editing. Finally, the
evolutionary pressures acting on many ncRNAs may not require the maintenance of the RNA
sequence, so the signal of evolutionary conservation is hard to identify. Bioinformatic analysis
in mammals and in Drosophilae has revealed that DNA elements can be identified based on
sequence conservation (Xie et al. 2005; Stark et al. 2007). A similar approach focused on
ncRNAs could reveal functional RNA secondary structures that occur more frequently and are
more highly conserved than would be expected by chance.
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Appendix A
Supplemental Material for Chapter 2
Chromatin Structure and Gene Expression Programs of
Human Embryonic and Induced Pluripotent Stem Cells
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Supplemental Experimental Procedures
ES, iPS, and fibroblast cells and cell culture
All primary human fibroblasts cells described in this paper (PDB-AG20442 and GM-MO1660)
were purchased from the Coriell Cell Repository (Camden, NJ). Fibroblasts were cultured in
fibroblast medium (Dulbecco's modified Eagle's medium [DMEM] supplemented with 15% fetal
bovine serum [FBS; Hyclone], 1 mM glutamine [Invitrogen], 1% nonessential amino acids
[Invitrogen], and penicillin/streptomycin [Invitrogen]).
hiPS cell lines iPS AL, iPS CL, iPS4, iPS A6 (Hockemeyer et al. 2009); hiPS cell lines
iPS PDB2 ox -17, iPS PDB2ox-21, iPS PDB2ox-5, iPS PDB2Iox-22, iPS PDB"x-17puro-5, iPS
PDB" -17puro-10, iPS PDB' lo-17puro-33, iPS PDB" *-21puro-20, iPS PDB"ox-21puro-26,
and iPS PDB"ox-21puro-28 (Soldner et al. 2009); hES cell lines BGO1 and BG03 (National
Institutes of Health code: BGO1 and BG03; BresaGen, Inc., Athens, GA); hES cell lines WIBRI,
WIBR2, WIBR3, and WIBR7 (Lengner et al., 2010; Whitehead Institute Center for Human Stem
Cell Research) and hES cell line H9 (NIH Code:WA09, Wisconsin Alumni Research
Foundation, Madison, WI) were maintained on mitomycin C-inactivated mouse embryonic
fibroblast (MEF) feeder layers in hESC medium (DMEM/F12 [Invitrogen] supplemented with
15% FBS [Hyclone], 5% KnockOut Serum Replacement [Invitrogen], 1 mM glutamine
[Invitrogen], 1% nonessential amino acids [Invitrogen], 0.1 mM p-mercaptoethanol [Sigma], and
4 ng/ml FGF2 [R&D Systems]). Cultures were passaged every 5 to 7 days either manually or
enzymatically with collagenase type IV (Invitrogen; 1.5 mg/ml). hiPS cell lines were passaged
15-25 times prior to ChIP-Seq and gene expression analysis.
ChIP-Seq Experiments and Analysis
Chromatin immunoprecipitation
Protocols describing chromatin immunoprecipitation (ChIP) materials and methods can be
downloaded from http://web.wi.mit.edu/young/hESPRC and have previously been described in
detail (Lee et al. 2006).
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Human ES, iPS or fibroblast cells were grown to a final count of -5x1 07 cells to obtain
starting material for six chromatin immunoprecipitations. Cells were chemically cross-linked by
the addition of one-tenth volume of fresh 11% formaldehyde solution for 15 minutes at room
temperature. Cells were rinsed twice with IX PBS, harvested by centrifugation, and flash frozen
in liquid nitrogen. Cross-linked cells were stored at -80'C prior to use.
Cells were re-suspended, lysed and sonicated to solubilize and shear cross-linked DNA.
Sonication was performed using a Misonix Sonicator 3000 at a power of 27W for ten 30 second
pulses with a 90 second pause between each pulse. Samples were kept on ice at all times.
The resulting whole cell extract was incubated overnight at 4 degrees C with 10pl of
Dynal Protein G magnetic beads that had been pre-incubated with approximately 3 pIg of the
appropriate antibody. Each individual immunoprecipitation used 1/6 of the 3ml total, or ~8 x10 6
cells per IP. The immunoprecipitation was allowed to proceed overnight. Beads were washed
three times (3 x 1.5ml) with RIPA buffer and one time (lx 1.5ml) with TE containing 50 mM
NaCl. Bound complexes were eluted from the beads by heating at 65 degrees C with occasional
vortexing and cross-linking was reversed by overnight incubation at 65 degrees C. Whole cell
extract DNA (reserved from the sonication step) was also treated for cross-link reversal.
Immunoprecipitated DNA and whole cell extract DNA were then purified by treatment with
RNAse A, proteinase K and two phenol:chloroform:isoamyl alcohol extractions.
The ChIP antibodies used were ab8580 (Abcam) for H3K4me3 and ab6002 (Abcam) for
H3K27me3.
ChIP-Seq sample preparation
All protocols for Solexa sample preparation and sequencing are provided by Illumina
(http://www.illumina.com/). A brief summary of the technique, minor protocol modifications,
and data analysis methods are described below.
Purified ChIP DNA was prepared for sequencing according to a modified version of the
Illumina/Solexa Genomic DNA protocol. Approximately 50-200ng of IP DNA was prepared for
ligation of Solexa linkers by repairing the ends and adding a single adenine nucleotide overhang
to allow for directional ligation. A 1:100 dilution of the Adaptor Oligo Mix (Illumina) was used
in the ligation step. A subsequent PCR step with 18 amplification cycles added additional linker
sequence to the fragments to prepare them for annealing to the Genome Analyzer flow-cell.
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Amplified material was purified by Qiaquick MinElute (Qaigen) and a narrow range of fragment
sizes was selected by separation on a 2% agarose gel and excision of a band between 150-300
bp, representing IP fragments between 50 and 200nt in length and ~100bp of primer sequence.
The DNA was purified from the agarose and diluted to 10 nM for loading on the flow cell.
Solexa sequencing
The DNA library (2-4 pM) was applied to one lane of the flow-cell (eight samples per flow-cell)
using a Cluster Station device (Illumina). The concentration of library applied to the flow-cell
was calibrated so that polonies generated in the bridge amplification step originate from single
strands of DNA. Multiple rounds of amplification reagents were flowed across the cell in the
bridge amplification step to generate polonies of approximately 1,000 strands in Ip m diameter
spots. Double stranded polonies were visually checked for density and morphology by staining
with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a microscope under
fluorescent illumination. Validated flow-cells were stored at 4 degrees C until sequencing.
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the Genome
Analyzer 1G (Illumina). After the first base was incorporated in the sequencing-by-synthesis
reaction the process was paused for a key quality control checkpoint. A small section of each
lane was imaged and the average intensity value for all four bases was compared to minimum
thresholds. Flow-cells with low first base intensities were re-primed and if signal was not
recovered the flow-cell was aborted. Flow-cells with signal intensities meeting the minimum
thresholds were resumed and sequenced.
Images acquired from the Genome Analyzer were processed through the bundled image
extraction pipeline (Illumina), which identified polony positions, performed base-calling and
generated QC statistics.
Sequencing of the H3K27me3 ChIP from the hES BG03 cell line failed several quality
control metrics and this sample not used for analysis except for gene track comparisons and the
profile shown in Figure IF.
Genomic mapping of ChIP-Seq data
165
ChIP-Seq reads were aligned using the software Bowtie (Langmead et al., 2009) to NCBI build
36.1 (hgl8) of the human genome with default settings. Sequences uniquely mapping to the
genome with zero or one mismatch were used in further analysis.
Public availability of ChIP-Seq data
Complete ChIP-Seq data are available from the Gene Expression Omnibus database
(http://www.ncbi.nih.gov/geo/) under the accession number GSE22499.
ChIP-Seq density calculation and normalization of ChIP-Seq samples
The analysis methods used were derived from previously published methods (Barski et al., 2007;
Johnson et al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007). The genome was divided
into bins 100 base pairs in width, beginning at the first base of each chromosome. For
identification of genomic regions with statistically significant differential ChIP-Seq occupancy
250 bp bins were used due to computer memory constraints. Each ChIP-Seq read was shifted
100 bp from its mapped genomic position and strand to the approximate middle of the sequenced
DNA fragment. The ChIP-Seq density within each genomic bin was then calculated as the
number of ChIP-Seq reads mapping within a 1kb window (+/- 500bp) surrounding the middle of
that genomic bin.
In order to facilitate comparison of ChIP-Seq samples a quantile normalization method
was used. In each ChIP-Seq sample the genomic bin with the greatest ChIP-Seq density was
identified. The mean of these values was calculated and the bin with the greatest signal in each
sample was assigned this mean value. This was repeated for all genomic bins from the greatest
signal to the least, assigning each the average ChIP-Seq signal for all bins of that rank across all
samples. H3K4me3 and H3K27me3 samples were subjected to quantile normalization as
separate groups.
Identification of ChIP enriched genomic regions and genes
Genomic bins with a normalized ChIP-Seq density greater than a defined threshold were
considered enriched. Adjacent enriched bins were combined into enriched regions. For
H3K4me3 a threshold of 30 normalized reads per kb and for H3K27me3 a threshold of 25
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normalized reads per kb was used. A summary of the H3K4me3 and H3K27me3 occupied
regions is provided in Table Si.
The genomic coordinates of the full set of transcripts from the RefSeq database
(http://www.ncbi.nlm.nih.gov/RefSeq/) from the March 2006 version of the human genome
sequence (NCBI Build 36.1, hgl8) was downloaded from the UCSC Genome Browser
(http://genome.ucsc.edu/cgi-bin/hgTables) on March 1, 2009. Genes were associated with
H3K4me3 and H3K27me3 occupied genomic regions if the gene transcription start site (TSS)
occurred within the region or if the distance from the TSS to the boundary of the region was less
than or equal to 2 kb. If multiple regions were associated with a single gene, all of these gene are
reported the region with the greatest peak ChIP-Seq density used. A summary of the genes
associated with H3K4me3 and H3K27me3 occupied regions is provided in Table S1.
Pairwise comparisons of H3K4me3 and H3K27me3 occupied genes and peak heights
For each RefSeq gene the peak normalized ChIP-Seq density in the region from -2 kb to +2 kb of
the transcription start site was examined. A gene was considered to have different ChIP-Seq
occupancy between two cell lines for H3K4me3 if the peak signal at the transcription start site
(+/- 2 kb) was greater than or equal to 30 units in one cell line and less than 20 units in the other
cell lines. A gene was considered to have different ChIP-Seq occupancy between two cell lines
for H3K27me3 if the peak signal at the transcription start site (+/- 2kb) was greater than or equal
to 25 units in one cell line and less than 15 units in the other cell line. The percentage of all
RefSeq genes with different ChIP-Seq occupancy between the two samples was reported in
Table S2.
To compare H3K4me3 or H3K27me3 peak heights between two samples the peak ChIP-
Seq density in the region from -2 kb to +2 kb of the transcription start site was examined. For
each gene that was occupied by that histone mark in at least one of the two samples the
coefficient of variation was recorded. The average coefficient of variation of peak heights
between the two samples was reported in Table S2.
ChIP-Seq density heatmaps and composite ChIP-Seq density profiles
For ChIP-Seq density heatmaps, genes were aligned using the position and direction of their
transcription start sites. Heatmaps showing the H3K4me3 and H3K27me3 ChIP-Seq density
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around gene start sites (-4,500 bp to +4,500 bp) within 500bp bins were generated using Java
Treeview (http://jtreeview.sourceforge.net/).
For composite ChIP-Seq density profiles, genes were aligned using the position and
direction of their transcription start sites. The average ChIP-Seq density around the transcription
start sites of all genes in 500 bp bins was calculated for ES cells and iPS cells.
Statistical method for identifying genomic regions with differential ChIP-Seq occupancy
A test statistic, the 'differential ChIP-Seq score' was created to quantify the degree of differential
ChIP-Seq density at a given position in the genome for two groups of ChIP-Seq samples. For
each set of four adjacent 250 bp genomic bins the differential ChIP-Seq score was calculated as
the absolute value of the mean signal of the samples in group A (A) minus the mean signal in of
the samples in the group B (B) divided by an estimate of the noise of these measurements
(NOISEAB), which is described in more detail below.
Differential ChIP-Seq score = | A - B I / NOISEAB
The value of the NOISEAB was calculated using the following method. First, in each set of four
adjacent 250 bp bins across the genome, the mean and standard deviation of the ChIP-Seq signal
for all samples, rounded to the nearest integer, was tabulated. Second, for each mean ChIP-Seq
signal, the median standard deviation (stdev) was recorded. Third, a power function, predicting
the noise in these ChIP-Seq datasets, was fit to this set of mean/stdev pairs. This function was of
the form;
NOISE(MEAN)= x * MEAN/y
This power function provided a good representation of the dependence between the signal
intensity and noise for these ChIP-Seq experiments across the full range of signal intensities,
from zero to hundreds of reads per kilobase.
The value of NOISEAB was then calculated as the mean of the maximum of the value of
the power function at the mean signal for the samples in group A, NOISE(A), and the actual
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standard deviation of these measurements A and the maximum of NOISE(B) and the actual
standard deviation of the measurements in group B.
NOISEAB= mean( max( GA, NOISE(A)), max( GB, NOISE(B))
GA= STANDARD DEVIATION OF THE SIGNAL IS SAMPLES FROM GROUP A
GB= STANDARD DEVIATION OF THE SIGNAL IS SAMPLES FROM GROUP B
To assess the statistical significance of a given differential ChIP-Seq score, a permutation
method was used. The distribution of differential ChIP-Seq scores under the null hypothesis was
modeled by shuffling the sample to group assignments and re-calculating the test statistic. Based
on the permuted sample/group assignments the differential ChIP-Seq scores were re-calculated
and tabulated. All possible combinations of sample/group assignments were used to determine
the null distribution except for the actual assignments and the inverse of the actual assignments.
Using this null distribution of differential ChIP-Seq scores, a false discovery rate (FDR)
associated with any differential ChIP-Seq score could be calculated. This was the fraction of the
genomic bins in the null distribution with that score or greater, (PNULL) divided by the fraction in
the actual distribution with that score or greater (PACTUAL)-
FDR( differential ChIP-Seq score ) = PNULL / PACTUAL
A false discovery rate threshold of 5% was used for the identification of genomic regions with
statistically significant differential ChIP-Seq occupancy between male and female cells and
between ES and iPS cells and an FDR threshold of 1% was used for the comparison of
pluripotent to fibroblast cells. Adjacent sets of genomic bins that were identified as differentially
occupied were combined into regions.
Gene Expression Experiments and Analysis
Sample preparation, hybridization, staining, scanning, and image analysis
5 ig total RNA was used to prepare biotinylated cRNA according to the manufacturer's protocol
(Affymetrix One Cycle cDNA Synthesis Kit). Briefly, this method involves SuperScript II-
169
directed reverse transcription using a T7-Oligo-dT promoter primer to create first strand cDNA.
RNase H-mediated second strand cDNA synthesis is followed by T7 RNA Polymerase directed
in vitro transcription, which incorporates a biotinylated nucleotide during cRNA amplification.
Samples were prepared for hybridization using 15 ptg biotinylated cRNA in a IX
hybridization cocktail with additional hybridization cocktail components provided in the
GeneChip Hybridization, Wash and Stain Kit (Affymetrix). GeneChip arrays (Human U133
Plus 2.0) were hybridized in a GeneChip Hybridization Oven at 45 degrees C for 16 hours at 60
RPM. Washing was performed using a GeneChip Fluidics Station 450 according to the
manufacturer's instructions, using the buffers provided in the Affymetrix GeneChip
Hybridization, Wash and Stain Kit. Arrays were scanned on a GeneChip Scanner 3000 and
images were extracted and analyzed using the default settings of GeneChip Operating Software
v1.4.
Public availability of gene expression data
Complete gene expression data are available from the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE22499.
Previously published gene expression datasets
Three previously published datasets comparing gene expression profiles of human ES, iPS and
fibroblast cells, using the Affymetrix U133 Plus 2.0 (GPL570) microarray platform were
obtained from the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) database. For
Chin et al. (Chin et al., 2009) data were obtained from the GEO accession numbers GSE9865
and GSE16654 and data from GSE16654 were subjected to an inverse (backwards) logarithmic
(base 2) transformation to return them to the same linear scale as the other datasets. For
Maherali et al. (Maherali et al., 2008) data were obtained from the GEO database accession
GSE12390 and used with no additional processing. For Yu et al. (Yu et al., 2009) data were
obtained from the GEO database accession GSE15148 and subjected to an inverse (backwards)
logarithmic (base 2) transformation to return them to the same linear scale as the other datasets.
Each expression dataset was normalized and analyzed for statistically significant differential
expression separately using the methods described below except in Figure 4, where all datasets
were normalized and clustered as one group.
170
Expression data normalization
The data from each gene expression sample were floored at zero and linearly scaled to a mean
expression signal of 500 units. Then, all expression signal values were increased by ten units to
force all signals to be greater than one unit in logarithmic space. Subsequently, within each
dataset, expression signal values were quantile normalized by assigning each probeset the
average signal intensity for all probesets of the same rank across all samples. Each expression
dataset was normalized separately except in Figure 4, where all datasets were normalized as one
group.
Expression data annotation and identification of differentially expressed transcripts
Probeset annotations were downloaded from the NetAffx database (http://www.affymetrix.com
/analysis/index.affx) on October 1, 2009. Expression datasets were analyzed for statistically
significant differential expression using the online NIA Array Analysis Tool
(http://lgsun.grc.nia.nih.gov/ANOVA/). Expression data was transformed into log space by the
webtool upon upload. All probesets were tested for differential expression using the following
settings.
Threshold z-value to remove outliers: 10000
Error Model: Bayesian
Size of sliding window for averaging error variances: 500
Proportion of highest variance values to be removed: 0
Desirable degrees of freedom for Bayesian error model: 10
Number of permutations: 0
For identification of differentially expressed transcripts between ES and iPS cells an FDR
threshold of 0.05 was used. For identification of differentially expressed transcripts between
pluripotent cell lines and fibroblast cells an FDR threshold of 0.01 was used. We required that
differentially expressed transcripts had at least a 1.5 fold change in signal intensity.
The probesets differentially expressed between human ES and iPS cells and between
pluripotent and fibroblast cells in this study, Chin et al., Maherali et al., and Yu et al. are
171
provided in Table S5. The numbers of overlapping probesets and genes between these four
datasets are also provided in Table S5.
Heatmap display and hierarchical clustering of expression data
For heat map display expression data was normalized using a formula similar to a Z-score with
the following modifications. Instead of using the mean and standard deviation of all samples, the
mean and standard deviation was calculated within each cell type. Then, the mean of the within
cell type means, and the mean of the within cell type standard deviations was used for Z-score
normalization. This served to create a balanced color range, which was not biased towards
groups of samples greater numbers of expression samples.
Centroid linkage, centered correlation distance, hierarchical clustering was performed
using the software Cluster 3.0 (http://bonsai.ims.u-tokyo.ac.jp/-mdehoon/software/cluster/).
Heatmaps were generated using the software Java Treeview (http://jtreeview.sourceforge.net/).
Cluster branches were flipped about tree nodes for optimal display.
RT-PCR validation of microarray based expression data
For RNA analysis, hES and hiPS colonies were mechanically isolated and pooled for RNA
extraction. Total RNA was isolated from ES, iPS, and fibroblast cells using RNeasy MiniKit
(Qiagen). One microgram of total RNA was reverse transcribed using the Invitrogen Superscript
III First Strand Synthesis System with oligo-dT primers to produce cDNA. One microliter of
cDNA (1/150 of cDNA synthesis reaction) was used for each individual quantitative PCR
measurement. cDNA was amplified using TaqMan Pre-developed gene expression assays (20X
mixture supplied by Applied Biosystems which included pre-optimized primers and
probe;Applied Biosystems). Triplicate reactions were performed in a total of 20pl using Taqman
universal PCR master mix in an Applied Biosciences 7500 Real Time PCR Thermocycler. The
following probes were used to detect expression in each of four ES cell lines (BG03, WIBR2,
WIBRI, WIBR3), four iPS cell lines (iPS 21, iPS Cl, iPS 17, iPS A6), and two donor fibroblast
cell lines (Fibroblast PDB, Fibroblast GM):
Positive control: POU5FI, Hs00999632_gl
Internal standard: GAPDH, Hs02786624_gl
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Test (previously determined by Affymetrix expression array
Chin et al.) SOX9 - HsO0165814_ml
Test (previously determined by Affymetrix
Chin et al.) CAT - HsOO 156308_ml
Test (previously determined by Affymetrix
Chin et al.) FN1 - Hs01549980_gl
Test (previously determined by Affymetrix
Guenther et al.) PUS7L - HsO 1094423_ml
Test (previously determined by Affymetrix
Chin et al.) BMPR2 - Hs00176148_ml
Test (previously determined by Affymetrix
Maherali et al.) IRX3 - Hs00735523_ml
Test (previously determined by Affymetrix
Yu et al.) GREM1 - Hs00171951_ml
expression array as differential in iPS vs ES cells in
expression array as differential in iPS vs ES cells in
expression array as differential in iPS vs ES cells in
expression array as differential in iPS vs ES cells in
expression array as differential in iPS vs ES cells in
expression array as differential in iPS vs ES cells in
Detection of abundance was determined by measuring the point during cycling when
amplification could first be detected, rather than the endpoint of the 40 cycle reaction. This cycle
threshold (Ct) value corresponds to the fractional cycle number where the florescent Taqman
probe increases above a fixed threshold (Auto Ct) determined by the ABI Prism 7000 Sequence
Detection System software. The measured Ct value was used to calculate the estimated
transcripts present in the test sample using relative quantization to the average internal standard
GAPDH. Average Ct was calculated for each condition, a "delta Ct" value calculated by
subtracting control GAPDH Ct. Expression was calculated as relative to Fibroblast PDB line,
with fibroblast PDB expression normalized to 1.
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Figure S1. Expression of genes associated with genomic regions having differential
H3K4me3 and H3K27me3 occupancy between ES and iPS cells
A. Expression data for genes differentially occupied by H3K27me3 between ES and iPS cells.
Genes are ordered by the magnitude of differential H3K27me3 occupancy. Samples with higher
than average expression are shown in red and samples with lower than average expression are
shown in green (scale in standard deviations).
B. Expression data for genes differentially occupied by H3K4me3 between ES and iPS cells.
Genes are ordered by the magnitude of differential H3K4me3 occupancy. Samples with higher
than average expression are shown in red and samples with lower than average expression are
shown in green (scale in standard deviations). See also main text Figure 3.
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Figure S2. RT-PCR based validation of genes identified as differentially expressed by
microarray data
Expression of genes (relative to expression level in fibroblast cells) in ES and iPS cells.
Triplicate reactions were performed using Taqman universal expression probes. All samples
were normalized to Internal standard GAPDH gene. cDNA from the cell lines 1) Fibroblast
PDB, 2) Fibroblast GM, 3) iPS PDB 2ox-21, 4) iPS C1, 5) iPS PDB21ox17, 6) iPS A6, 7) BG03, 8)
ES WIBR2, 9) ES WIBRI, 10) ES WIBR3 was used. The Taqman probes used were POU5F1
(Positive control); SOX9 (previously determined by Affymetrix expression array as differential
in iPS vs ES cells in Chin et al.); CAT (identified as differentially expressed in iPS vs ES cells in
Chin et al.); FN1 (identified as differentially expressed in iPS vs ES cells in Chin et al.); PUS7L
(identified as differentially expressed in iPS vs ES cells in Guenther et al.) BMPR2 (identified as
differentially expressed in iPS vs ES cells in Chin et al.); IRX3 (identified as differentially
expressed in iPS vs ES cells in Maherali et al.); GREMI (identified as differentially expressed in
iPS vs ES cells in Yu et al.). The results show that POU5F1 is highly expressed in ES and iPS
cells relative to fibroblasts as expected and that the PUS7L gene is differentially expressed in iPS
vs ES cells, consistent with microarray based expression analysis in the same cells. Other genes
do not show consistent differences between ES and iPS cells in our cell lines, which is not
consistent with previously published results. See also main text Figure 3.
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Supplemental Tables
Table S1. H3K4me3 and H3K27me3 occupied genomic regions and genes in ES, iPS, and
fibroblast cells
A) H3K4me3 occupied genomic regions
B) H3K27me3 occupied genomic regions
C) H3K4me3 occupied genes
D) H3K27me3 occupied genes
Table S2. Pairwise comparisons of H3K4me3 and H3K27me3 occupied genes and peak
heights between ES, iPS, and fibroblast cells and between iPS cells with integrated and
excised transgenes
A) Comparisons of H3K4me3 occupied genes
B) Comparisons of H3K27me3 occupied genes
C) Comparisons of H3K4me3 peak heights
D) Comparisons of H3K27me3 peak heights
Table S3. Genomic regions with statistically significant differential H3K4me3 and
H3K27me3 occupancy between male and female pluripotent cells, between pluripotent and
fibroblast cells, and between ES and iPS cells
A) Regions with different H3K4me3 between male and female pluripotent cells
B) Regions with different H3K27me3 between male and female pluripotent cells
C) Regions with different H3K4me3 between pluripotent and fibroblast cells
D) Regions with different H3K27me3 between pluripotent and fibroblast cells
E) Regions with different H3K4me3 between ES and iPS cells
F) Regions with different H3K27me3 between ES and iPS cells
Table S4. Chromatin differences between ES and iPS cells do not reflect cell of origin
A) H3K4me3 differences do not reflect cell of origin
B) H3K27me3 differences do not reflect cell of origin
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Table S5. The probesets differentially expressed between ES and iPS cells and between
pluripotent and fibroblast cells in this study, Chin et al., Maherali et al., and Yu et al. and
the numbers of differentially expressed genes and probesets overlapping between these
datasets
A) Differentially expressed probesets between ES and iPS cells in this study,
Guenther et al.
B) Differentially expressed probesets between ES and iPS cells in Chin et al.
C) Differentially expressed probesets between ES and iPS cells in Maherali et al.
D) Differentially expressed probesets between ES and iPS cells in Yu et al.
E) Differentially expressed probesets between pluripotent and fibroblast cells in this
study, Guenther et al.
F) Differentially expressed probesets between pluripotent and fibroblast cells in Chin
et al.
G) Differentially expressed probesets between pluripotent and fibroblast cells in
Maherali et al.
H) Differentially expressed probesets between pluripotent and fibroblast cells in Yu
et al.
I) The numbers of differentially expressed genes and probesets overlapping between
Guenther et al., Chin et al., Maherali et al., and Yu et al..
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Appendix B
Supplemental Material for Chapter 3
Connecting microRNA Genes to the Core
Transcriptional Regulatory Circuitry of Embryonic Stem Cells
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Supplemental Experimental Procedures
Growth conditions and quality control for human ES cells
Human embryonic stem cells were obtained from WiCell (Madison, WI; NIH Code WA09) and
grown as described. Cell culture conditions and harvesting have been described previously
(Boyer et al., 2005; Lee et al., 2006; Guenther et al., 2007). Quality control for the H9 cells
included immunohistochemical analysis of pluripotency markers, alkaline phosphatase activity,
teratoma formation, and formation of embryoid bodies and has been previously published as
supplemental material (Boyer et al., 2005; Lee et al., 2006).
Growth conditions for murine ES cells
V6.5 (C57BL/6-129) murine ES cells were grown under typical ES cell culture conditions on
irradiated mouse embryonic fibroblasts (MEFs) as previously described (Boyer et al., 2006).
Briefly, cells were grown on gelatinized tissue culture plates in DMEM-KO (Gibco/Invitrogen)
supplemented with 15% fetal bovine serum (characterized from Hyclone), 1000 U/ml leukemia
inhibitory factor (LIF) (Chemicon; ESGRO ESGI 106), non-essential amino acids, L-glutamine,
Penicillin/Streptomycin andB-mercaptoethanol. Immunostaining was used to confirm expression
of pluripotency markers, SSEA 1 (Developmental Studies Hybridoma Bank) and Oct4 (Santa
Cruz, SC-5279). For location analysis, cells were grown for one passage off of MEFs, on
gelatinized tissue-culture plates.
Antibodies
Oct4-bound genomic DNA was enriched from whole cell lysate using an epitope specific goat
polyclonal antibody purchased from Santa Cruz (sc-8628) and compared to a reference whole
cell extract (Boyer et al., 2005). A summary of regions occupied with high confidence for this
antibody identified by ChIP-Seq in mES cells is provided in Table S3 and by ChIP-chip on
genome-wide tiling arrays in hES cells are on Table S8. Oct4 ChIP-Seq data can be visualized
on the UCSC browser by uploading supplemental file:
mES regulatorChIPseq.mm8.WIG.gz
Sox2-bound genomic DNA was enriched from whole cell lysate using an affinity purified
goat polyclonal antibody purchased from R&D Systems (AF2018) and compared to a reference
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whole cell extract (Boyer et al., 2005). A summary of regions occupied with high confidence for
this antibody identified by ChIP-Seq in mES cells is provided in Table S3. Sox2 ChIP-Seq data
can be visualized on the UCSC browser by uploading supplemental file:
mES regulatorChIPseq.mm8.WIG.gz
Nanog-bound genomic DNA was enriched from whole cell lysate using an affinity
purified rabbit polyclonal antibody purchased from Bethyl Labs (b11662) and compared to a
reference whole cell extract (Boyer et al., 2005).. A summary of regions bound with high
confidence for this antibody is provided in Table S3. Nanog ChIP-Seq data can be visualized on
the UCSC browser by uploading supplemental file: mES regulatorChIPseq.mm8.WIG.gz
Tcf3-bound genomic DNA was enriched from whole cell lysate using an epitope specific
goat polyclonal antibody purchased from Santa Cruz (sc-8635) and compared to a reference
whole cell extract (Cole et al., 2008). A summary of regions occupied with high confidence for
this antibody identified by ChIP-Seq in mES cells is provided in Table S3. Tcf3 ChIP-Seq data
can be visualized on the UCSC browser by uploading supplemental file:
mES regulatorChIPseq.mm8.WIG.gz
Suzl2-bound genomic DNA was enriched from whole cell lysate using an affinity
purified rabbit polyclonal antibody purchased from Abcam (AB12073) and compared to a
reference whole cell extract (Lee et al., 2006). A summary of regions bound with high
confidence for this antibody is provided in Table S10. Suzl2 ChIP-Seq data can be visualized on
the UCSC browser by uploading: supplemental file: mESchomatin ChIPseq.mm8.WIG.gz
H3K4me3-modified nucleosomes were enriched from whole cell lysate using an epitope-
specific rabbit polyclonal antibody purchased from Abcam (AB8580) (Santos-Rosa et al., 2002;
Guenther et al., 2007). Samples were analyzed using ChIP-Seq. Comparison of this data with
ChIP-Seq published previously (Mikkelsen et al., 2007) showed near identify in profile and
bound regions (Table S5). H3K4me3 ChIP-Seq data can be visualized on the UCSC browser by
uploading supplemental file: mESchomatinChIPseq.mm8.WIG.gz
H3K79me2-modified nucleosomes were isolated from mES whole cell lysate using
Abcam antibody AB3594 (Guenther et al., 2007). Chromatin immunoprecipitations against
H3K36me3 were compared to reference WCE DNA obtained from mES cells. Samples were
analyzed using ChIP-Seq and were used for visual validation of predicted miRNA promoter
association with mature miRNA sequences only (Figure 2). H3K79me2 ChIP-Seq data can be
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visualized on the UCSC browser by uploading supplemental file:
mESchomatinChIPseq.mm8.WIG.gz
H3K36me3-modified nucleosomes were isolated from mES whole cell lysate using rabbit
polyclonal antibody purchased from Abcam (AB9050) (Guenther et al., 2007). Chromatin
immunoprecipitations against H3K36me3 were compared to reference WCE DNA obtained from
mES cells. Samples were analyzed using ChIP-Seq and were used for visual validation of
predicted miRNA promoter association with mature miRNA sequences only (Figure 2).
H3K36me3 ChIP-Seq data can be visualized on the UCSC browser by uploading supplemental
file: mESchomatinChIPseq.mm8.WIG.gz
Chromatin immunoprecipitation
Protocols describing all materials and methods have been previously described (Lee et al. 2007)
and can be downloaded from: http://web.wi.mit.edu/young/hES_PRC/. Briefly, we performed
independent immunoprecipitations for each analysis. Embryonic stem cells were grown to a final
count of 5x10 7 - 1x10 8 cells for each location analysis experiment. Cells were chemically
crosslinked by the addition of one-tenth volume of fresh 11% formaldehyde solution for 15
minutes at room temperature. Cells were rinsed twice with 1xPBS and harvested using a silicon
scraper and flash frozen in liquid nitrogen. Cells were stored at -800 C prior to use.
Cells were resuspended, lysed in lysis buffers and sonicated to solubilize and shear
crosslinked DNA. Sonication conditions vary depending on cells, culture conditions,
crosslinking and equipment. We used a Misonix Sonicator 3000 and sonicated at approximately
28 watts for 10 x 30 second pulses (90 second pause between pulses). For ChIP of Oct4, Nanog,
Tcf3 and Suzl2 in murine ES cells, SDS was added to lysate after sonication to a final
concentration of 0.1%. Samples were kept on ice at all times.
The resulting whole cell extract was incubated overnight at 4*C with 100 p1 of Dynal
Protein G magnetic beads that had been preincubated with approximately 10 pg of the
appropriate antibody. Beads were washed 4-5 times with RIPA buffer and 1 time with TE
containing 50 mM NaCl. For ChIP of Oct4, Nanog, Tcf3 and Suzl2 in murine ES cells, the
following 4 washes for 4 minutes each were used instead of RIPA buffer: IX low salt (20mM
Tris pH 8.1, 150mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1% SDS), IX high salt (20mM
Tris pH 8.1, 500mM NaCl, 2mM EDTA, 1% Triton X-100, 0.1% SDS), IX LiCl (10mM Tris
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pH 8.1, 250mM LiCl, 1mM EDTA, 1% deoxycholate, 1% NP-40), and IX TE+ 50mM NaCl.
Bound complexes were eluted from the beads by heating at 65*C with occasional vortexing and
crosslinking was reversed by overnight incubation at 65*C. Whole cell extract DNA (reserved
from the sonication step) was also treated for crosslink reversal.
ChIP-Seq Sample Preparation and Analysis
All protocols for Illumina/Solexa sequence preparation, sequencing and quality control are
provided by Illumina (http://www.illumina.com/pages.ilmn?ID=203). A brief summary of the
technique and minor protocol modifications are described below.
Sample preparation
Purified immunoprecipitated (ChIP) DNA were prepared for sequencing according to a modified
version of the Illumina/Solexa Genomic DNA protocol. Fragmented DNA was prepared for
ligation of Solexa linkers by repairing the ends and adding a single adenine nucleotide overhang
to allow for directional ligation. A 1:100 dilution of the Adaptor Oligo Mix (Illumina) was used
in the ligation step. A subsequent PCR step with limited (18) amplification cycles added
additional linker sequence to the fragments to prepare them for annealing to the Genome
Analyzer flow-cell. After amplification, a narrow range of fragment sizes was selected by
separation on a 2% agarose gel and excision of a band between 150-300 bp (representing shear
fragments between 50 and 200nt in length and ~100bp of primer sequence). The DNA was
purified from the agarose and diluted to 10 nM for loading on the flow cell.
Polony generation on Solexa flow-cells
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using the
Cluster Station device from Illumina. The concentration of library applied to the flow-cell was
calibrated such that polonies generated in the bridge amplification step originate from single
strands of DNA. Multiple rounds of amplification reagents were flowed across the cell in the
bridge amplification step to generate polonies of approximately 1,000 strands in 1 lpm diameter
spots. Double stranded polonies were visually checked for density and morphology by staining
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with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a microscope under
fluorescent illumination. Validated flow-cells were stored at 40C until sequencing.
Sequencing
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the Illumina
Genome Analyzer 1G. After the first base was incorporated in the Sequencing-by-Synthesis
reaction the process was paused for a key quality control checkpoint. A small section of each
lane was imaged and the average intensity value for all four bases was compared to minimum
thresholds. Flow-cells with low first base intensities were re-primed and if signal was not
recovered the flow-cell was aborted. Flow-cells with signal intensities meeting the minimum
thresholds were resumed and sequenced for 26 cycles.
Solexa data analysis
Images acquired from the Illumina/Solexa sequencer were processed through the bundled Solexa
image extraction pipeline, which identified polony positions, performed base-calling and generated
QC statistics. Sequences were aligned using the bundled ELAND software using murine genome
NCBI Build 36 and 37 (UCSC mm8, mm9) as the reference genome. Alignments to build 37 were
used for analysis of the mmu-mir-290 cluster only as that cluster is not represented on build 36. Only
sequences perfectly and uniquely mapping to the genome were used. A summary of the number of
reads used is shown in Table S1.
The analysis methods used were derived from previously published methods (Johnson et
al., 2007, Mikkelsen et al., 2007). Sequences from all lanes for each chromatin IP were
combined, extended 200bp (maximum fragment length accounting for ~100bp of primer
sequence), and allocated into 25 bp bins. Genomic bins containing statistically significant ChIP-
Seq enrichment were identified by comparison to a Poissonian background model, using a p-
value threshold of 10~9. A list of the numbers of counts in a genomic bins required for each
sample to meet this threshold are provided in Table Sl. Addtionally, we used and empirical
background model obtained from identical Solexa sequencing of DNA from whole cell extract
(WCE) from matched cell samples (> 5x normalized enrichment across the entire region, see
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below). A summary of the bound regions and their relation to gene targets can be found in Tables
S2, S3, S5 and S10.
The p-value threshold was selected to minimize the expected false-positive rate.
Assuming background reads are spread randomly throughout the genome, the probability of
observing a given number of counts can be modelled as a Poisson process where the expectation
can be calculated as the number of mapped reads times the number of bins per read (8) divided
by the total number of bins available (we assumed 50% as a very conservative estimate). With
the genome divided into ~108 bins of 25 bp, a probability of p< 10-9 represents the likelihood that
- experiment in 10 will randomly enrich one bin in the genome.
The Poisson background model assumes a random distribution of binding events,
however we have observed significant deviations from this expectation in ChIP-Seq datasets.
These non-random events can be detected as sites of enrichment using control IPs and create a
significant number of false positive events for actual ChIP-Seq experiments. To remove these
regions, we compared genomic bins and regions that meet the statistical threshold for enrichment
to an empirical distribution of reads obtained from Solexa sequencing of DNA from whole cell
extract (WCE) from matched cell samples. We required that enriched regions have five-fold
greater ChIP-Seq density in the specific IP sample as compared with the non-specific WCE
sample, normalized for the total number of reads. This served to filter out genomic regions that
are biased to having a greater than expected background density of ChIP-Seq reads. We
observed that ~200-500 regions in the genome showed non-specific enrichment in these
experiments.
Identifications of regions enriched for Oct4/Sox2/Nanog/Tcf3
The identification of enriched regions in ChIP-chip and ChIP-Seq experiments is typically done
using threshold for making a binary determination of enriched or not enriched. Unfortunately,
there is not actually a clear delineation between truly bound and and unbound regions. Instead,
enrichment is a continuum and the threshold is set to minimize false positives (high-confidence
sites). This typically requires that thresholds be set at a level that allows a high false-negative
rate (~30% for ChIP-chip, Lee et al). When multiple factors are compared, focusing only on the
intersection of the different data sets compounds this effect, leading to higher false negative rates
and the loss of many critical target genes.
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Oct4, Sox2, Nanog and Tcf3 co-occupy promoters throughout the genome (Cole, Figure
1) and cluster analysis of enriched sites reveals apparent co-enrichment for all 4 factors at >90%
of sites (Frampton & Young, unpublished data). However, the overlap for any two factors at the
cut-off for high-confidence enrichment is only about two thirds (Figure S 1, Tables S2 and S3).
Therefore many of these sites must have enrichment that is below the high-confidence threshold
for at least some of the participating factors. Variability in the enrichment observed for each
factor at different binding sites is common in the data (Figures Ib, 3, and S2).
To determine a threshold of binding for multiple factors, we used two complementary
methods to examine high-confidence targets of the four regulators. First, the classes of genes
enriched by different numbers of factors at high-confidence were compared to the known classes
of targets based on gene ontology (Figure Slb, http://gostat.wehi.edu.au/cgi-bin/goStat.pl,
Beissbarth and Speed, 2004). The highest confidence targets (those with high levels of immuno-
enrichment observed for all for factors) preferentially encoded factors involved in DNA binding,
regulation of transcription and development as has been previously shown (Boyer et al., 2005).
These gene ontology categories continued to be overrepresented among high-confidence targets
of either 3 of the 4 factors or 2 of 4 the factors, albeit at lower levels, but were barely enriched
among high confidence targets of only one factor.
As a second test, we examined how different numbers of overlapping high-confidence
targets affected the overlap with our previous genome-wide studies using ChIP-chip. Because
not all regions of the genome are tiled with equal density on the microarrays used for ChIP-chip,
we first determined the minimum probe density required to confirm binding detected by ChIP-
Seq (Figure S2). At most genes with high probe density, the ChIP-Seq and ChIP-chip data were
very highly correlated. However, regions of the genome with microarray coverage of less than
three probes per kilobase were generally unreliable in detecting these enrichment. These
regions, which had low probe coverage on the microarrays, represent approximately 1/3 of all
sites co-enriched for the four factors by ChIP-Seq. In regions where probe density was greater
than three probe per kilobase the fraction of ChIP-Seq sites confirmed by ChIP-chip experiments
increased with additional factors co-binding with a large fall off below 2 factors (data not
shown). Based on these two analyses, we elected to choose targets occupied at high-confidence
by 2 or more of the 4 factors tested for further analysis in this manuscript. (Figures 1 a and Sl a).
While a majority of the miRNA promoters identified as occupied by
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Oct4/Sox2/Nanog/Tcf3 are not occupied by all four factors at high-confidence, it is interesting to
note that all of the miRNA genes that share highly similar seeds to miR-302 are occupied at high
confidence by all four factors (miR-302 cluster, miR-290 cluster and miR-106a cluster), similar
to the promoters of core transcriptional regulators of ES cells. By comparison, promoters also
occupied by Suzl2 almost never showed high-confidence binding for all four factors (Table S4,
see mmu-miR-9-2 in Figure 3). Similar effects were observed for protein-coding genes in mES
cells (Lee et al., 2006). Whether this is caused by reduced epitope availability in PcG bound
regions or reflects reduced protein binding is unclear.
DNA motif discovery and high-resolution binding-site analysis
DNA motif discovery was performed on the genomic regions that were enriched for Oct4 at
high-confidence. In order to obtain maximum resolution, a modified version of the ChIP-Seq
read mapping algorithm was used. Genomic bins were reduced in size from 25 bp to 10 bp.
Furthermore, a read extension that placed greater weight towards the middle of the 200 bp
extension was used. This model placed 1/3 count in the 8 bins from 0-40 and 160-200 bp, 2/3
counts in the 8 bins from 40-80 and 120-160 bp and 1 count in the 4 bins from 80-120 bp. This
allowed increased precision for determination of the peak of ChIP-Seq density in each Oct4
bound region. 100bp surrounding the 500 Oct4 bound regions with the greatest peak ChIP-Seq
density were submitted to the motif disocvery tool MEME (Bailey and Elkan, 1995; Bailey,
2006) to search for over-represented DNA motifs. A single sixteen basepair motif was
discovered by the MEME algorithm (Table S4, Figure S2i). This motif was significantly (p<10-
100) over-represented in the Oct4 bound input sequences and occurred in 445 of the 500 hundred
basepair sequences.
As a default, MEME uses the individual nucleotide frequencies within input sequences to
model expected motif frequencies. This simple model might result discovery of motifs which
are enriched because of non-random di-, tri-, etc. nucleotide frequencies. Consequently, three
different sets of control sequences of identical length were used to ensure the specificity of the
motif discovery results. First, the sequences immediately flanking each input sequence were
used as control sequences. Second, randomly selected sequences having the same distribution of
distances from transcription start sites as the Oct4 input sequences were used as control
sequences. Third, sequences from completely random genomic regions were used as control
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sequences. Each of these sets of control seqeunces were also examined using MEME. For each
of these controls, the motif discovered from actual Oct4 bound sequences was not identified in
the control sequences.
The motif discovery process was repeated using different numbers and lengths of
sequences, but the same motif was discovered for a wide array of input sequences. Furthermore,
when motif discovery was repeated with the top 500 Sox2, Nanog, and Tcf3 occupied regions,
the same motif was identified. Overall, the motif occurs within 100 bp of the peak of ChIP-Seq
density at more than 90% of the top regions enriched in each experiment, while occuring in the
same span at 24-28% of control regions and within 25 bp of the ChIP-Seq peak at more than
80% of regions versus 9-11% of control regions.
We next attempted to determine the precise sites on the genome bound by Oct4, Sox2,
Nanog, and Tcf3 at basepair resolution using composite analysis of the bound regions for each
factor. In particular, we examined if the different factors tended to associate with specific
sequences within the assymetric DNA motif identified at a high fraction of the sites occupied by
Oct4, Sox2, Nanog, and Tcf3. A set of ~2,000 of the highest confidence bound regions was
determined for each factor based on a count threshold approximately two fold higher than the
threshold for high-confidence regions shown in Table SI (Poisson: p < 10-9). Regions without a
motif within 50bp of the peak of ChIP-Seq enrichment, typically ~10% of regions, were removed
from this analysis. The distance from the first base of the central motif in each bound region to
the 5' end of all reads within 250bp was tabulated, keeping reads mapping to the same strand as
the motif separate from reads mapping to the oppositie strand. The difference in ChIP-Seq read
frequency between reads mapping to the same strand as the motif and the reads mapping to the
oppositite strand was calculated at every basepair within the 500 bp window Figure S3. We
made the assumption that the precise peak of the ChIP-Seq distribution was the point at which
this strand bias was equal to zero.
To determine the precise position where the strand bias was equal to zero, we created a
simplified model of the strand bias for each transcription factor. We chose a function with 4
parameters (A,B, C, and M), one of which (M) was the point at which the curve crosses the x-
axis.
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x-M Bf (x)= A X arctan( B x e
Least squares curve fitting was performed with GNUplot (http://www.gnuplot.info/) using an
approximated set of initial conditions (A = -1000, B = 100, C = 2, M = 10). The variablity in M
was detemined by monte carlo simulation (n=25) using a random set of half of the ChIP-Seq
reads in each dataset and is shown in Figure S3.
Identification of miRNA promoters in human and mouse
To better understand the regulation of miRNAs, we sought to identify the sites of transcription
initiation for all miRNAs in both human and mouse, at least to low resolution (-kb). Most
methods used to identify promoters require active transcription of the miRNA and isolation of
rare primary miRNA transcripts. We decided to use an approach based on in vivo chromatin
signature of promoters. This approach has two principle advantages. First, the required data has
been published by a variety of laboratories and is readily accessible and second, it does not
require the active transcription of the miRNA primary transcript.
Recent results using genome-wide location analysis of H3K4me3 indicate that between
60 and 80% of all protein-coding genes in any cell population have promoters enriched in
methylated nucleosomes, even where the gene is not detected by typical transcription profiling
(Guenther et al., 2007) Importantly, over 90% of the H3K4me3 enriched regions in these cells
map to known or predicted promoters, suggesting that H3K4me3 can be used as a proxy for sites
of active initiation. Our strategy to identify miRNA promoters, therefore, uses H3K4me3
enriched sites from as many sources as possible as a collection of promoters. In human,
H3K4me3 sites were identified in ES cells (H9), hepatocytes, a pro-B cell line (REH cells)
(Guenther et al., 2007) and T cells (Barski et al., 2007). Mouse H3K4me3 sites were identified
from ES cells (V6.5), neural precursors, and embryonic fibroblasts (Mikkelsen et al., 2007). In
total, we identified 34,793 high-confidence H3K4me3 enriched regions in human and 34,096
high-confidence regions enriched in mouse, collectively present at ~75% of all protein-coding
genes.
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The list of miRNAs identified in the miRNA atlas (Landgraf et al., 2007) was used as the
basis for our identification. The total list consists of 496 miRNAs in human, 382 miRNAs in
mouse. -65% of the murine miRNAs can be found in both species.
For each of these miRNAs, possible start sites were derived from both all H3K4me3
enriched regions within 250kb upstream of the miRNA as well as all known start sites for any
miRNAs that were identified as being within known transcripts from RefSeq (Pruitt et al., 2005)
Mammalian Gene Collection (MGC) (Gerhard et al., 2004) Ensembl (Hubbard et al., 2005), or
University of California Santa Cruz (UCSC) Known Genes (genome.ucsc.edu) (Kent et al.,
2002) for which EntrezGene (http://www.ncbi.nlm.nih.gov/entrez/) gene IDs had been generated.
Where an annotated start site was found to overlap an H3K4me3 enriched region, the known
start was used in place of the enriched region.
A scoring system was derived empirically to select the most likely start sites for each
miRNA. Each possible site was given a bonus if it was either the start of a known transcript that
spanned the miRNA or of an EST that spanned the miRNA. Scores were reduced if the
H3K4me3 enriched region was assignable instead to a transcript or EST that did not overlap the
miRNA. Additional positive scores were given to enriched sites within 5kb of the miRNA, while
additional negative scores were given based on the number of intervening H3K4me3 sites
between the test region and the miRNA. Finally, each enriched region was tested for
conservation between human and mouse using the UCSC liftover program (Hinrichs et al.,
2006). If two test regions overlapped, they were considered to be conserved (21%). In the cases
where human and mouse disagreed on the quality of a site, if the site had an EST or gene
overlapping the miRNA, that site was given a high score in both species. Alternatively, if one
species had a non-overlapping site, that site was considered to be an unlikely promoter in both
species. Finally, for miRNAs where a likely promoter was identified in only one species, we
manually checked the homologous region of the other genome to search for regions enriched for
H3K4me3-modified nucleosomes that may have fallen below the high-confidence threshold.
Start sites were considered to be likely if the total score was > 0 (Figure S4 and S5). In total, we
identified likely start sites for -85% of all miRNAs in both species (Tables S6 and S7). Predicted
miRNA genes can be visualised on the UCSC browser by uploading the supplemental files:
mouse miRNAtrack.mm8.bed and humanmiRNA track.hg1 7.bed
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Several lines of evidence suggest the high quality of these predictions. First, previous
studies have found that miRNAs within 50kb of each other are likely to be co-regulated (Lagos-
Quintana et al., 2001; Lau et al., 2001). While the nature of these clusters was not included in our
analysis, nearly all miRNAs within a cluster end up identifying the same promoter region (see
Figures 2, 3, 5 and S3). The only exceptions to this are found in the large clusters of repeat
derived miRNAs found in chromosome 12 of mouse and chromosome 14 in human where a
single H3K4me3 enriched region splits the clusters. Second, consistent with the frequent
association of CpG islands with the transcriptional start sites for protein-coding genes, ~50% of
the miRNA promoters identified here overlap CpG islands (Tables S6 and S7). Finally, for
miRNAs that were active in ES cells, histone modifications associated with elongation were able
to "connect" the mature miRNAs to the predicted transcription start site (Figure 2).
To further ascertain the accuracy of our promoter predictions, we compared our predicted
start sites to those identified in recent studies. Predictions were tested against mmu-mir-34b /
mmu-mir-34c (Corney et al., 2007), hsa-mir-34a (Chang et al., 2007) mmu-mir-10la, mmu-mir-
202, mmu-mir-22, mmu-mir-124a-1, mmu-mir-433 (Fukao et al., 2007), and hsa-mir-
17/18a/19a/20a/19b-1/92a-1 (O'Donnell et al., 2005). Additional miRNA promoters in these
manuscripts were not predicted strongly by the above algorithm. For these 14 miRNAs,
H3K4me3 sites were identified within 1kb of all but two of the sites. mmu-mir-202 was
predicted about 20kb upstream of the annotated start site, but may reflect an H3K4me3 site
absent from the tissues sampled. mmu-mir-433 is in the middle of a large cluster of miRNAs on
mouse chromosome 12. The annotated TSS lies within the cluster between mir-433 and mir-431
suggesting the promoter may be incorrect. Overall, the accuracy of the promoter predictions is
believed to be ~75% (6/8). Additional H3K4me3 data sets and EST data should allow for
improved accuracy in predicting and validating these initiation sites.
ChIP-chip sample preparation and analysis
Immunoprecipitated DNA and whole cell extract DNA were purified by treatment with RNAse
A, proteinase K and multiple phenol:chloroform:isoamyl alcohol extractions. Purified DNA was
blunted and ligated to linker and amplified using a two-stage PCR protocol. Amplified DNA
was labeled and purified using Bioprime random primer labeling kits (Invitrogen):
immunoenriched DNA was labeled with Cy5 fluorophore, whole cell extract DNA was labeled
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with Cy3 fluorophore.
Labeled DNA was mixed (~5 ptg each of immunoenriched and whole cell extract DNA)
and hybridized to arrays in Agilent hybridization chambers for up to 40 hours at 40*C. Arrays
were then washed and scanned.
Slides were scanned using an Agilent DNA microarray scanner BA. PMT settings were
set manually to normalize bulk signal in the Cy3 and Cy5 channel. For efficient batch
processing of scans, we used Genepix (version 6.0) software. Scans were automatically aligned
and then manually examined for abnormal features. Intensity data were then extracted in batch.
44k human whole genome array
The human promoter array was purchased from Agilent Technology (www.agilent.com). The
array consists of 115 slides each containing ~44,000 60mer oligos designed to cover the non-
repeat portion of the human genome. The design of these arrays are discussed in detail elsewhere
(Lee et al., 2006).
Data normalization and analysis
We used GenePix software (Axon) to obtain background-subtracted intensity values for each
fluorophore for every feature on the whole genome arrays. Among the Agilent controls is a set
of negative control spots that contain 60-mer sequences that do not cross-hybridize to human
genomic DNA. We calculated the median intensity of these negative control spots in each
channel and then subtracted this number from the intensities of all other features.
To correct for different amounts of each sample of DNA hybridized to the chip, the
negative control-subtracted median intensity value of control oligonucleotides from the Cy3-
enriched DNA channel was then divided by the median of the control oligonucleotides from the
Cy5-enriched DNA channel. This yielded a normalization factor that was applied to each
intensity in the Cy5 DNA channel.
Next, we calculated the log of the ratio of intensity in the Cy3-enriched channel to
intensity in the Cy5 channel for each probe and used a whole chip error model to calculate
confidence values for each spot on each array (single probe p-value). This error model functions
by converting the intensity information in both channels to an X score which is dependent on
both the absolute value of intensities and background noise in each channel using an f-score
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calculated as described for promoter regions or using a score of 0.3 for tiled arrays. When
available, replicate data were combined, using the X scores and ratios of individual replicates to
weight each replicate's contribution to a combined X score and ratio. The X scores for the
combined replicate are assumed to be normally distributed which allows for calculation of a p-
value for the enrichment ratio seen at each feature. P-values were also calculated based on a
second model assuming that, for any range of signal intensities, IP:control ratios below 1
represent noise (as the immunoprecipitation should only result in enrichment of specific signals)
and the distribution of noise among ratios above 1 is the reflection of the distribution of noise
among ratios below 1.
High confidence enrichment
To automatically determine bound regions in the datasets, we developed an algorithm to
incorporate information from neighboring probes. For each 60-mer, we calculated the average X
score of the 60-mer and its two immediate neighbors. If a feature was flagged as abnormal
during scanning, we assumed it gave a neutral contribution to the average X score. Similarly, if
an adjacent feature was beyond a reasonable distance from the probe (1000 bp), we assumed it
gave a neutral contribution to the average X score. The distance threshold of 1000 bp was
determined based on the maximum size of labeled DNA fragments put into the hybridization.
Since the maximum fragment size was approximately 550 bp, we reasoned that probes separated
by 1000 or more bp would not be able to contribute reliable information about a binding event
halfway between them.
This set of averaged values gave us a new distribution that was subsequently used to
calculate p-values of average X (probe set p-values). If the probe set p-value was less than
0.001, the three probes were marked as potentially bound.
As most probes were spaced within the resolution limit of chromatin
immunoprecipitation, we next required that multiple probes in the probe set provide evidence of
a binding event. Candidate bound probe sets were required to pass one of two additional filters:
two of the three probes in a probe set must each have single probe p-values < 0.005 or the centre
probe in the probe set has a single probe p-value < 0.001 and one of the flanking probes has a
single point p-value < 0.1. These two filters cover situations where a binding event occurs
midway between two probes and each weakly detects the event or where a binding event occurs
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very close to one probe and is very weakly detected by a neighboring probe. Individual probe
sets that passed these criteria and were spaced closely together were collapsed into bound regions
if the centre probes of the probe sets were within 1000 bp of each other.
Comparing enriched regions to known genes and miRNAs
Enriched regions were compared relative to transcript start and stop coordinates of known genes
compiled from four different databases: RefSeq (Pruitt et al., 2005), Mammalian Gene
Collection (MGC) (Gerhard et al., 2004), Ensembl (Hubbard et al., 2005), and University of
California Santa Cruz (UCSC) Known Genes (genome.ucsc.edu) (Kent et al., 2002). All human
coordinate information was downloaded in January 2005 from the UCSC Genome Browser
(hgl7, NCBI build 35). Mouse data was downloaded in June of 2007 (mm8, NCBI build 36).
To convert bound transcription start sites to more useful gene names, we used conversion tables
downloaded from UCSC and Ensembl to automatically assign EntrezGene
(http://www.ncbi.nlm.nih.gov/entrez/) gene IDs and symbols to the RefSeq, MGC, Ensembl,
UCSC Known Gene. Comparisons of Oct4, Sox2, Nanog, Tcf3, H3K4me3 and Suzl2 to
annotated regions of the genomes can be found in Tables S3, S5, S8 and S1O
For miRNAs start sites, two separate windows were used to evaluate overlaps. For
chromatin marks and non-sequence specific proteins, miRNA promoters were considered bound
if they were within 1kb of an enriched sequence. For sequence specific factors such as Oct4, we
used a more relaxed region of 8kb surrounding the promoter, consistent with previous work we
have published (Boyer et al., 2005). A full list of the high confidence start sites bound to
promoters can be found in Tables S6 and S7.
Growth conditions for neural precursors and mouse embryonic fibroblasts
To generate neural precursor cells, ES cells were differentiated along the neural lineage using
standard protocols. V6.5 ES cells were differentiated into neural progenitor cells (NPCs) through
embryoid body formation for 4 days and selection in ITSFn media for 5-7 days, and maintained
in FGF2 and EGF2 (R&D Systems) (Okabe et al., 1996).
Mouse embryonic fibroblasts were prepared from DR-4 strain mice as previously
described (Tucker et al., 1997). Cells were cultured in Dulbecco's modified Eagle medium
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supplemented with 10% cosmic calf serum, beta-mercaptoethanol, non-essential amino acids, L-
glutamine and penicillin/streptomycin.
Analysis of Mature miRNA Frequency by Solexa Sequencing
Polony generation on Solexa flow-cells
The DNA library (2-4 pM) was applied to the flow-cell (8 samples per flow-cell) using the
Cluster Station device from Illumina. The concentration of library applied to the flow-cell was
calibrated such that polonies generated in the bridge amplification step originate from single
strands of DNA. Multiple rounds of amplification reagents were flowed across the cell in the
bridge amplification step to generate polonies of approximately 1,000 strands in 1p m diameter
spots. Double stranded polonies were visually checked for density and morphology by staining
with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a microscope under
fluorescent illumination. Validated flow-cells were stored at 4'C until sequencing.
Sequencing and analysis
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the Illumina
Genome Analyzer 1G. After the first base was incorporated in the Sequencing-by-Synthesis
reaction the process was paused for a key quality control checkpoint. A small section of each
lane was imaged and the average intensity value for all four bases was compared to minimum
thresholds. Flow-cells with low first base intensities were re-primed and if signal was not
recovered the flow-cell was aborted. Flow-cells with signal intensities meeting the minimum
thresholds were resumed and sequenced for 36 cycles. Images acquired from the Illumina/Solexa
sequencer were processed through the bundled Solexa image extraction pipeline which identified
polony positions, performed base-calling and generated QC statistics. Sequences were then
assigned to a miRNA if they perfectly matched at least the first 20bp of the mature miRNA
sequences downloaded from targetScan (http://www.targetscan.org/). Mature miRNA
frequencies were then normalized to each other by determining the expected frequency in
mapped reads/million. A full list of the miRNAs detected can be found in Table S9.
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miRNA microarray expression analysis
Mouse embryonic fibroblasts and neural precursor cells were cultured as described above.
Murine induced pluripotent (iPS) cells, derived as previously described (Wernig et al., 2007),
were cultured under the same conditions as murine embryonic stem cells (described above).
RNA was extracted with RNeasy (Qiagen) reagents. 5 ptg total RNA from treated and control
samples were labeled with Hy3TM and Hy5TM fluorescent label, using the miRCURYTM LNA
Array labeling kit (Exiqon, Denmark) following the procedure described by the manufacturer.
The labeled samples were mixed pair-wise and hybridized to the miRNA arrays printed using
miRCURYTM LNA oligoset version 8.1 (Exiqon, Denmark). Each miRNA was printed in
duplicate, on codelink slides (GE), using GeneMachines Omnigrid 100. The hybridization was
performed at 60C overnight using the Agilent Hybridization system - SurHyb, after which the
slides were washed using the miRCURYTM LNA washing buffer kit (Exiqon, Denmark)
following the procedure described by the manufacturer. The slides were then scanned using
Axon 4000B scanner and the image analysis was performed using Genepix Pro 6.0.
Median minus background signal intensities for all microarray probes were tabulated and
quantile normalized. Within each sample, each probe was given a signal value of the average
signal of the probe of that rank, across the full dataset. Intensities were then floored at one unit
and log normalized. Control probes were removed from further analysis. Statistically significant
differential expression was calculated using the online NIA Array Analysis Tool
(http://lgsun.grc.nia.nih.gov/ANOVA/). Probes were tested for differential expression using the
following settings:
Threshold z-value to remove outliers: 10000
Error Model: Max(Average,Bayesian)
Error variance averaging window: 100
Proportion of highest error variances to be removed: 0.01
Bayesian degrees of freedom: 5
FDR threshold: 0.10
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Of 1008 probes, 230 were determined to be differentially expressed between 3 MEF and 2 ES
samples. Expression data for the iPS samples were not used for identifying differentially
expressed miRNAs.
For clustering and heat map display, expression data were Z-score normalized. Centroid
linkage, Spearman rank correlation distance, hierarchical clustering of genes and arrays was
performed using Gene Cluster 3.0 (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/
software.htm#ctv). Heatmaps were generated using Java Treeview (http://jtreeview.
sourceforge.net/) with color saturation at 0.6 standard deviations. Complete miRNA microarray
expression data, differentially expression results, and clustergram data are provided
(Supplemental Tables S99).
Tissue-specificity of miRNAs
To determine the global tissue-specificity for miRNAs we used data from the recent publication
of the miRNA atlas4 . Specificity scores were taken from Table S34 Node 0 from Landgraf et al.
(2007). Of the 45 distinct mature miRNAs with specificity scores >1 that are not bound only by
Oct4/Sox2/Nanog/Tcf3, 16 were identified as Suzl2 targets. These 16 represent over 40% of the
distinct mature miRNAs whose promoters are occupied by Suzl2 (p < 5x10-4 for specificity
scores > 1.3)
Identification of Oct4/Sox2/Nanog/Tcf3 occupied feed forward loops
To identify feed forward loops we examined the recent data set identifying functional targets of
the miR-290 cluster (Sinkkonen et al., 2008). In their study, Sinkkonen et al. identified miR-290
targets by both looking at mRNAs that increase in level in a Dicer -/- cell line and overlap that
data set with mRNAs that decrease in expression when miR-290 is added back to the cells.
Because the promoter of the miR-290 gene is occupied by Oct4/Sox2/Nanog/Tcf3, any targets of
the miRNA cluster that are also occupied by the 4 factors would represent feed forward targets.
Of the 245 miR-290 cluster targets identified in the intersect of the two data sets, promoters for
64 are occupied by Oct4/Sox2/Nanog/Tcf3. This is approximately 50% more interactions then
would be expected by random (binomial p-value < Ix10-4).
Interestingly, only a small minority of these genes is also occupied by significant
quantities of the PRC2 subunit Suzl2. Of the 64 targets whose promoters are occupied by
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Oct4/Sox2/Nanog/Tcf3, only 5 are occupied by domains of Suzl2 binding >500bp (larger region
sizes have been correlated with gene silencing, Lee et al., 2006). This may be because PcG
bound proteins are not functional targets of mir-290 in mES cells or because these proteins are
not expressed following Dicer deletion, they are excluded from the target list, but may be targets
at other stages of development. In the later case, the miRNAs may serve as a redundant silencing
mechanism for ES cells to help prevent even low levels of expression of the developmental
regulators bound by PcG complexes.
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Figure SI. Comparison of ChIP-Seq and RT-PCR data for Oct4 and Suz12
A.ChIP-Seq reads for Oct4 enrichment were compared to RT-PCR results previously described
in Loh et al. 71 probes that were identified as enriched are shown in blue and 39 regions
identified as not-enriched are shown in gray. The maximum number of ChIP-Seq reads assigned
within the region is shown on the vertical axis. Red line denoted the threshold of binding with
p < 10-9. Ambiguous RT-PCR results were excluded.
B. ChIP-Seq reads for Suzl2 enrichment were compared to RTPCR results previously described
in Boyer et al. as in A. ChIP-Seq data within 200bp of 68 probes identified as enriched by RT-
PCR and confirmed by ChIP-chip are shown in blue and 18 probes identified as not-enriched are
shown in gray.
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Figure S2. Promoters for known genes occupied by Oct4/Sox2/Nanog/Tcf3 in mES cells
A. Overlap of genes whose promoters are within 8kb of sites enriched for Oct4, Sox2, Nanog, or
Tcf3. Not shown are the Nanog:Oct4 overlap (289) and Sox2:Tcf3 overlap (26). Red line
deliniates genes considered occupied by Oct4/Sox2/Nanog/Tcf3.
B. Enrichment for selected GO-terms previously reported to be associated with
Oct4/Sox2/Nanog binding (Boyer et al., 2005) was tested on the sets of genes occupied at high-
confidence for 1 to 4 of the tested DNA binding factors. Hypergeometric p-value is shown for
genes annotated for DNA binding (blue), Regulation of Transcription (green) and Development
(red).
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Figure S3
3000
Figure S3. Comparison of ChIP-Seq and ChIP-chip genome wide data for Oct4, Nanog
and Tcf3
A. Binding of Oct4 (blue), Nanog (orange) and Tcf3 (red) across 17kb surrounding the Wnt8a
and Nodal genes (black below the graph, arrow indicates transcription start site) as in Figure lb.
(upper) Binding derived from ChIP-Seq data plotted as reads per million. (lower) Binding
derived from ChIP-chip enrichment ratios (Cole et. al., 2008)
B. Poor probe density prevents detection of -1/3 of ChIP-Seq binding events on Agilent
genome-wide tiling arrays. Top panel shows the fraction of regions that are occupied by
Oct4/Sox2/Nanog/Tcf3 at high-confidence in mES cells as identified by ChIP-Seq that are
enriched for Oct4 (blue), Nanog (orange) and Tcf3 (red) on Agilent genome-wide microarrays
(Cole et al., 2008). Numbers on the x-axis define the boundaries used to classify probe densities
for the histogram. Bottom panel illustrates a histogram of the microarray probe densities of the
enriched regions identified.
208
E
OCT4 +300
-250 +250
Position
SOX2
C,,
(a
00
"0
+250 -,3
P0
Position
Position
+200.
+100-
0
a -100
a)
r -200
_300
+450,-*SX
+300 (11.06 +/- 0.17)
+150
-10 -10 +5
NANOG G +150
0
LO +100
+50
0 0
" -50
t -100
-150
H
TCF3
0
(a
"0C
~ (a
-o(a
a,
Position
OCT4
(7.99 +/- 0.20)
.10 *+25
NANOG
(11.96 +/- 0.23)
TCF3
(13.28 +/- 0.43)
.10 25
.ILA JlAk
0 0<0
1 2 3 4 5 6 7 8 9 10111213141516
Octomer HMG box
209
Figure S4
"0
c J
(a)
0
C
ma
.~; ~
U,
"0(a
a,
0::
Figure S4. High resolution analysis of Oct4/Sox2/Nanog/Tcf3 binding based on meta-
analysis
A-D. Short sequence reads for A. Oct4, B. Sox2, C. Nanog, D. Tcf3 mapping within 250bp of
2000 highly enriched regions where the peak of binding was found within 50bp of a high quality
Oct4/Sox2 motif were collected. Composite profiles were created at base pair resolution for
forward and reverse strand reads centered on the Oct4/Sox2 motif (aligned at +1). The difference
between the number of positive and negative strand reads are shown for each base pair (circles).
The best fit line is shown for each factor (see Supplemental Text). E-H. Zoomed in region of A-
D showing 20bp surrounding the Oct4/Sox2 motif. Dashed line indicates the position where the
best fit line crosses the X-axis. For reference, the motif is shown below each graph. I. Summary
of meta-analysis for Oct4, Sox2, Nanog and Tcf3. Arrows indicate the nucleotide where each
transcription factor switches from a positive strand bias to a negative strand bias. The octomer
and HMG box motifs are indicated.
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Figure S5
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Figure S5. Algorithm for identification of miRNA promoters
A. Flowchart describing the method used to identify the promoters for primary miRNA
transcripts in human and mouse. For a full description, see supplemental text.
B. Two examples of identification of miRNA promoters. Top, Initial identification of possible
start sites based on H3K4me3 enriched regions from four cell types. Enrichment of H3K4me3-
modified nucleosomes is shown as shades of gray. Red bar represents the position of the mature
miRNA. Black bars below the graph are regions enriched for H3K4me3. Initial scores are shown
below the black bars. The region on the far right was excluded from the analysis (score = X)
since it is downstream of the mature miRNA. Middle, Identification of candidate start sites <5kb
upstream of the mature miRNA (yellow shaded area). Bottom, identification of candidate start
sites that either initiate overlapping (left) or non-overlapping (right) transcripts. EST and
transcript data is shown. Scores associated with identified genes are shown bold.
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Figure S6. Summary of miRNA promoter classification
A. Promoters assigned to mature miRNAs were classified by the dominant feature of their
scoring. Green: miRNAs that were found to have overlapping ESTs or genes confirming their
promoters. Orange: miRNAs that were found to have a candidate start site within 5kb of the
mature miRNA. Gray: miRNAs with either no candidates within 250kb of the mature miRNA or
where all candidates had a score less then zero (see Fig. S4b, right). Yellow: miRNAs for which
the closest candidate start site was selected solely on the basis of its proximity.
B. The basis of miRNA promoter identification, including Gene or EST evidence (green),
distance of <5 kilobases to mature miRNA (orange), nearest possible promoter to miRNA
(yellow), tended to be conserved between human and mouse
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Figure S7. Regulation of miRNAs by Oct4
A. In an engineered murine cell line (Niwa et al., 2000), endogenous Oct4 is deleted, and Oct4
expression is maintained by a Dox-repressible transgene.
B. By 24 hours of Dox-treatment, Oct4 mRNA levels are reduced as shown by reverse
transcription (RT)-PCR.
C. 24 hours following Dox-treatment, cells remain ES-like by morphology.
D. 24 hours following Dox-treatment Sox2 protein can still be detected by immunofluorescence.
E. Changes in levels of Oct4/Sox2/Nanog/Tcf3 occupied mature miRNAs based on Solexa
sequencing of small RNAs. Fold change was calculated by comparing normalized read counts
from untreated cells and cells 24 hours after Dox treatment. A full list of miRNA reads can be
found in Table S9. Details about the normalization procedure are contained in the supplemental
text.
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Figure S8. Regulation of miRNAs by Tcf3
Tcf3 was knocked down in V6.5 mES cells using lentiviral vectors containing shRNAs.
A. RT-PCR confirmation of knockdown at 72 hours post-infection using Taqman probes against
Tcf3 (relative to levels in cells infected with GFP control lentivirus).
B. Schematic of the position of RT-PCR probes used to measure the levels of pri-miRNA
transcripts in Figure 3d and part c
C. Results of quantitative RT-PCR analysis of probes designed to several pri-miRNAs occupied
by Oct4/Sox2/Nanog/Tcf3. Change in the level of primary transcript compared to GFP control
lentivirus are shown. * = p < 0.05, ** = p < 0.001 using a two-sampled t-test assuming equal
variance. Standard deviation is indicated with error bars.
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Figure S9. miRNA genes occupied by the core master regulators in ES cells are expressed
in iPS cells
RNA was extracted from MEFs (columns 1-3), mES cells (columns 4,5) and iPS cells (column
6) and hybridized to microarrays with LNA probes targeting all known miRNAs. Differentially
expressed miRNAs enriched in either MEFs or mES cells are shown (FDR < 10%, see
supplemental text, iPS cells were not used to determine differential expression). Data were Z-
score normalized, and cell types were clustered hierarchically (top). Active miRNA promoters
associated with Oct4/Sox2/Nanog/Tcf3 are listed to the right.
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Figure S1O
Figure S10. PcG occupied miRNAs are generally expressed in a tissue specific manner
Mature miRNAs derived from genes occupied by Suzl2 and H3K27me3-modified nucleosomes
were compared to the list of tissue specific miRNAs derived from the miRNA expression atlas
(Landgraf et al., 2007). Vertical axis represents tissue-specificity and miRNAs with specificity
score >1 are shown. miRNAs bound by Oct4/Sox2/Nanog/Tcf3 and expressed in mES cells are
not shown (largely ES cell specific miRNAs). Among the tissue-specific miRNAs there is
significant enrichment (p < 0.005 by hypergeometric distribution) for miRNAs occupied by
Suzl2 (green)
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Appendix C
Supplemental Material for Chapter 4
Foxp3 Occupancy and Regulation of Key Target Genes
During T Cell Stimulation
220
Supplemental Experimental Procedures
Cell Culture, stimulation and analysis of cytokine production
CD4* 5B6-2 hybridoma cells expressing a PLP139.1s-specific TCR, which was kindly provided
by Vijay Kuchroo, were cultured in Dulbecco's modified Eagle medium (Invitrogen). Primary
murine CD4* T cells were cultured in RPMI-1640 medium (Invitrogen). Media were
supplemented with 10% FCS, 2 mM Glutamax, 1 mM HEPES, 1 mM sodium pyruvate, 0.1 mM
non-essential amino acids, 0.55 mM 2-mercaptoethanol, 100U/ml penicillin/streptomycin and
0.1 mg/ml gentamycin. For gene expression profiling, real-time RT-PCR, and location analysis,
cells were cultured in the absence or presence of 50 ng/ml phorbol 12-myristate 13-acetate
(PMA) and 200 ng/ml ionomycin at 370C and harvested after 6h. Where indicated, cells were
preincubated for 1h with 2 pM cyclosporin A. For the analysis of cytokine production of 5B6-2
hybridoma cells, 10 Dg/ml brefeldin A was added for the last 4h of 6 and 36h cultures. Cells
were harvested at various time points and intracellular cytokine staining was performed using the
Cytofix/Cytoperm kit (Becton Dickinson) according to manufacturer's recommendations and
phycoerythrin-conjugated anti-mouse IL-2 (JES6-5H4) and TNF- E (MP6-XT22) antibodies.
Generation of Foxp3-expressing CD4* T cell hybridoma clones
The murine full-length Foxp3 was amplified from cDNA of purified BALB/c CD4*CD25*
spleen cells using 5'-ATGCCCAACCCTAGGCCAGCCAA-3' as the sense and 5'-
TCAAGGGCAG GGATTGGAGCAC-3' as the antisense primers. A minimal Kozak consensus
sequence (double-underlined) just upstream of the initiator codon and a FLAG-tag (single-
underlined) and were added using 5'-GAATTCACCATGATGGACTACAAGGACGA
CGACGACAAGCCCAACCCTAGGCCAGCCAA-3' as the sense and 5'-GGATCCTCAA
GGGCAGGGATTGGAGCAC-3' as the antisense primers. For further cloning sense and
antisense primer sequences contained 5' EcoRI and BamHI restriction sites, respectively.
Lentiviral vectors encoding the N-terminal FLAG-tagged Foxp3-IRES-GFP or Empty-IRES-
GFP control were generated from the pLenti6/V5-D-TOPO vector (Invitrogen). The integrity of
cloned cDNA was confirmed by sequencing and sequence comparison to GenBank accession no.
NM_054039. Concentrated culture supernatants of 293FT transfected with lentiviral vectors
were used to infect 5B6-2 hybridoma cells. Stably transduced 5B6-2-[Foxp3]-IRES-GFP or 5B6-
221
2-[Empty]-IRES-GFP 5B6-2 hybridoma cell clones were established after flow cytometric
single-cell sorting.
Transgenic mice
TCR-hemagglutinin (TCR-HA) BALB/c mice express a transgenic TCR specific for the H2-IEd
HA10 7 .11 9 peptide. Double-transgenic TCR-HA x pgk-HA mice additionally express the HA
protein under the control of the phosphoglycerate kinase (pgk) promoter and are characterized by
high frequencies of TCR-HA-expressing Treg cells (Klein et al., 2003). Mice were bred in the
Dana-Farber Cancer Institute animal facility under specific pathogen-free conditions. Animal
care and all procedures were in accordance with the guidelines of the Animal Care and Use
Committee of the Dana-Farber Cancer Institute.
Purification and FACS analysis of primary CD4* T cells
Single cell suspensions of pooled spleen and lymph node cells were prepared from TCR-HA and
TCR-HA x pgk-HA mice for the purification of naive and Treg cells, respectively. Cells were
stained with fluorochrome-conjugated anti-mouse mAbs CD4 (RM4-5), CD25 (PC61) and TCR-
HA (6.5). HA10 7.1 19-specific CD4*CD25 naive T cells and Foxp3-expressing CD4*CD25hig
Treg cells were then purified using a FACSAria cell sorter and FACSDiva software (Becton
Dickinson). Cells were >98% pure upon re-analysis. Intracellular staining with the anti-
mouse/rat mAb FJK-16s (eBioscience) revealed that ~95% of purified TCR-HA*CD4*CD25high
cells express Foxp3. CD4*CD25~ naYve T cells showed negligible staining for Foxp3 (<0.5%).
For the analysis of Ly6a surface expression on freshly isolated or in vitro stimulated antigen-
specific Teff and Treg cells, primary T cells were purified as described above and additionally
stained using a phycoerythrin-conjugated anti-mouse mAb Ly6a/e (E13-161.7).
Foxp3 Location Analysis
Chromatin immunoprecipitation
Protocols describing ChIP methods are available from: http://jura.wi.mit.edu/youngpublic
/hESregulation/ChIP.html Briefly, for each location analysis reaction ~108 N-terminal FLAG-
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tagged Foxp3-IRES-GFP or Empty-IRES-GFP 5B6-2 hybridomas were chemically crosslinked
by the addition of 11% formaldehyde solution for 20 min at room temperature. Cells were
washed twice with 1 x PBS and pellets were stored at -80'C prior to use. Cells were resuspended,
lysed, and sonicated to solubilize and shear crosslinked DNA. We used a Misonix Sonicator
3000 and sonicated at power 7 for 10 to 18, 20 second pulses (60 second pause between pulses)
at 4'C while samples were immersed in an ice bath. The resulting whole cell extract was
incubated overnight at 4'C with 100 ul of Dynal Protein G magnetic beads preincubated with 10
pg of the appropriate antibody for at least 4 hrs. Beads were then washed 4 times with RIPA
buffer and 1 time with TBS. Bound complexes were eluted from the beads in elution buffer by
heating at 65'C with occasional vortexing, and crosslinking was reversed by ~6 hour incubation
at 65 0C.Whole cell extract DNA (reserved from the sonication step) was also treated for
crosslink reversal. Immunoprecipitated DNA and whole cell extract DNA were then purified by
treatment with RNaseA, proteinase K and multiple phenol:chloroform:isoamyl alcohol
extractions. Purified DNA was blunted, ligated to a universal linker and amplified using a two-
stage PCR protocol. Amplified DNA was labeled using Invitrogen Bioprime random primer
labelling kits (immunoenriched DNA was labeled with Cy5 fluorophore, whole cell extract DNA
was labeled with Cy3 fluorophore). Labeled and purified DNA was combined (4 - 5 pg each of
immunoenriched and whole cell extract DNA) and hybridized to arrays in Agilent hybridization
chambers for 40 hours at 40'C. Arrays were then washed and scanned.
Antibodies for ChIP
For ChIP experiments, we used Anti-FLAG (Sigma M2) and anti-E2F4 (Santa Cruz 1082)
antibodies. E2F4 antibody has been shown to specifically recognize previously reported E2F4
target genes (Ren et al., 2002; Weinmann et al., 2002). Anti-FLAG antibody has also been
demonstrated to work for chromatin immunoprecipitation (Henry et al., 2003).
Ten slide promoter array
This study employed a 10-slide mouse promoter array set that has been used in previously
published work (Boyer et al., 2006). These arrays were designed to contain oligonucleotides that
cover approximately 10 kb around the transcription start sites of approximately 16,000 of the
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best annotated mouse transcription start sites. Arrays were manufactured by Agilent
Technologies (www.agilent.com).
Selection of regions and design of subsequences
To define transcription start sites, we first selected transcripts from three of the most commonly
used databases for sequence information (Refseq, Ensembl, MGC). Transcription start sites
within 500 bp of each other were considered single start sites. To restrict our array to the most
likely transcription start sites, we selected only those that were found in at least two of the three
databases. We also included microRNAs from the RFAM database.
25 kb of sequence around each transcription start site (20 kb upstream to 5 kb downstream)
was initially extracted for analysis from the repeat-masked sequence derived from the May 2004
build of the mouse genome. Because we were balancing feature number, exact number of
transcription start sites, tiling density and extent of upstream genomic coverage for our array
design, we chose to design oligos across a much larger region than we were likely to fit on the
array. Each transcription start site was considered independent, even if the 25 kb region
overlapped with the 25 kb region of another transcription start site. While we anticipated not
being able to use all of these oligos, this allowed us flexibility in later design steps to add oligos
for additional upstream genomic coverage if space became available. The subset of probes from
-8 kb to +2 kb was selected for the actual array. We used the program ArrayOligoSelector 10
(AOS; http://arrayoligosel.sourceforge.net/) to score 60-mers for every unmasked subsequence
greater than 62 bp across all promoter regions. The scores for each oligo were retained but not
put through the built-in AOS selection process. Instead, the collection of scored 60-mers was
divided by promoter and sorted by genomic position. Each set of 60-mers was then filtered based
on the AOS oligo scoring criteria: GC content, self-binding, complexity and uniqueness. For our
most stringent filter, we selected the following ranges for each parameter: GC content between
30 percent and 100 percent, self-binding score less than 100, complexity score less than or equal
to 24, uniqueness greater than or equal to -40.
From this subset of 60-mers, we selected oligos designed to cover the promoter region with
an estimated density of one probe every 280 bp. At this point, we restricted oligo selection to
those oligos found within the region 8 kb upstream to 2 kb downstream of the transcription start
site. To achieve more uniform tiling, we instituted a simple method to find probes within a
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particular distance from each other. Starting at the upstream end of the region, we selected the
first qualified probe and then selected the next qualified probe located 150 bp to 280 bp away. If
there were multiple eligible probes, we chose the most distal probe within the 280 bp limit. If no
probes were identified within this limit, we continued scanning until we found the next
acceptable probe. The process was then repeated with the most recently selected probe until we
reached the end of the promoter region.
For regions that were not covered by high quality probes, we returned to the full set of
scored 60-mers and filtered using less stringent criteria. This gave us an additional set of 60-mers
that we then used to fill gaps in our coverage. After this second pass, we identified gaps in our
coverage and added oligos that were properly spaced and best fit our criteria regardless of
whether they passed the filter cutoffs. This iterative process gave us a compromise between
optimal probe quality and optimal probe spacing.
Compiled probes and controls
There are 407,355 features split over 10 arrays. The probes are arranged such that array 1 begins
with the first selected transcript start site on the left arm of chromosome 1, array 2 picks up
where array 1 ends, array 3 picks up where array 2 ends, and so on. Over 16,000 genes are
represented on the arrays and each promoter region corresponding to a unique start site is
covered by approximately 25-27 probes. A true average distance between probes is difficult to
calculate due to the presence of large gaps in the probe tiling. Most of these gaps simply
represent the distance between the first and last oligos of two different sets of probes designed
against two different genes. Other gaps are caused by lack of available sequence information,
repeat masking or sequences that are otherwise highly repetitive and not suitable for oligo
design.
Several sets of controls were added. A total of 353 oligos representing Arabidopsis thaliana
genomic sequence were included. These Arabidopsis oligos were BLASTed against the mouse
genome and do not register any significant hits. These oligos were intended to check background
signal. We added a total of 186 oligos representing five proximal promoter regions of genes that
are known targets of the transcriptional regulator Oct4 (Pipox, Foxhl, Oct4/Pou5fl, Msh2 and
Hoxbl). Each of the four promoters is represented by 21 - 32 different oligos that are evenly
positioned across the regions. The oligos for the Hoxbl region are printed an additional two
225
times. These promoter regions can be used as positive controls. There are 481 gene desert
controls. To identify these probes, we identified intergenic regions of 1 Mb or greater and
designed probes in the middle of these regions. These are intended to identify genomic regions
that are most likely to be unbound by promoter-binding transcriptional regulators (by virtue of
their extreme distance from any known gene). We have used these as normalization controls in
situations where a factor binds to a large number of promoter regions. There are 224 features
printed as intensity controls; 37 oligos are printed twice and 25 of these 37 are printed an
additional six times. Based on a limited number of test hybridizations, this set of oligos gives
signal intensities that cover the entire dynamic range of the array. Our intention was that this set
could serve as a way to normalize intensities across multiple slides throughout the entire signal
range. There are 2,256 controls added by Agilent (standard) and the remainder of each array
consists of blank spots.
Single slide proximal promoter array
Anti-FLAG Foxp3 IPs were compared to control IPs (E2F4, empty vector) on a single slide array
with -95,000 probes (Supplemental Figure S4). Oligo probes were designed essentially as
described above. Probes were designed to tile the entire genome with 1 probe placed every
-250bp. A subset of these probes, covering 800bp upstream and 200bp downstream of
annotated transcriptional start sites, were then selected to cover the proximal promoters of
approximately 18,000 genes.
Array scanning and data extraction
Slides were scanned using an Agilent DNA microarray scanner BA. PMT settings were set
manually to normalize bulk signal in the Cy3 and Cy5 channel. For efficient batch processing of
scans, we used GenePix 6.0 software (Molecular Devices). Scans were automatically aligned
and then manually examined for abnormal features. Intensity data were then extracted in batch.
The complete ChIP-chip datasets have been submitted to the online data repository ArrayExpress
(http://www.ebi.ac.uk/arrayexpress/) and are associated with accession code E-TABM-154.
Data normalization and analysis
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GenePix was used to obtain background-subtracted intensity values for each fluorophore for
every feature on the array. To obtain set-normalized intensities we first calculated, for each slide,
the median intensities in each channel for a set of control probes that are included on each array.
We then calculated the average of these median intensities for the set of 10 slides. Intensities
were then normalized such that the median intensity of each channel for an individual slide
equalled the average of the median intensities of that channel across all slides.
Each slide contains a set of negative control spots that contain 60-mer sequences that do
not cross-hybridize to murine genomic DNA. We calculated the median intensity of these
negative control spots in each channel and then subtracted this number from the set-normalized
intensities of all other features.
To correct for different amounts of genomic and immunoprecipitated DNA hybridized to
the chip, negative control-subtracted median intensity value of the IP enriched DNA channel for
the set of intensity control probes described above was then divided by the median of the
genomic DNA channel for the same set of probes. This yielded a normalization factor that was
applied to each intensity in the genomic DNA channel.
Because binding events are rare in the genome, DNA fragments can only be enriched using
ChIP, and not anti-enriched. Therefore, the distribution of probes that are below the 1:1 axis (X-
score = 0) can provide an empirical non-parametric noise distribution for the experiment. For
each X score above 0, the probability of enrichment was calculated to be equal to the number of
probes with an X score greater then (more enriched) the test score divided by the total number of
probes (enriched + noise) with an absolute value of the X score greater then the test score. This
calculation removes the assumption that the X scores on a given array are normally distributed.
Identification of bound regions
To automatically determine bound regions in the datasets, we developed an algorithm to
incorporate information from neighbouring probes. For each 60-mer, we calculated the average
X score of the 60-mer and its two immediate neighbours. If a feature was flagged as abnormal
during scanning, we assumed it gave a neutral contribution to the average X score. Similarly, if
an adjacent feature was beyond a reasonable distance from the probe (1000 bp), we assumed it
gave a neutral contribution to the average X score. The distance threshold of 1000 bp was
determined based on the maximum size of labeled DNA fragments put into the hybridization.
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Since the maximum fragment size was approximately 550 bp, we reasoned that probes separated
by 1000 or more bp would not be able to contribute reliable information about a binding event
halfway between them. This set of averaged values gave us a new distribution that was
subsequently used to calculate test statistics for each probe set.
As most probes were spaced within the resolution limit of chromatin immunoprecipitation,
we next required that multiple probes in the probe set provide evidence of a binding event.
Bound probes were required to have a single probe probability of enrichment and a probe set
probability of enrichment greater than 0.95 (5% False Discovery Rate) for high stringency
binding calls and .90 (10% False Discovery Rate) for low stringency binding calls. Individual
probe sets that passed these criteria and were spaced closely together were collapsed into bound
regions if the centre probes of the probe sets were within 1000 bp of each other.
Comparing bound regions to known genes
The location of all bound regions was compared to a composite set of transcripts compiled from
three databases: RefSeq (Pruitt et al., 2005), Ensembl (Hubbard et al., 2005), and UCSC
annotated known genes (http://genome.ucsc.edu/cgi-bin/hgTrackUi?g=knownGene) that were
associated with Entrez Gene identifiers and miRNAs downloaded from the the RFAM database
(http://www.sanger.ac.uk/Software/Rfam/). By this method approximately 16,000 Entrez Genes
have a least one probe within -8 kb to +2 kb of their transcription start site. All coordinate
information was downloaded from the UCSC Genome Browser (NCBI build 6; March 2005).
For genes, we assigned bound regions within the -8 kb to +2 kb of the transcriptional start site,
which is consistent with our array design. MicroRNAs allowed a less stringent binding within
10kb upstream or downstream of the 5' end of the miRNA.
Control location analysis experiments
Control location analysis experiments demonstrate the specificity of our antibodies for the
appropriate targets. When Foxp3 location analysis was performed in hybridoma cells that were
not transduced with FLAG-tagged Foxp3 almost no enrichment of DNA was detected. Location
analysis experiments with anti-E2F4 antibodies identified expected E2F4 targets, which are
dissimilar from the Foxp3 targets that were discovered. These control experiments were
performed using the single slide proximal promoter arrays.
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Site-specific PCR analysis
We used site-specific PCR to confirm binding of Foxp3 to a panel of Foxp3 target genes
identified by ChIP-chip. A subset of the bound probe sets was selected and primer pairs were
designed to amplify a 150-200 bp region around the genomic location of probes that show peak
levels of immunoenrichment. PCR was performed on ligation-mediated PCR amplified IP
samples (Figure 3c). 10 ng of immunoprecipitated (IP) DNA was used in PCR reactions. For
input whole cell extract (WCE) samples, a range of DNA amounts (90, 30 and 10 ng of DNA)
was used. The PCR was performed for 23 cycles and products were visualized on an agarose gel
stained with SYBR Gold (Amersham) and quantified using ImageQuant (Amersham).
Enrichment ratios shown in Figure 3c were calculated as the ratio of the intensity of the PCR
product from 1Ong IP DNA to the product from 1Ong WCE DNA. Ratios were normalized
relative to the ratio observed for the unenriched ft actin control. For site-specific PCR in
unamplified IP material from cyclosporin A treated cells (Figure S3), ChIP protocol was
followed through the proteinase K digestion. For site-specific PCR, 2ul of IP material was used.
Again, for whole cell extract (WCE) samples a range of DNA amounts (90, 30 and 10 ng of
DNA) was used. 28 cycles of PCR were performed and products were visualized on agarose gel
with ethidium bromide. For all site-specific ChIP analysis, a region of the p3 actin promoter
where no Foxp3 binding is expected is used as a negative control.
GENE 5' OLIGO 3' OLIGO SIZE
Itk GCTGTTCTTCCAGGAGGATG AGGCTGGCTGATGCTGATAG 190
Jak2 ACGGCAGGACTAATTGTTGC GAAAGGGGGAGAAAGAGACG 180
Zap70 TCTAGGACAGGAACACATTGGGTGTCGGGAACACAAGAGGA 158
Ptpn22 TTCTGCCTTTCTTCTGGGAAT CTAGCGCCTTCCTTTCTCAA 162
112 GTCCTCATGGGCTCAACATC GGGAGGCCAACCTTTGTAAT 156
Pou2afl TTCATGAGACGGAAACCACA CACATCTACAGGAGGGAACCA156
Ly6a CCCAGCACAGTGGTAAGAGG GGCAGGGTTTATCACTTGGA 182
Tnfrsf9 TGTGTGTGTGAAGAGGGGTTT TCCACAGACGTGACAAGGAG 151
CD25 GGGTGAAAAGACAGCTTGGT GGGTGTGGGATTCACAAATG 151
r Actin AGGGTACCACCGGAAAAGTC CCCCAAAGGCTGAGAAGTTA 150
DNA motif analysis
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Discovery of the Foxp3 sequence motif from the ChIP-chip binding data was performed using
the THEME algorithm (MacIsaac et al., 2006). THEME tests specific, biologically informed
hypotheses about a transcription factor's binding specificity and identifies a motif consistent with
both the binding data and prior knowledge regarding the protein's DNA-binding domain
structural family.
We extracted genomic sequence corresponding to the regions bound by Foxp3 at high
confidence in stimulated cells for use as the "foreground" data set in THEME. We then
extracted sequence regions at random from unbound regions on the array for use as the
"background" data set. The length of these unbound sequences was matched to the average size
of the bound set (700bp) to avoid biasing either set towards motif presence or absence. We then
ran THEME, testing hypotheses consistent with the Forkhead DNA-binding domain family, and
identified the motif that yielded the lowest bound vs. unbound classification error after 5-fold
cross-validation. The statistical significance of the best motif's cross-validation error was
assessed by running THEME on randomized data (using the starting hypothesis from which the
best motif was derived) and calculating a Z-score for the observed error under the null
hypothesis that the sequences were selected at random from the background set. We then tested
hypotheses corresponding to 35 other distinct DNA-binding domains in an identical fashion, and
found that the best motif identified from the Forkhead family yielded a lower cross-validation
error than any motif from all other families tested.
The Foxp3 motif learned by THEME, and the Nfat motif from the TRANSFAC (version
8.3) database (Wingender et al., 1996) were used to scan all arrayed sequences to identify
matches to the motif. Each potential site was assessed by summing the position-specific scores
from the motif log-odds matrix. Sites were identified as matches if their score was greater than
or equal to the threshold, determined by the THEME algorithm, which classified bound and
unbound sequences with the lowest error during motif discovery. For the Nfat motif from
TRANSFAC a threshold of 60% of the maximum possible score was used. Foxp3 motif
conservation in bound regions was determined using mm6/hgl7 mouse-human pairwise
alignments obtained from the UCSC Genome Browser (Karolchik et al., 2003). If the human
sequence directly aligned to the motif match in mouse also met the score threshold we identified
that site as a conserved match. We performed the same conservation calculations for randomly
selected unbound microarray sequence regions. Statistical significance was determined by fitting
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a hypergeometric distribution to the data and testing the null hypothesis that the number of
conserved Foxp3 motifs observed in bound regions arose from random selection without
replacement from the background population. We then examined the distribution of spacings
between Foxp3 and Nfat motifs (when they occurred together in the same Foxp3 bound region).
Statistical significance was determined using the hypergeometric test described above. Results
are summarized in Supplemental Table S5. The online tool WebLogo
(http://weblogo.berkley.edu) was used to generate DNA motif sequence logo in Figure 2b.
Gene Expression Analysis
Gene expression profiling
For each hybridoma culture condition, total RNA was prepared from 1 x 107 cells using Trizol
(Gibco) followed by additional purification using the RNeasy Mini Kit (Qiagen). Biotinylated
antisense cRNA was then prepared according to the Affymetrix standard labelling protocol (one
amplification round). For each primary T cell culture condition, total RNA was isolated from 5 x
105 cells with RNeasy. Biotinylated antisense cRNA was prepared by two rounds of in vitro
amplification using the BioArray RNA Amplification and Labeling System (Enzo Life Sciences)
according to the protocol for 10-1000 ng of input RNA provided by the manufacturer.
Biotinylated cRNAs of hybridomas and primary T cells were fragmented and hybridized to
Affymetrix GeneChip Mouse Expression Set 430 2.0 arrays at the Microarray Core Facility
(Dana-Farber Cancer Institute). Arrays were stained, scanned, and quantified according to
standard Affymetrix protocols. Data were annotated according the NetAffx database
(http://www.affymetrix.com/analysis/index.affx) as of March, 2006. The complete expression
datasets have been submitted to the online data repository ArrayExpress
(http://www.ebi.ac.uk/arrayexpress/) and are associated with accession code E-TABM- 154.
Expression data normalization
Quantile normalization was performed separately on the hybridoma and ex vivo expression
datasets. Expression data were ranked within each sample. Each probeset was given the value
of the average signal of the probesets of that rank, across the dataset.
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Identification of differentially expressed genes
The hybridoma dataset was analyzed for statistically significant differential expression using the
online NIA Array Analysis Tool (Sharov et al., 2005; http://lgsun.grc.nia.nih.gov/ANOVA/).
Probesets were tested for differential expression using the following settings:
Threshold z-value to remove outliers: 10000
Error Model: Max(Average,Bayesian)
Error variance averaging window: 200
Proportion of highest error variances to be removed: 0.01
Bayesian degrees of freedom: 5
FDR threshold: .05
Of 45,101 probesets on the Affymetrix Mouse 430 2.0 array, 256 were differentially expressed
between Foxp3- and Foxp3+ stimulated hybridomas, while 23 probesets were differentially
expressed in the unstimulated cells. The expression data for these probesets are provided
(Supplemental Tables S7 and S8). Probesets were excluded that had an average signal intensity
that was not in the upper tercile on the arrays (54.4 units). Probesets that did not map to the
genes for which we had Foxp3 binding data and probesets that mapped to multiple genes were
also excluded. In the cases where multiple probesets mapping to one gene were differentially
expressed, only the probeset showing the largest differential expression was displayed.
It is worth noting that a stringent cutoff to call differential expression is used. This
identifies expression changes with high confidence but produces an underestimate because there
are many genes that show small changes. Our goal is to gain insight into Foxp3 action, and by
focusing on only the most pronounced transcriptional effects, we aim to minimize the effects of
noise in the expression data. As a result of this approach, some genes that are likely to be
regulated directly by Foxp3 exhibit small transcriptional effects that are not called differentially
expressed. For example the genes Bcl10, Cd53, Rbpsuh, and Rgs1 are all direct Foxp3 binding
targets that are known to play a role in regulation of T cells, and have the characteristic
expression pattern of suppressed activation, but do not meet the FDR < 5% statistical
significance cutoff for differential expression.
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Genes with consistent Foxp3 dependent differential expression in between stimulated ex
vivo T helper and Treg cells and between stimulated Foxp3- and Foxp3+ hybridoma cells were
determined according to the following method. Probesets were excluded that had an average
signal intensity that was smaller than the median signal on the arrays (26.2 units). Probesets that
did not map to the genes for which we had Foxp3 binding data and probesets that mapped to
multiple genes were also excluded. In the cases where multiple probesets mapping to one gene
were differentially expressed, only the probeset showing the largest differential expression was
displayed.
A score for Foxp3 dependent differential expression was calculated in the hybridoma and
ex vivo datasets separately. The product of these scores was used to sort the genes and identify
those with the largest Foxp3 dependent differential expression, which was consistent in the two
cell types. To calculate each score, the average signal intensity within the two groups being
compared was calculated. The difference in signal between the groups being compared was
divided by the median signal intensity of all probesets on the array (26.2 units) plus one eighth of
the average signal intensity for that probeset.
(A - B) / ( (A + B) / 16 + median)
This generated a differential expression score that is comparable to a signal to noise ratio, where
noise is estimated be a linear function of signal intensity. In Figure S5, the 125 genes with the
highest overall differential expression score were displayed, to match the number of genes that
are shown in Figure 3A.
Hierarchical clustering and heatmap display
For clustering and heat map display, expression data were Z-score normalized separately within
the hybridoma and ex vivo datasets. For heatmap display in Figure S5 data were Z-score
normalized within the full hybridoma and ex vivo datasets including the unstimulated samples,
though only the stimulated samples are displayed. Average linkage, correlation distance,
centered, hierarchical clustering was performed using Gene Cluster (http://bonsai.ims.u-
tokyo.ac.jp/-mdehoon/software/cluster/software.htm#ctv). Heatmaps were generated using Java
Treeview (http://jtreeview.sourceforge.net/). Cluster branches were flipped about tree nodes for
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optimal display. In Figure 3B, those genes from panel A that are bound by Foxp3 and are
expressed in ex vivo cells are displayed in panel B. Slc] 7a6 and Adam10 are excluded because
they are not expressed in the ex vivo samples.
Real-time RT-PCR
Total RNA was prepared from hybridoma cells or FACS purified primary T cell populations
using the RNeasy kit (Qiagen) followed by DNase digestion (Qiagen). cDNA was synthesized
from total RNA using Superscript II reverse transcriptase and oligo(dT) (Invitrogen Life
Technologies) according to the manufacturer's recommendations. Real-time RT-PCR was
performed on an ABI PRISM thermal cycler (Applied Biosystems) using SYBR* Green PCR
core reagents (Applied Biosystems). Real-time RT-PCR primer sets were either obtained from
SuperArray or are available upon request.
Significance of list overlap
Statistical significance of overlap between differentially expressed genes and Foxp3 bound genes
was calculated using a standard Chi-Square test.
Functional annotation and statistical significance of gene lists
Functional annotation and statistical significance of gene lists was performed with the on-line
tool, DAVID (http://niaid.abcc.ncifcrf.gov/) (Dennis et al., 2003). Genes were imported as
EntrezGene IDs and, using the Functional Annotation tool, compared to KEGG pathways
(Kanehisa et al., 2000).
The Foxp3 binding targets in PMA/ionomycin-stimulated CD4' hybridomas were enriched
for genes associated with the following KEGG pathways:
KEGG Pathway P-Value
T CELL RECEPTOR SIGNALING PATHWAY 1.4E-5
CELL CYCLE 4.3E-3
FATTY ACID ELONGATION IN MITOCHONDRIA 2.5E-2
CYTOKINE-CYTOKINE RECEPTOR INTERACTION 5.9E-2
PYRIMIDINE METABOLISM 9.2E-2
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The Foxp3 target genes that are downregulated in Foxp3+ stimulated hybridomas relative to their
levels in Foxp3- stimulated hybridomas were enriched for genes associated with the following
KEGG pathways:
KEGG Pathway
T CELL RECEPTOR SIGNALING PATHWAY
P-Value
6.1E-3
CYTOKINE-CYTOKINE RECEPTOR INTERACTION 3.6E-2
Supplemental Tables are available online at:
http://www.nature.com/nature/journal/v445/n7130/suppinfo/nature05478.html
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Figure S1. Flow cytometric analysis of Foxp3 expression
5B6-2-[Foxp3]-IRES-GFP or 5B6-2-[Empty]-IRES-GFP 5B6-2 hybridoma cells (A.) or FACS-
purified ex vivo TCR-HA transgenic CD4 CD25~ naYve or CD4*CD25* Treg cells (B.) were
cultured in the absence or presence of PMA/ionomycin. After 6h cells were harvested and
intracellular staining was performed using the mAb FJK16s (anti-Foxp3). Histograms show
relative levels Foxp3 protein expression, which demonstrates that Foxp3 is expressed at a similar
level in the transduced hybridomas as in ex vivo Treg cells.
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Figure S2. Cytokine production of Foxp3-transduced 5B6-2 hybridomas
5B6-2-[empty]-IRES-GFP (A.) or 5B6-2-[Foxp3]-IRES-GFP (B.) hybridoma cells were cultured
in the presence of PMA/ionomycin for the indicated times. Brefeldin A was added for the last 4h
of 6h and 36h cultures. After surface staining for CD4 expression and fixation, intracellular
staining with the indicated cytokine antibodies or appropriate isotype controls was performed.
Numbers in dot plots indicate the frequencies of cells in the respective quadrant. These data
show that Foxp3 transduction suppresses production of 112, but does not suppress production of
TNF-alpha.
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Figure S3
Figure S3. The promoters of most Foxp3 target genes are bound by Foxp3 before and after
T cell stimulation
A. The lists of genes whose promoters are bound by Foxp3 in unstimulated (blue) and stimulated
(pink) hybridoma cells are shown in a Venn diagram. The genes occupied by Foxp3 in
stimulated T cells (FDR < .05) are represented by the pink circle. The genes occupied by Foxp3
in unstimulated T cells (FDR < .05) are represented by the blue circle. The dotted light blue
circle represents the genes occupied by Foxp3 in unstimulated cells if the threshold is relaxed to
FDR < .10. Most of the genes bound in stimulated cells are prebound in unstimulated cells.
B. Although most Foxp3 bound genes in stimulated cells were also bound in unstimulated cells,
the binding profiles were not identical in the two conditions. Ptpn22 and Jak2 were
representative of target genes where strong immunoenrichment was observed in both conditions.
The binding profile for Foxp3 is shown at these promoters with binding in unstimulated cells
displayed with a blue line and binding in stimulated cells displayed with a pink line. The profile
across these promoter regions indicates that additional Foxp3 binding events are stabilized in
response to PMA/ionomycin stimulation. This phenomenon is observed at several Foxp3 targets.
In contrast to the strong immunoenrichment observed in both conditions at Ptpn22 and Jak2,
recent reports (Wu et al., 2006; Chen et al., 2006) indicate that Foxp3 is stabilized at the
promoters of 112 and CD25 in response to T cell stimulation. This finding is confirmed in our
Foxp3 binding data as shown here.
C. Foxp3 binding at the Ptpn22 and Jak2 promoters in unstimulated cells was independently
confirmed with site-specific ChIP in cyclosporin A treated cells. Primers flanking the binding
peaks indicated with asterisks in B. were used for ChIP PCR reactions shown here.
Immunoenrichment at the Ptpn22 and Jak2 promoters was observed. As expected,
immunoenrichment was not observed at the 112, CD25, and controlfi actin promoters.
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Figure S4. Control experiments confirm the specificity of Foxp3 ChIP-chip
When log2 intensity values of IP (Cy5 label) material are plotted against 10g2 intensity values of
whole cell extract (Cy3 label), considerable enrichment of IP material is observed in ChIP
experiments in FLAG-tagged Foxp3+ cells both before (A.) and after (B.) PMA/ionomycin
stimulation. In contrast, very little IP enrichment is observed when the same IPs are performed
in Foxp3- hybridomas (C.). A positive control IP with an anti-E2F4 antibody identifies expected
IP enriched E2F4 targets (D.), which are largely distinct from the identified Foxp3 target genes
(see Supplemental Table S4).
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Figure S5. Many Foxp3 targets show consistent Foxp3 dependent differential expression in
ex vivo and hybridoma cells
Genes were selected that showed consistent Foxp3 dependent differential expression in ex vivo
and hybridoma cells according to methods described in the Supplemental section, Identification
of Differentially Expressed Genes. 125 genes are displayed to match the number of genes in
Figure 3a. For clustering and heatmap display data were Z-score normalized within the full
hybridoma and ex vivo datasets including the unstimulated samples, though only the stimulated
samples are displayed. Data were hierarchically clustered and are displayed in a heatmap. The
Z-score normalized induction (red) or repression (green) is shown for each gene. Direct targets
of Foxp3 are signified with blue bars, with dark blue representing genes called bound with a
false discovery rate of 5% and light blue representing a false discovery threshold of 10%. There
is a significant enrichment of direct Foxp3 targets among the genes that are downregulated in
stimulated Foxp3+ cells (p < 10-19).
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Figure S6. Analysis of Ly6a protein expression on primary Treg cells
Surface expression of Ly6a on CD4*6.5* naive T cells from TCR-HA mice or Foxp3-expressing
CD4*CD25hig6.5* Treg cells from double-transgenic TCR-HA x pgk-HA mice was analyzed on
(A.) freshly FACS-purified cells or after 18h of culture in the absence or (B.) presence of 50
ng/ml PMA and 200 ng/ml ionomycin with or without a 1 h preincubation with 2 pM cyclosporin
A.
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Appendix D
Supplemental Material for Chapter 5
Aberrant Chromatin at Genes Encoding Stem Cell Regulators
in Human Mixed-lineage Leukemia
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Supplemental Experimental Procedures
Antibodies
The antibodies for ChIP were specific for MLL-N terminus (Bethyl BL1289), MLL-C terminus
(Nakamura et al. 2002), AF4-C terminus (wis50 Rabbit polyclonal raised against amino acids
767-931), H3K79me2 (Abcam, ab3594). H3K4me3 (Abcam, ab8580) (Santos-Rosa et al. 2002),
H3 (Abcam, ab1791), ENL (wis11 provided by Eli Canaani), hypophosphorylated RNA
polymerase 1I (8WG16) (Thompson et al. 1989) and High-affinity HA (Roche clone 3F10).
Chromatin immunoprecipitation
Protocols describing all materials and methods can be downloaded from
http://web.wi.mit.edu/young/hESPRC and have previously been described in detail (Lee et al.
2006).
Human REH or SEM cells were grown to a final count of 5x10 7 - 1x10 8 cells for each
chromatin immunoprecipitation (ChIP). Cells were chemically crosslinked by the addition of
one-tenth volume of fresh 11% formaldehyde solution for 15 minutes at room temperature. Cells
were rinsed twice with 1xPBS, harvested by centrifugation and flash frozen in liquid nitrogen.
Cells were stored at -800C prior to use.
Cells were resuspended, lysed and sonicated to solubilize and shear crosslinked DNA.
Sonication conditions vary depending on cells, culture conditions, crosslinking and equipment.
We used a Misonix Sonicator 3000 and sonicated at a power of 27W for 10 x 30 second pulses
(90 second pause between pulses). Samples were kept on ice at all times.
The resulting whole cell extract was incubated overnight at 4*C with 100 pl of Dynal
Protein G magnetic beads that had been preincubated with approximately 10 pg of the
appropriate antibody. The immunoprecipitation was allowed to proceed overnight. Beads were
washed 5 times with RIPA buffer and 1 time with TE containing 50 mM NaCl. Bound
complexes were eluted from the beads by heating at 65*C with occasional vortexing and
crosslinking was reversed by overnight incubation at 65*C. Whole cell extract DNA (reserved
from the sonication step) was also treated for crosslink reversal. Immunoprecipitated DNA and
whole cell extract DNA were then purified by treatment with RNAse A, proteinase K and
multiple phenol:chloroform:isoamyl alcohol extractions.
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HA-ChIPs were performed as described in Lee et al. (2006) with minor modifications
made to the sonication/IP buffer (Final: 50 mM Hepes, 140 mM NaCl, 1 mM EDTA, 1% Triton-
X, 0.1% DOC). Washes of the immunoprecipitate were performed with IP buffer, with IP buffer
containing 500 mM NaCl, RIPA buffer and finally with TE.
ChIP-Seq Experiments and Analysis
All protocols for Illumina/Solexa sequence preparation, sequencing and quality control are
provided by Illumina (Illumina, San Diego, CA, http://www.illumina.com/pages.ilmn?ID=252).
A brief summary of the technique, minor protocol modifications, and data analysis methods are
described below.
Sample preparation
Purified chromatin immunoprecipitated (ChIP) DNA was prepared for sequencing according to a
modified version of the Illumina/Solexa Genomic DNA protocol. Approximately 50-200ng of IP
DNA was prepared for ligation of Solexa linkers by repairing the ends and adding a single
adenine nucleotide overhang to allow for directional ligation. A 1:100 dilution of the Adaptor
Oligo Mix (Illumina) was used in the ligation step. A subsequent PCR step with 18
amplification cycles added additional linker sequence to the fragments to prepare them for
annealing to the Genome Analyzer flow-cell. Amplified material was purified by Qiaquick
MinElute (Qaigen) and a narrow range of fragment sizes was selected by separation on a 2%
agarose gel and excision of a band between 150-300 bp, representing IP fragments between 50
and 200nt in length and ~100bp of primer sequence. The DNA was purified from the agarose
and diluted to 10 nM for loading on the flow cell.
Polony generation on Solexa flow-cells
The DNA library (2-4 pM) was applied to one lane of the flow-cell (eight samples per flow-cell)
using a Cluster Station device (Illumina). The concentration of library applied to the flow-cell
was calibrated so that polonies generated in the bridge amplification step originate from single
strands of DNA. Multiple rounds of amplification reagents were flowed across the cell in the
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bridge amplification step to generate polonies of approximately 1,000 strands in 1p m diameter
spots. Double stranded polonies were visually checked for density and morphology by staining
with a 1:5000 dilution of SYBR Green I (Invitrogen) and visualizing with a microscope under
fluorescent illumination. Validated flow-cells were stored at 40C until sequencing.
Sequencing
Flow-cells were removed from storage and subjected to linearization and annealing of
sequencing primer on the Cluster Station. Primed flow-cells were loaded into the Genome
Analyzer 1G (Illumina). After the first base was incorporated in the sequencing-by-synthesis
reaction the process was paused for a key quality control checkpoint. A small section of each
lane was imaged and the average intensity value for all four bases was compared to minimum
thresholds. Flow-cells with low first base intensities were re-primed and if signal was not
recovered the flow-cell was aborted. Flow-cells with signal intensities meeting the minimum
thresholds were resumed and sequenced for 26 cycles.
Genomic mapping of ChIP-Seq reads
Images acquired from the Genome Analyzer were processed through the bundled image
extraction pipeline (Illumina), which identified polony positions, performed base-calling and
generated QC statistics. Sequences were aligned to NCBI build 36.1 (hgl8) of the human
genome using ELAND software (Illumina). Sequences uniquely mapping to the genome with
zero or one mismatch were used in further analysis. Twenty-six basepair sequences that did not
meet these criteria were truncated by one base and remapped. Truncated sequences, which
uniquely mapped to the genome with zero or one mismatches were added to the set to be used in
further analysis. Truncation and remapping were repeated down to a sequence length of 15
bases. Sequences from two flow cells for each chromatin IP target were combined. A summary
of the number of reads used in each ChIP-Seq experiment is provided in Table S1. Complete
ChIP-Seq data is available in the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE13313.
Identification of enriched genomic regions
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The analysis methods used were derived from previously published methods (Barski et al. 2007;
Johnson et al. 2007; Mikkelsen et al. 2007; Robertson et al. 2007). Each ChIP-Seq read was
extended 100 bp from its mapped genomic position and strand to approximate the middle of the
sequenced DNA fragment. The genome was divided into 25 bp wide bins. The ChIP-Seq
density within each genomic bin was then calculated as the number of ChIP-Seq reads mapping
within a 1kb window (+/- 500bp) surrounding the middle of that the genomic bin.
Genomic bins containing statistically significant ChIP-Seq enrichment were identified
using a Poissonian background model using a p-value threshold of 10-8. Assuming the
background ChIP-Seq density was spread randomly throughout the genome, the probability of
observing a given density can be modeled as a Poisson process with an expectation value equal
to the total number of ChIP-Seq reads times the number of genomic bins into which each read
maps (1,000bp / 25bp per bin = 40 bins) divided by the total number of genomic bins with
unique sequence (estimated to be 70% of total bins) available for mapping. A list of the
minimum ChIP-Seq density required in each dataset to meet this threshold is provided in Table
S1. ChIP enriched genomic bins within 2kb were compressed into enriched regions. Regions
less than 100 bp in length were discarded.
The Poisson background model assumes a random distribution of background ChIP-Seq
density. This model has numerous shortcomings, both statistical and biological, and we have
observed significant deviations from its expectations. These non-random events create a large
number of false positive events for actual ChIP-Seq experiments analyzed using a Poisson
model. To remove these regions, we compared genomic bins and regions that meet the statistical
threshold for enrichment to an empirical distribution of reads obtained from Solexa sequencing
of DNA from whole cell extract. We required that enriched genomic bins and regions have five-
fold greater ChIP-Seq density in the specific IP sample as compared with the non-specific
background, normalized for the total number mapped ChIP-Seq reads in each sample. We
observed that ~100-500 regions in the genome showed non-specific enrichment in these
experiments.
A summary of the ChIP-Seq enriched regions in each experiment is provided in Tables
SI1 through S20.
Comparing enriched regions to gene annotation
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The genomic coordinates of the full set of ~ 26,000 transcripts from the RefSeq database
(http://www.ncbi.nlm.nih.gov/RefSeq/) was downloaded from the UCSC Genome Browser
(http://genome.ucsc.edu/cgi-bin/hgTables?) on May 12, 2008. Transcripts were assigned to ChIP
enriched genomic regions for AF4, MLL-N, MLL-C, and H3K79me2 based on the following
algorithm. First, for each ChIP enriched region, all transcripts with transcription start sites (TSS)
occurring within the region were assigned to that region. Second, all transcripts for which the
region from 2kb upstream of the TSS to the transcription stop site overlapped the ChIP enriched
region were recorded. Of these overlapping transcripts, the single transcript whose TSS was
closest to the enriched region's peak of ChIP density was assigned to the region. A different
algorithm focused on transcription starts sites was used to assign transcripts to H3K4me3 ChIP
enriched regions. All transcripts for which the region from 2kb upstream to 2kb downstream of
the TSS overlapped a H3K4me3 ChIP enriched region were assigned to that region. This
resulted in the assignment of zero, one, or many transcripts to each ChIP enriched region. In
some cases more than one ChIP enriched region mapped to the same transcript.
A summary of the genes called enriched in each ChIP-Seq experiment is provided in
Table S3. Additionally, supplemental data files are provided that contain genome browser tracks
showing genome-wide Chip-seq density and enriched regions for all experiments.
Identification of MLL-AF4 fusion protein target regions
Locating MLL-AF4 fusions in cancer cells is complicated by the fact that both wild type and
fusion proteins are present in the cells, making it difficult to distinguish between a 'normal'
binding site, and the site of the fusion protein. In order to locate MLL-AF4 binding sites in the
genome of SEM cells, we therefore sought to find patterns of binding that were found uniquely
in SEM cells and not in the comparable REH cells that lack the fusion. Because these patterns
were unique to SEM cells, we concluded that they must be derived, at least in part, from the
fusion protein.
It is important to note that, while the loci we identify a very likely to be bound by AF4-
MLL, we cannot definitively evaluate binding of MLL-AF4 at many other places in the genome.
To specifically find the fusion protein, we created a strict set of criteria that would be certain to
eliminate any regions that might be falsely identified as fusion protein target regions. Regions
that do not satisfy the rules of our algorithm but are enriched for both AF4-C and MLL-N
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epitopes may well be bound by the fusion protein, but we cannot rule out the possibility that they
are bound only by the normal proteins. Thus, to minimize false positives, we have excluded these
regions, even when there is a high likelihood that they are derived from the fusion protein,
In order to identify the MLL-AF4 enriched regions, we used the following algorithm. For
each AF4 ChIP enriched region larger than 3kb in SEM and REH cells, the pattern of AF4 ChIP-
Seq density was compared to the pattern of MLL-N ChIP-Seq density using a correlation based
similarity metric, which is described in detail below. Large regions were selected because they
were more prevalent in cells containing the fusion protein than in control cancer cells. Regions
were called candidate fusion targets if the AF4 to MLL-N similarity was greater than 0.8,
indicating high similarity. Of 5,062 AF4 ChIP enriched regions in SEM cells, 308 regions met
these criteria and of 1,057 AF4 ChIP enriched regions in REH cells, only one region met these
criteria.
We then removed candidate MLL-AF4 fusion protein target regions if they appeared to
have similar AF4 and MLL-N occupancy in SEM and REH cells, since REH cells do not contain
the MLL-AF4 fusion protein. This likely results in the removal of some real MLL-AF4 targets
and as well as regions that are targets of endogenous AF4 and MLL. This was accomplished by
eliminating regions if the SEM to REH AF4 similarity or the SEM to REH MLL-N similarity
was greater than 0.8 or if the SEM to REH AF4 similarity and the SEM to REH MLL-N
similarity were greater than 0.4. This resulted in the elimination of 82 candidate fusion protein
target regions in SEM cells and the single region in REH cells. This left 226 MLL-AF4 fusion
protein target regions in SEM cells none in REH cells. A summary of the identification of MLL-
AF4 target regions in SEM cells is provided in Table S4. A summary of the identification of
MLL-AF4 target regions in REH cells is provided in Table S5. A list of the MLL-AF4 fusion
protein target regions in SEM cells is provided in Table S6. A list of the RefSeq transcripts and
gene symbols that are MLL-AF4 targets is provided in Table S2.
We considered the possibility that the enrichment of signal for anti-MLL-N and anti-
AF4-C at "MLL-AF4" sites in SEM cells reflected the recruitment of endogenous (full length,
wild type) MLL and endogenous (full length, wild type) AF4 and not the true MLL-AF4 fusion
protein. Three lines of evidence argue against this possibility. First, ChIP-Seq using an antibody
(anti-MLL-C) that recognized only non-fusion (native) MLL antibody resulted in promoter
proximal binding that did not overlap completely with AF4 binding (Figure S2). In contrast,
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there was very high concordance between the AF4-C and MLL-N signals consistent with the
occupancy of a single protein (MLL-AF4) rather than two independent proteins. (Figure 1B;
Figure 2A,B; Figure S2). In fact, the binding patterns of AF4-C and MLL-N were nearly
indistinguishable at MLL-AF4 target regions (Figure 1B;Figure 2A,B). A composite binding
profile for all 169 MLL-AF4 target genes confirmed this by showing a striking positional overlap
of the MLL-N and AF4-C epitopes, but no such overlap in control cells (Figure 2B, Tables S4
and S5). Second, if detection of MLL-AF4 target genes were actually an artifact of highly
expressed genes recruiting endogenous MLL-N and AF4-C, we would expect the binding
behavior of the MLL-AF4 target set to be the same as a random set of highly expressed genes.
This was not found to be the case when a set of the 500 most highly expressed genes in SEM
cells was compared to the MLL-AF4 target set. Here, the MLL-AF4 gene set was dramatically
different in binding profile and extended >6kb into the coding regions of target genes (Figure
S2A). In fact, we found many active genes in both SEM and REH cells that are bound by AF4
(Table S11,S16), but these genes show little co-recruitment of normal (non-fusion) MLL at the
same genes (Table S2), indicating that co-occurrence of MLL and AF4 is not a general
characteristic of active genes in ALL cells. Third, we tested a subset of MLL-AF4 target regions
for the ability to recruit exogenous MLL-AF4 protein. HA-MLL-AF4 plasmids were introduced
into SEM cells and anti-HA ChIP analysis was performed. Quantitative PCR detection of a
randomly selected group MLL-AF4 targets revealed that 85% of binding events could be verified
using this assay (Figure S3). Taken together, our results identify more than 200 genomic regions
that are targeted by the MLL-AF4 fusion protein in leukemia cells.
ChIP-Seq density similarity metric
In order to compare the ChIP-Seq density profiles between different ChIP targets (AF4, MLL-N,
MLL-C) and different cell types (SEM and REH) we developed an algorithm, based on a
correlation coefficient, to score the similarity between two ChIP-Seq density profiles in a given
genomic region. First, the genomic region was extended 2kb on either side. Since the similarity
algorithm is based on a Pearson correlation it was important to include un-enriched regions
surrounding regions of ChIP enrichment. Second, each ChIP-Seq density profile was
transformed by subtracting the density threshold for calling ChIP-Seq enrichment in that
experiment (14-17) and then imposing a minimum of zero counts. This was done to ensure that
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similarities between two profiles within background signal range have a small influence on the
similarity score. Third, the Pearson correlation coefficient between the two extended,
transformed ChIP-Seq profiles was calculated. This similarity score was used to make
comparison of the following ChIP-Seq profiles; AF4:MLL-N in SEM cells, AF4:MLL-N in REH
cells, AF4 in SEM:REH cells, and MLL-N in SEM:REH cells. A score of 1 indicates perfect
similarity between two profiles while a score of zero or below indicates no similarity between to
profiles. We used a threshold of greater than 0.8, which indicates high similarity, and a threshold
of less than 0.4, which indicates low similarity between two profiles.
Composite ChIP-Seq density profiles
Composite profiles of enrichment were generated as described previously (Pokholok et al. 2005;
Guenther et al. 2007). Selected genes were aligned with each other according to the position and
direction of their transcription start sites. The average ChIP-Seq density in 25 bp bins was
calculated. For each experiment, the composite profile was normalized to the density per million
total reads.
ChIP-Seq density heatmaps
Selected genes were aligned with each other according to the position and direction of their
transcription start site. For each experiment, the ChIP-Seq density profiles were normalized to
the density per million total reads. Additionally, ChIP-Seq density profiles were background
subtracted using a background signal value of two reads per million. Genes were sorted by the
total AF4 and MLL-N ChIP-Seq density in the displayed region. Heatmaps were generated
using Java Treeview (http://jtreeview.sourceforge.net/) with color saturation at six reads per
million.
Gene Set enrichment analysis
The gene symbols of transcripts targeted by MLL-AF4 were submitted to the online tool Gene
Set Enrichment Analysis, Molecular Signatures Database (http://www.broad.mit.edu/gsea/
msigdb/index.jsp) (Subramanian et al. 2005) on May 15, 2008. The MLL-AF4 target genes were
compared to curated (n=1,892), computational (n=883), and Gene Ontology (n=1,454) gene sets.
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Selected statistically significant results are presented in Figure 2. Complete Gene Set
Enrichment Analysis results are provided in Table S10.
ChIP-Chip Experiments and Analysis
Microarray design
The 95K feature human promoter array (H23a) used in Figure S5 was purchased from Agilent
Technology (Santa Clara, CA). This microarray (ID# 13950) contains ~95,000 60mer
oligonucleotide probes tiled at a density of approximately 1 probe per 250 bp. The array
included all four HOX clusters (HOXA-D with 100kb flanking each clusters 3' and 5' ends) as
well as the promoter regions of ~17,000 genes from ~750 bp upstream to -250 bp downstream of
the transcription start sites.
Sample preparation, hybridization, and imaging
Purified DNA was blunted and ligated to linker and amplified using a two-stage PCR protocol.
Amplified DNA was labeled and purified using Bioprime random primer labeling kits
(Invitrogen), RNA Polymerase II, MLL-N, AF4, ENL, H3K79me2, and H3K4me3
immunoenriched DNA was labeled with Cy5 fluorophore, whole cell extract and H3 (control
ChIP for histone modifications) immunoenriched DNA was labeled with Cy3 fluorophore.
Labeled DNA (5-6 pg) was mixed and hybridized to arrays in Agilent hybridization chambers
for 36-42 hours at 40*C. Arrays were then washed and scanned using an Agilent DNA
microarray scanner BA. PMT settings were set manually to normalize bulk signal in the Cy3
and Cy5 channel.
Image quantification, data normalization and analysis
We used GenePix Pro software (Molecular Devices, Sunnyvale, CA) to obtain background-
subtracted intensity values for each fluorophore for every feature on the arrays respectively.
Among the Agilent controls is a set of negative control spots that contain 60-mer sequences that
do not cross-hybridize to human genomic DNA. We calculated the median intensity of these
negative control spots in each channel and then subtracted this number from the intensities of all
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other features. To correct for different amounts of each sample of DNA hybridized to the chip,
the negative control-subtracted median intensity value of control oligonucleotides from the Cy3-
enriched DNA channel was then divided by the median of the control oligonucleotides from the
Cy5-enriched DNA channel. This yielded a normalization factor that was applied to each
intensity in the Cy5 DNA channel. For graphical display, the enrichment ratio of each probe was
plotted as the average of the raw enrichment ratio of that probe and the nearest 5' and 3' probes
(sliding average of three probes).
Complete ChIP-chip data is available in the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE 13313.
Gene-specific realtime-PCR
For relative quantification by real-time PCR, dilutions of the whole cell extract DNA were used
to construct standard curves for the amplifications of the SEM immunoprecipitates for each
primer pair. PCRs were performed in duplicate reactions on the 7700 ABI Detection System
using the POWER SYBR Green PCR master mix (ABI) and standard deviations were calculated.
Enrichment was calculated from the difference between the threshold cycle of the target region
and ACTB control primers for the ChIP DNA minus the difference between the threshold cycle
of the target region and ACTB control primers for the WCE DNA. Primers were selected that are
within 1kb of the peak of the MLLAF4 fusion domains from ChIP-Seq data. Genes were selected
that were expected to be bound by the fusion gene as well as several control genes that were
negative by ChIP-Seq and expressed (ACTB, RPS3, SUZl2) or not expressed (ILIF10, HOXD9,
NANOG, POU5F1) in SEM cells. Results are displayed in Figure S3. A table of the primer
sequences used is provided in Table S21.
GeneChip Expression Experiments and Analysis
Sample preparation
5 ptg total RNA was used to prepare biotinylated cRNA according to the manufacturer's protocol
(Affymetrix One Cycle cDNA Synthesis Kit). Briefly, this method involves SuperScript II-
directed reverse transcription using a T7-Oligo-dT promoter primer to create first strand cDNA.
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RNase H-mediated second strand cDNA synthesis is followed by T7 RNA Polymerase directed
in vitro transcription, which incorporates a biotinylated nucleotide during cRNA amplification.
Hybridization, staining, scanning, and image analysis
Samples were prepared for hybridization using 15 pg biotinylated cRNA in a IX hybridization
cocktail with additional hybridization cocktail components provided in the GeneChip
Hybridization, Wash and Stain Kit (Affymetrix). GeneChip arrays (Human U133 2.0) were
hybridized in a GeneChip Hybridization Oven at 45*C for 16 hours at 60 RPM. Washing was
performed using a GeneChip Fluidics Station 450 according to the manufacturer's instructions,
using the buffers provided in the Affymetrix GeneChip Hybridization, Wash and Stain Kit.
Arrays were scanned on a GeneChip Scanner 3000 and images were extracted and analyzed
using the default settings of GeneChip Operating Software v1.4 (GCOS).
Expression signal values were quantile normalized by assigning each probeset the
average signal intensity for all probesets of the same rank across the four experiments. Control
probes were removed from further analysis. Probeset annotations were downloaded from the
NetAffx (http://www.affymetrix.com/analysis/index.affx) database on May 14, 2008.
Complete expression data are provided in Table S3 and available in the Gene Expression
Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) under the accession number GSE 13313.
Identification of top 500 expressed genes
The average expression signal of each probeset in each cell type was calculated and the probesets
were ranked. Transcripts corresponding to the 500 genes with the highest signal in each cell type
were used. Transcripts that were identified as MLL-AF4 fusion protein targets were excluded.
This identified -400 of the most highly expressed Refseq transcripts in each cell type.
Expression based present/absent calls
Present (P), marginal (M), absent (A) transcript detection calls from GCOS for each probeset
were tabulated. Transcripts were called present if at least one corresponding probeset was called
present in at least one of the two experiments for each cell type.
MLL-AF4 fusion target expression hierarchical clustering
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Expression data from SEM and REH cells was combined with gene expression data profiling 132
leukemia samples (Ross et al. 2003). The full dataset was quantile normalized by assigning each
probeset the average signal intensity for all probesets of the same rank across all experiments.
Expression data was extracted for all transcripts assigned to MLL-AF4 fusion target regions
larger than 10kb for Figure 3. This cutoff was used to enable sufficient space for each target
gene to be listed. Expression data was extracted for all transcripts assigned to all MLL-AF4
fusion target regions for Figure S4. Genes with no expression data were excluded. Expression
signals from multiple probesets mapping to the same gene were averaged to produce a single
expression profile for each gene. Expression values were log (base 10) transformed and then
mean centered for each gene. Centroid linkage, centered Pearson correlation distance,
hierarchical clustering of arrays and centroid linkage, centered Pearson correlation distance,
hierarchical clustering of genes was performed using Gene Cluster 3.0 (http://bonsai.ims.u-
tokyo.ac.jp/-mdehoon/software/cluster/software.htm#ctv). Heatmaps were generated using Java
Treeview (http://jtreeview.sourceforge.net/). Array tree branches were flipped for optimal
display. Complete input data and clustering results are provided in Table S8 and Table S9.
Identification of binding partners by IP-Western blot
Nuclear extracts were prepared as described in Nakamura et al. 2002 (Nakamura et al. 2002).
Aliquots of 0.5 - 0.7 mg of nuclear extract protein were immunoprecipitated. Polyclonal
antibodies were raised in rabbits against AF4 polypeptides spanning residues 3-148 (N-AF4),
767-931 [C-AF4 (1)], and 727-885 [C-AF4 (2)]. Polyclonal antibodies to ENL were directed
against polypeptides spanning residues 145-298 (ENLI) or 215-366 ENL2). Mouse monoclonal
antibodies for MLL immunoprecipitation were purchased from Upstate and were directed against
N-terminal and C-terminal sequences 05-764 and 05-765, respectively). For western analysis we
used antibody 169 raised against MLL segment encompassing residues 79-290. Santa Cruz
antibody T-18 sc-8127 was used for immunoprecipitation and detection of cyclin T1. Note:
antibodies against MLL-N, which precipitates the MLL-AF4 fusion and normal ENL in SEM
cells, does not precipitate normal AF4 (Figure S5). This, in conjunction with the failure to
precipitate MLL-AF4 by AF4-N antibodies, indicate that normal AF4 is not complexed to MLL-
AF4. Thus, MLL-AF4 does not recruit the entire normal AF4 complex , but rather the necessary
components (e.g. ENL, cyclin TI). These results provide the first demonstration that an MLL
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fusion protein is associated with a normal partner protein (ENL) and with pTEFb.
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Figure Si. Endogenous MLL and AF4 bind near the 5' end of active genes
Mapped ChIP-Seq reads within 10 kb window surrounding the transcriptional start site of
representative genes bound by MLL-N terminus and AF4-C in both SEM and REH cells
A. Endogenous MLL and AF4 fusion protein binding in REH cells.
B. MLL-AF4 fusion binding in SEM cells. ChIP-Seq tracks normalized to reads per million for
each factor. Gene models are below each example. The start site and direction of transcription is
indicated by an arrow.
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Figure S2. MLL-N and AF4 signals co-occupy at MLL-AF4 target genes in SEM cells
A. AF4 (red), MLL-N (black), and MLL-C (blue) composite ChIP-Seq density profiles for all
MLL-AF4 targets (left) and the top 500 expressed genes (right) in SEM cells.
B. AF4 (red), MLL-N (black), and MLL-C (blue) composite ChIP-Seq density profiles for all
MLL-AF4 targets (left) and the top 500 expressed genes (right) in REH cells
C. ChIP-Seq density heatmap of AF4 (red), MLL-N terminus (black) and MLL-C terminus
(blue) for all MLL-AF4 target genes in SEM cells. The genomic region from -5kb to +10kb
relative to the transcription start site of each gene is shown. Gene order is determined by highest
average MLL/AF4 read density from top to bottom. The start site and direction of transcription
of the genes are indicated by an arrow. Methods for generating composite profiles and for
identifying top 500 expressed and fusion target genes are described in detail in the Supplemental
Experimental Procedures section.
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Figure S3. Verification of MLL-AF4 fusion targets by HA-MLL-AF4 ChIP
A. Schematic diagram of experimental verification of MLL-AF4 targets .Chromatin
immunoprecipitation and gene-specific PCR were performed in SEM cells electroporated with
constructs expressing either HA-tagged MLL-AF4 or HA-control vector. Cells were collected
30 hrs after electroporation, crosslinked, and ChIP was performed using an antibody against HA
(Roche 3F10).
B. Site-specific quantitative PCR analysis of HA-MLL-AF4 chromatin immunoprecipitations or
HA-Control (HA-CNL) immunoprecipitations. This analysis confirmed that genomic regions
incorporated the tagged MLL-AF4 fusion construct. Immunoprecipitated (IP) DNA was
compared to serial dilutions (100, 10 and 1 ng) of whole cell extract (WCE) DNA. Enrichment
ratios of target genes are normalized relative to beta-actin (ACTB) control.
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Figure S4. MLL-AF4 target genes define MLL-linked leukemia in vivo, hierarchical
clustering of all fusion protein target genes
Hierarchical clustering of relative expression levels of 169 transcripts occupied by MLL-AF4
fusion protein target regions. Comparisons were made across the SEM and REH cell lines and
132 peripheral blood samples of patients diagnosed with leukemia. Each row corresponds to a
gene that is bound by MLL-AF4 for which expression data was available. Each column
corresponds to a single gene expression microarray. For each gene, expression is shown relative
to the average expression level of that gene across all samples, with shades of red indicating
higher than average expression and green lower than average expression. Columns and rows
were ordered by unsupervised hierarchical clustering. A detailed description of data analysis
methods is provided in the Supplemental Experimental Procedures section.
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Figure S5. Wide domains of H3K4me3 and H3K79me2 in SEM cells are not due only to
high levels of expression
Composite ChIP-Seq density profiles for SEM (a) and REH (b) cells from -6kb to +6kb relative
to transcription start site. The start site and direction of transcription of the average gene are
indicated by an arrow. (Left) H3K4me3 (blue) and H3K79me2 (green) composite ChIP-Seq
density profiles for MLL-AF4 targets in each cell type. (Middle) H3K4me3 (blue) and
H3K79me2 (green) composite ChIP-Seq density profiles for all genes in each cell type. (Right)
H3K4me3 (blue) and H3K79me2 (green) composite ChIP-Seq density profiles for the top 500
expressed probesets in SEM (top) and REH (bottom) cells. Methods for generating composite
profiles and for identifying top 500 expressed and fusion target genes are described in detail in
the Supplemental Experimental Procedures section.
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Figure S6
SEM Cells
Pol li
ENL
Figure S6. The elongation factor ENL associates with Pol 11 and H3K79me2at MLL-AF4
targets
ChIP-chip enrichment for RNAP2, H3K4me3, H3K79me2, ENL, AF4, and MLL-N antibodies
across a 100 Kb region of the HOXA cluster in REH cells (left) and SEM cells (right). Individual
gene models within HOXA cluster are shown at bottom. H3K4me3 and H3K79me2 ChIPs were
normalized to total H3 ChIPs in each cell line.
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Figure S7. MLL-AF4 associates with ENL and pTEFb
Coimmunoprecipitation of MLL-AF4,ENL and the pTEFb component Cyclin TI in SEM cells
containing the MLL-AF4 fusion protein (left). Antibodies used for immunoprecipitation are
shown at top and all eluates were detected by immunoblot using anti-MLL, anti-AF4, or anti-
ENL antibodies. AF4,ENL and Cyclin TI do not coimmunoprecipitate with normal MLL, as
evident in analysis of the SEM cells and of control K562 cells (right). Note that normal AF4 does
not coprecipitate with MLL-AF4 and it's associated proteins, indicating that the fusion protein
does not recruit the entire normal AF4 complex (Bltoun et al. 2007), but rather the necessary
components (e.g. ENL and Cyclin TI).
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Appendix E
Supplemental Material for Chapter 6
CpG Island Structure Defines Polycomb/Trithorax Chromatin Domains
in Human ES and iPS Cells
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Supplemental Experimental Procedures
Cells and cell culture
The human induced pluripotent stem (iPS) cell line M2 3 F was derived as described previously
(Soldner et al. 2009) and was maintained on mitomycin C-inactivated mouse embryonic
fibroblast (MEF) feeder layers in hESC medium (DMEM/F12 [Invitrogen] supplemented with
15% FBS [Hyclone], 5% KnockOut Serum Replacement [Invitrogen], 1 mM glutamine
[Invitrogen], 1% nonessential amino acids [Invitrogen], 0.1 mM p-mercaptoethanol [Sigma], and
4 ng/ml FGF2 [R&D Systems]). Cultures were passaged every 5 to 7 days either manually or
enzymatically with collagenase type IV (Invitrogen; 1.5 mg/ml). The hiPS cell line M2 3 F was
passaged 15-25 times prior to ChIP-Seq analysis.
Information about cells and cell culture for human ES cell lines, WIBRI, WIBR2,
WIBR3, and WIBR7, human iPS cell lines, iPS PDB"ox-17puro-5, and iPS PDB" x-21puro-26,
primary human fibroblast cells, GM-M01660 (Guenther et al., 2010), human fetal lung fibroblast
cells, IMR90(GEO accession number GSM469970), and human primary CD4+ T cells (Barski et
al., 2007) was described previously.
Chromatin immunoprecipitation
Protocols describing chromatin immunoprecipitation (ChIP) materials are freely available on the
internet (http://web.wi.mit.edu/young/hESPRC) and have been described previously in detail
(Lee et al. 2006).
Cells were grown to a final count of ~5x 1 07 to obtain starting material for six chromatin
immunoprecipitations. Cells were chemically cross-linked by the addition of one-tenth volume
of fresh 11% formaldehyde solution for 15 minutes at room temperature. Cells were rinsed twice
with IX PBS, harvested by centrifugation, and flash frozen in liquid nitrogen. Cross-linked cells
were stored at -80'C prior to use.
Cells were re-suspended, lysed and sonicated to solubilize and shear cross-linked DNA.
Sonication was performed using a Misonix Sonicator 3000 at a power of 27 watts for ten 30
second pulses with a 90 second pause between each pulse. Samples were kept on ice at all times.
The resulting whole cell extract was incubated overnight at 4 degrees C with 10pl of
Dynal Protein G magnetic beads that had been pre-incubated with approximately 3 pg of the
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appropriate antibody. Each individual immunoprecipitation used 1/6 of the 3ml total, or ~8 x106
cells per IP. The immunoprecipitation was allowed to proceed overnight. Beads were washed
three times (3 x 1.5ml) with RIPA buffer and one time (lx 1.5ml) with TE containing 50 mM
NaCl. Bound complexes were eluted from the beads by heating at 65 degrees C with occasional
vortexing and cross-linking was reversed by overnight incubation at 65 degrees C. Whole cell
extract DNA reserved from the sonication step was also treated for cross-link reversal.
Immunoprecipitated DNA and whole cell extract DNA were then purified by treatment with
RNAse A, proteinase K and two phenol:chloroform:isoamyl alcohol extractions.
The ChIP antibodies used were ab8580 (Abcam) for H3K4me3 and ab6002 (Abcam) for
H3K27me3.
ChIP-Seq sample preparation and Solexa sequencing
All protocols for Illumina library preparation and sequencing are provided by Illumina
(http://www.illumina.com/). A brief summary of the technique, minor protocol modifications,
and data analysis methods are described below.
Purified ChIP DNA was prepared for sequencing according to a modified version of the
Illumina Genomic DNA protocol. Approximately 50-200ng of IP DNA was ligated to a 1:100
dilution of the Illumina Adaptor Oligo Mix. After 18 cycles of PCR amplification library
fragments between 150-300bp were purified on a 2% agarose gel. Between 4-6 pmoles of DNA
library was applied to each lane of the flow cell and sequenced on Illumina GAII sequencers
according to standard Illumina protocols. Images acquired from the Genome Analyzer were
processed through the bundled image extraction pipeline.
Public availability of ChIP-Seq data
Complete H3K4me3 and H3K27me3 ChIP-Seq data for the M2 3F iPS cell line has been submitted to
the Gene Expression Omnibus database (http://www.ncbi.nih.gov/geo/).
Previously published ChIP-Seq datasets
ChIP-Seq data from human ES cell lines WIBR1, WIBR2, WIBR3, and WIBR7, human iPS cell
lines iPS PDB" o-17puro-5, and iPS PDB" x-21puro-26, and from primary human fibroblast
cells GM-MO1660 were obtained from the GEO database accession number GSE22499
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(Guenther et al., 2010). ChIP-Seq data from human lung fibroblast IMR90 cells were obtained
from the GEO database accession number GSM469970. ChIP-Seq data from human primary
CD4+ T cells were obtained from were obtained from the authors directly (Barski et al., 2007).
Genomic mapping of ChIP-Seq data
ChIP-Seq reads were aligned using the software Bowtie (Langmead et al., 2009) to NCBI build
36.1 (hgl8) of the human genome with default settings. Sequences uniquely mapping to the
genome with zero or one mismatch were used in further analysis. In the cases where multiple
reads mapped to the same position and strand all beyond the first two were discarded.
ChIP-Seq density calculation
The genome was divided into bins 25 base pairs in width, beginning at the first base of each
chromosome. Each mapped ChIP-Seq read was shifted 100 bp from its mapped genomic
position and strand to the approximate middle of the sequenced DNA fragment. Subsequently,
the ChIP-Seq density within each genomic bin was calculated as the number of ChIP-Seq reads
mapping within a 1kb window (+/- 500bp) surrounding the middle of that genomic bin.
Identification of genes occupied by H3K4me3 and H3K27me3
The genomic coordinates of the full set of transcripts from the RefSeq database
(http://www.ncbi.nlm.nih.gov/RefSeq/) from the March 2006 version of the human genome
sequence (NCBI Build 36.1, hgl8) was downloaded from the UCSC Genome Browser
(http://genome.ucsc.edu/cgi-bin/hgTables) on September 1, 2010.
For each RefSeq gene the peak ChIP-Seq density in the region +/-1 kb around the
transcription start site (TSS) for H3K4me3 and +/- 25kb around the TSS for H3K27me3 was
examined. A gene was considered to be occupied by H3K4me3 or H3K27me3 if the peak ChIP-
Seq density in this region was greater than a defined threshold (defined below) and the ratio of
specific IP to background signal at this position was greater than 3. Two different thresholds
were used in each experiment to call H3K4me3 and H3K27me3 occupied genes at both high and
low confidence. Since the ChIP and sequencing efficiencies were different for each experiment,
appropriate thresholds were different for each dataset. The total number of ChIP-Seq reads used
from each experiment as well as the high and low confidence thresholds are reported (Table S1).
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A gene was considered differentially occupied by H3K4me3 or H3K27me3 between two
experiments if it was called occupied at high confidence in one experiment and was not called
occupied at low confidence in the other experiment. We examined only autosomal genes, since
iPS cell lines exhibit varying degrees of X-inactivation and H3K27me3 occupancy of the X-
chromosome. A summary of the genes occupied by H3K4me3 and H3K27me3 in each cell line
is provided (Tables S2A and S2B).
Identification of CpG islands and assignment to genes
The base composition criteria that were originally used to define CpG inlands (Gardiner-Garden
and Frommer, 1987) were created long before the complete sequence of the genome was known.
Since then, new definitions have been developed, which offer greatly enhanced sensitivity and
specificity in the genome-wide identification of CpG islands (Takai and Jones, 2002; Ponger et
al., 2002; Hackenberg et al, 2006; Glass et al., 2007; Wu et al., 2010).
We used a modified version of these methods optimized to provide the greatest
sensitivity and specificity in comparing CpG island positions to ChIP-Seq datasets. We
tabulated the local CG dinucleotide frequency in a 1 kb. window (+/- 500bp) at every position in
the genome. CG dinucleotides in protein coding regions of the genome were excluded.
Scanning the genome in 25 bp. bins, using the CG frequency at the middle position of each bin,
we identified bins in which the CG frequency was greater than or equal to 4.6%. Adjoining bins
were collapsed into regions and regions that were less than 300 bp. in length were excluded.
This method identifies 42,371 CpG islands in the NCBI build 36.1 (hgl8) of the human genome
(Table S2C).
In order to assign CpG islands to genes, the following method was used. The genome
was scanned and CpG islands within 4 kb. of one another were merged into CpG island clusters.
Most of these CpG island clusters consisted of only one CpG island, but there were several
thousand clusters of multiple CpG islands. If a CpG island cluster overlapped with the
transcription start site (+/-1 kb.) of a gene all CpG islands in that cluster were assigned to that
gene. A summary of the number of CpG islands for every gene is provided (Table S2D).
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Gene ontology analysis
For gene ontology analysis ChIP-Seq results from the human ES cell line WIBR2 were used.
Gene ontology analysis was performed using the online tool DAVID
(http://david.abcc.ncifcrf.gov/; Huang et al., 2009). A summary of the genes annotated as
encoding regulators of development and homeobox transcription factors is provided (Table S3).
Analysis of RNA secondary structure
For each gene, the sequence +/- 5kb around the TSS was analyzed for sequences which may
form the characteristic CG rich, PcG recruiting, hairpin structure (Wutz et al., 2002; Zhao et al.,
2008). A 28bp window was slid across each sequence in lbp increments and for each window
the minimum free energy of that sequence folding into the structure shown in Figure 2A was
calculated using rnaEval (Hofacker et al., 1994). In order to account for the possibility of the
hairpin forming transcript being generated from transcription of either strand and/or in either
direction, the free energy was calculated for four different sequence/structure pairs: the 28bp
sequence and its reverse complement were compared to the structure in Figure 2A as well as its
mirror image (with the smaller loop on the left). The minimum free energy of those 4
combinations was used as the free energy for that window. Windows with a GC mononucleotide
content of at least 50% and a minimum free energy at or below -5 kcal/mol were counted as a
potential PcG recruiting hairpin sequence. A summary of the number of hairpin hits for each
gene is provided (Table S2D).
The fold enrichment shown in Figure 2B and 2C, is a measure of the enrichment of genes
with a particular range of potential hairpin hits versus the expected number of genes. As an
example of how this is calculated, consider the calculation for the fold enrichment of genes with
15-20 hairpin hits in the multiple CpG class. First we calculate the percentage of multiple CpG
genes with between 15 and 20 possible hairpins, ~15%. Then, we calculate the percentage of all
genes with this range of hairpin hits, ~8%. The fold enrichment for 15-20 hairpin hits in the
multiple CpG class is then simply the observed percentage divided by the expected percentage,
or 15/8, for a fold enrichment of ~1.9. This calculation was done for each RNA hairpin range in
each gene class.
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Figure Si. CpG island structure and ES cell TrxG/PcG chromatin structure in the four
human Hox gene clusters.
For each of the four human Hox gene clusters H3K27me3 and H3K4me3 ChIP-Seq density in
the hES cell line WIBR2, local CG dinucleotide density, and CpG islands are shown.
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Supplemental Tables
Table Si: Summary of ChIP-Seq experiments and datasets. The number of ChIP-Seq reads
is for each ChIP-Seq experiment and the high and low confidence thresholds for
H3K4me3 and H3K27me3 occupancy for each experiment are provided.
Table S2: H3K4me3 and H3K27me3 occupancy in all cells, the number of CpG islands, and
the number of RNA hairpin hits for all genes are provided. The genomic
coordinates of all CpG islands are also provided.
E) H3K4me3 occupancy for every gene
F) H3K27me3 occupancy for every gene
G) Genomic coordinates of all CpG islands
H) The number of CpG islands and RNA hairpin hits for every gene
Table S3: The number of CpG islands for genes annotated as homeobox transcription
factors and as development regulators.
A) The number of CpG islands for genes annotated as homeobox transcription
factors
B) The number of CpG islands for genes annotated as development regulators
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